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 ABSTRACT 
This thesis presents an investigation of non-contact remote pulse oximetry and 
photoplethysmography. A thorough description is given of the technique of pulse 
oximetry along with some physiological effects and some characteristics of light-
tissue interaction that underlie pulse oximetry. A device is then described that is 
capable of capturing two photoplethysmograph (PPG) signals simultaneously in a 
multiplexed fashion. The device is comprised of a complementary metal oxide 
semiconductor (CMOS) camera and a dual wavelength array of light emitting diodes 
(LEDs) (760 nm and 880 nm). By alternately illuminating a region of tissue with 
each wavelength of light and detecting the backscattered light with the camera at a 
rate of 16 frames per second per wavelength, two PPG signals are simultaneously 
captured. This process forms the basis of pulse oximetry. A methodical investigation 
of the comparability of the camera-based device with a conventional clinical contact 
device is presented. The camera-based device is demonstrated to provide a 
comparable PPG waveform and measure of pulse rate and a description is given of 
how, with the inclusion of a calibration procedure, such a device could be used to 
estimate arterial oxygen saturation (SpO2). Some aspects of PPG signal acquisition 
that are unique to a camera-based device are highlighted and camera-based capture 
is shown to introduce both tractable complications and the potential for additional 
utility beyond that of a conventional contact device. Additionally this thesis 
describes a concept for camera-based reflection tomography with the potential to 
yield structural information about shallow vasculature and tissue morphology. 
Lastly this thesis describes areas of further work in relation to the development of 
clinically useful camera-based pulse oximetry, and areas of further research 
concerning the potential of camera-based photoplethysmography as an investigative 
tool.  
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CHAPTER 1  
 
INTRODUCTION 
 
 
 
Equation Chapter 1 Section 1 
It is fair to say that pulse oximetry has, since its invention in the nineteen seventies, 
revolutionised anaesthesia and critical care. The technique provides a robust and 
non-invasive means of accurately estimating arterial oxygen saturation—which is 
the amount of oxygen that arterial blood is carrying compared to the amount it 
could carry, expressed as a percentage. The provision of an estimate of arterial 
oxygen saturation yields a critical insight into the health and well being of a patient 
and provides a useful addition to the accepted four vital signs: heart rate, blood 
pressure, respiration rate, and temperature.  
The technique of pulse oximetry is based on near infrared (NIR) spectroscopy 
and requires capturing at least two photoplethysmograph (PPG) signals at two 
different wavelengths of light—a photoplethysmogram being a trace of the 
peripheral arterial pressure waveform obtained by optical means. The ability to 
capture and display a PPG signal as well as to derive the pulse rate has greatly 
extended the clinical and investigative usefulness of pulse oximeters, which today 
are employed in many diverse applications.  
Pulse oximeters originally operated by transmission of light through small 
extremities typically fingers, ear lobes, the bridge of the nose, and less commonly 
the toes. Such locations are easily accessible but in the case of fingers and toes, 
suffer from the disadvantage that in cases of trauma, surgery, shock, and 
hypothermia (or even mild cold), the circulation to the peripheries is immediately 
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reduced, making pulse oximetry difficult or impossible. Sensors were soon 
developed that operated using diffuse reflected light, making possible measurement 
from any part of the body surface, and in the process further extending the 
applications of pulse oximetry and photoplethysmography. 
This thesis describes an investigation of both the feasibility and practicalities 
of remote non-contact pulse oximetry, specifically a camera-based embodiment. It 
is hoped that such capabilities might further extend the uses of the technique. 
1.1 MOTIVATION 
Pulse oximetry and photoplethysmography are currently employed in a wide variety 
of applications, in routine and critical clinical applications, and in surgical, inves-
tigative, diagnostic, and experimental applications. A key factor in the emergence of 
so many applications was the development of reflectance-based probes that made 
measurement possible from any point on the body surface. However many more 
application have arisen that required the development of specialised probes, 
including: probes to monitor mother and child during child birth, probes to be used 
endoscopically during surgery, probes to fit in a pilot’s ear during aircraft testing, 
probes to interface with the eye to measure retinal profusion, and many more 
besides including ambulatory probes and probes for sports research (see the later 
discussion of pulse oximetry applications in Section 3.4.3).  
The development of non-contact capabilities might make possible and 
practical new applications of pulse oximetry and photoplethysmography. Applica-
tions already exist that might benefit from non-contact pulse oximetry. For example, 
the use of pulse oximeters (or any metal wire) in conjunction with magnetic 
resonance imaging (MRI) can result in serious burns to the patient (Dempsey and 
Condon 2001; Nakamura, et al. 2001). There also exist applications where it is 
undesirable to make contact with the patient, such as sleep studies, patients in 
isolation units, immunosuppressed patients susceptible to infection by cross-
contamination, and burns patients.  
Pyrometers and camera-based technologies already exist capable of non-
contact temperature measurement. Conventional pulse oximeters provide an 
estimate of arterial oxygen saturation, as well as pulse rate and potentially 
respiration rate. If non-contact pulse oximeter functionality were to be achieved, but 
2 
Introduction 
for the illusive non-contact measurement of blood pressure, non-contact vital signs 
monitoring would be a realistic goal. 
The ability to monitor a patient’s vital signs by non-contact means is a 
tantalising prospect, and would likely be well received in both surgical and clinical 
monitoring environments where efforts are already underway to minimise the 
amount of cabling and clutter currently associated with patient monitoring. Indeed 
non-contact vital signs monitoring and non-contact respiration monitoring using 
microwave radar are topical areas of research (Lohman, et al. 2002; Matsui, et al. 
2006; Uenoyama, et al. 2006).  
1.2 OBJECTIVES 
The broad objective of this thesis is to investigate the feasibility of non-contact 
pulse oximetry. The functionality that a conventional pulse oximeter possesses 
(which will be established in Chapter 3) includes the ability to estimate arterial 
oxygen saturation, display a trace of the peripheral arterial pressure waveform, and 
measure the pulse rate from that waveform. Thus it is necessary to investigate the 
feasibility of comparably replicating these functions by non-contact means.  
In pursuing this objective a camera-based approach is adopted. Thus a further 
objective of this thesis is to investigate what, if any, complications or limitations are 
introduced by a camera-based embodiment of a pulse oximeter? The complement to 
this objective is to identify any additional utility that a camera-based device might 
possess, beyond that of a conventional contact device.  
Having adopted a camera-based approach, a secondary objective of this thesis 
is to highlight any potential that camera-based devices might offer in NIR or optical 
investigations of tissue beyond their current application in tissue oximetry and their 
application here in determining arterial oximetry.  
1.3 CONTRIBUTIONS OF THIS THESIS 
The primary contribution of this thesis is the description of a device and method 
that resulted in the first demonstration of the simultaneous capture of two PPG 
signals at different wavelength, by remote non-contact means, from deep tissue and 
from a range of subjects, under realistic environmental and lighting conditions. The 
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subsequent analysis of the device’s performance and the demonstration of its 
comparability with a conventional device collectively establish the feasibility of 
(camera-based) non-contact pulse oximetry. 
Beyond the investigations of feasibility and comparability, an investigation is 
presented of some aspects of non-contact and camera-based pulse oximetry and 
photoplethysmography that are unique to a camera-based device. These analyses 
highlight previously unreported phenomena that allude to the complications and 
also the potential additional investigative capabilities of a camera-based device. 
Important necessary conditions are established pertaining to the choice of 
illumination pattern, which if neglected undermine the assumptions upon which the 
technique of pulse oximetry is based.  
A concept for camera-based tomography is described that highlights new 
avenues of research for camera-based NIR and optical investigations of tissue. 
1.4 OUTLINE OF THESIS 
This thesis is composed of six subsequent chapters, the subjects of which are 
outlined here. 
Chapter 2 establishes information pertaining to the physiology and anatomy of 
blood oxygen transportation. This information has importance later in the 
discussion of pulse oximeter operation, limitations, and accuracy. Chapter 2 also 
establishes the fundamentals of the Beer-Lambert law and Beer-Lambert based 
spectroscopy, of which pulse oximetry is a special case. Lastly Chapter 2 describes 
a Monte Carlo simulation of photon migration in tissue. The simulation is used in 
Chapter 2 to illustrate the path of light travelling through a turbid medium 
simulating tissue; knowledge of this path is later used to explain the operation of 
reflectance pulse oximetry (Chapter 3), to provide the rationale for certain design 
decisions pertaining to the non-contact device (Chapter 4), and to hypothesise the 
cause of some phenomena observed during non-contact photoplethysmography 
(Chapter 5). The Monte Carlo simulation is re-employed later in Chapter 5 to 
simulate the effect of tissue-detector separation on the received light intensity. 
Chapter 3 provides a compendious description of pulse oximetry including the 
history of the technique, its principles of operation, the practicalities of its impleme-
ntation, and a discussion of its applications and limitations. As such Chapter 3 
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provides the constraints, specifications, and objectives for the design of a non-
contact device. 
Chapter 4 describes design considerations pertaining to the source and 
detector. For the source these primarily include wavelength, bandwidth, and 
permissible exposure limits. The detector is ultimately chosen to be a digital camera 
and the discussion in Chapter 4 is concerned with establishing the desirable 
characteristics of the camera’s sensor and choosing between the two available 
technologies, charge coupled devices (CCD) and complementary metal oxide 
semiconductors (CMOS). 
Chapter 5 provides a description of the non-contact camera-based device for 
remote pulse oximetry and photoplethysmography. A detailed account is given of 
the device’s design, construction, operation, and performance. An examination of its 
comparability with a conventional contact device is presented along with an 
investigation of some aspects of photoplethysmography that are unique to a camera-
based implementation. Some further aspects of the device’s performance are 
investigated by simulation. 
In Chapter 6 the topic of discussion changes and a concept for camera-based 
diffuse optical or NIR tomography is described. The discussion is intended to 
highlight the potential of camera-based NIR and optical investigations of tissue. 
The thesis is concluded in Chapter 7 with a review of the arguments and 
findings and resulting contributions, as well as a discussion of areas for future work, 
both in further research and in the development of clinically useful devices. 
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CHAPTER 2  
 
SCIENTIFIC BACKGROUND 
 
 
 
Equation Chapter 2 Section 1 
The desire to monitor the oxygenation of body tissues or of the blood is motivated 
by the importance of oxygen to life. The motivation to measure the oxygenation of 
both tissue and blood by near infrared spectroscopy (NIRS) stems from the 
suitability of NIRS to safe, accurate, and non-invasive monitoring, of which much is 
said later in relation to pulse oximetry. NIRS is made possible by several fortuitous 
happenstances: tissue is relatively transparent to both red and near infrared light; an 
important respiratory molecule, haemoglobin, exhibits a useful oxygen dependent 
change in absorption over the same wavelength range; and the diffuse scattering of 
light over this range by tissue makes possible the detection of backscattered light—
facilitating local tissue oxygenation and arterial oxygen saturation measurement 
from any point on the body surface—and as this thesis advances, facilitates arterial 
oxygen saturation measurement from beyond the body’s surface. (Appended to this 
list of fortuities should be the abundance of suitable silicon-based near infrared 
sources and detectors.) The discussion that follows in this thesis, the rationale for 
the methods employed here and the analysis of the operation of the resulting device, 
as well as the concept for a camera-based tomography system, are based on these 
premises, and this chapter is intended to act as a primer for that discussion.  
Specifically this chapter has three purposes. first a basic description of the 
physiology and anatomy of oxygen transportation in the body is given. This 
discussion highlights both the importance and the mechanism of maintaining a 
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sufficient oxygen supply to body’s tissues, and in so doing hints at the motivation 
for, and means by which, arterial oxygen saturation can be measured—which is the 
subject of Chapter 3. Second this chapter is intended to provide a thorough 
discussion of the modified Beer-Lambert law that describes light attenuation in 
tissue, and upon which near infrared spectroscopy is based. Third the scattering of 
light in tissue is described and with the aid of a Monte Carlo simulation, the arced 
path of light travelling between two points on the tissue surface is illustrated, the 
profile of this path is a key presupposition in the development of a non-contact 
pulse oximeter and in explaining signals observed using such a device, as well as 
the concept of camera-based tomography described in Chapter 6. Additionally the 
Monte Carlo simulation, though it is employed here only as an illustrative tool, is 
reapplied in Chapter 5 as an investigative tool to characterise the effect of tissue-
detector separation. 
2.1 OXYGEN TRANSPORTATION 
Oxygen is addicting; in its grip are all the mitochondria-rich 
eukaryotes that learned to depend on it during the past 1.4 
billion years. This, the first atmospheric pollutant, is the waste 
product of stromatolites (formations of algal plankton), which 
excreted it at least 2.3 billion years ago. Since then, all 
sediments have been rusted or oxidized. Oxygen is toxic. It 
rusts a person in a century or less. With oxygen came the 
danger, and the blessing, of fire. If introduced today, this gas 
might have difficulty getting approved by the Food and Drug 
Administration.  
(Severinghaus 1987a) 
At sea level the pressure of air is defined as 1 atmosphere (1 atm), or 760 mmHg in 
a mercury barometer, or 101.3 Pascals (Pa) (that is 101.3 N/m2) in the international 
system of units. Dalton’s law of partial pressures states that the total pressure 
exerted by a gaseous mixture is equal to the sum of the partial pressures of the 
individual gases comprising the mixture. Under normal conditions oxygen accounts 
for approximately 21% of air and so has a partial pressure (PO2) of 0.21 atm 
(21.3 Pa or 159.6 mmHg). 
Air is drawn into the body by the mechanical actions of the lungs and 
respiratory muscles, under the control of respiratory neurons on the brain stem. 
Once in the lungs, oxygen from the air, diffuses across the thin boundary formed by 
the walls of the alveoli, into the oxygen depleted blood returning from supplying 
oxygen to the body’s tissues. The oxygenated blood leaves the lungs and is 
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distributed by the arteries around the body. Although the arterial blood passes tissue 
in need of oxygen, diffusion—also the mechanism by which oxygen is passed 
between the blood and tissue—can only take place over distances of about 1 mm, 
so the arterial blood loses no oxygen at this point. Arteries branch off into smaller 
arteries and eventually into arterioles, the walls of which are only one cell thick. At 
this point oxygen from the blood in the arterioles diffuses into the tissue, while 
CO2, the waste product of respiration, diffuses back into the blood. The arterioles 
meet with venules (which collectively form the capillaries), through which the now 
deoxygenated blood makes it way back into the veins and back towards the lungs to 
expel its CO2 and acquire more O2.  
Blood is composed of about 50% liquid (plasma). Under normal circum-
stances, Henry’s law describes the amount of gas that can be dissolved in a liquid at 
a given temperature, and that amount is directly proportional to the gas’s partial 
pressure. If oxygen dissolved in blood plasma were the only mechanism by which 
the blood could transport oxygen around the body, then the plasma would need to 
be circulated around the body about twenty times faster, just to meet the needs of a 
resting body. The blood however has a much more efficient means of delivering 
oxygen around the body: haemoglobin.  
Haemoglobin is a respiratory molecule found on red blood cells 
(erythrocytes). Each erythrocyte has approximately 265 million haemoglobin 
molecules, and each haemoglobin molecule is capable of bonding with four oxygen 
molecules (Curtis and Barnes 1989). Haemoglobin can typically carry 19 ml of O2 
per 100 ml of blood, which is about sixty five times that which could be carried 
dissolved in the plasma alone (Clark 1997).  
When a completely deoxygenated haemoglobin molecule obtains its first 
oxygen molecule, its affinity for oxygen increases, as it does again with the 
acquisition of each subsequent molecule, until it is saturated. The same is true of the 
reverse process. This characteristic of haemoglobin gives a sigmoidal shape to the 
haemoglobin dissociation curve, which relates haemoglobin oxygen saturation (the 
ratio of haemoglobin molecules with four attached O2 molecules, to all other 
haemoglobin molecules) to oxygen partial pressure, PO2. Figure 2.1 illustrates the 
profile of the haemoglobin oxygen dissociation curve, generated using Kelman’s 
formula (1966), 
 
2 3 4
1 2 3 4
2 2 3
4 5 6 7
O ( )
a x a x a x a x
S x
a a x a x a x x
+ + += + + + + 4 . (2.1) 
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SO2 is the oxygen saturation of haemoglobin, the variable x represents the oxygen 
partial pressure, and ai are constants defined by Kelman (1966). 
 
Figure 2.1 Haemoglobin oxygen dissociation curve, generated using the 
equation described in Kelman (1966). Partial pressure of oxygen is 
indicated in atmospheres (top axis) and millimetres of mercury (bottom 
axis). 
Figure 2.1 shows the normal dissociation curve, that is, for a blood pH of 7.4, 
carbon dioxide partial pressure (PCO2) of 40 mmHg, and a temperature of 37 °C. A 
change is any of these parameters, or a change in the concentration of phosphates in 
the blood, will cause the dissociation curve to shift (Moyle 1994). Decreasing 
PCO2 or temperature, or increasing pH, will cause the curve to shift to the left, 
resulting in haemoglobin becoming saturated at lower oxygen partial pressures. A 
change to the contrary in any of these parameters causes the curve to shift to the 
right. A left-shifted curve, increases haemoglobin’s affinity for oxygen, which aides 
in the uptake of oxygen from the environment but impairs tissue oxygenation—
since for the same pressure gradient, less oxygen will diffuse from the blood into 
the tissue. Fetal haemoglobin has this left-shifted dissociation curve compared to 
adult haemoglobin, that facilitates obtaining oxygen from the mother but prevents 
too high an oxygen saturation in the foetus itself, which can be harmful. When 
breathing an insufficient quantity of oxygen to meet the cellular demand, at high 
altitudes for example, some cells will switch their metabolism to anaerobic 
pathways, causing an increase in lactic acid production, resulting in an increase in 
plasma pH (Moyle 1994). The increasing pH causes a left shift of the dissociation 
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curve, making the situation worse. A right-shifted curve, conversely, results in 
decreased affinity, but better facilitates oxygen delivery (Clark 1997). 
The actual partial pressure of oxygen present in the alveoli, PAO2 is less than 
the ambient oxygen partial pressure of the environment. It is a function of water 
vapour partial pressure, and of the arterial carbon dioxide partial pressure PaCO2. 
The alveolar oxygen partial pressure is given by, 
 
2
2
2
A 2 ambient H O i 2 a 2
Vol. CO  produced
O O CO
Vol. O  consumed
( )P P P F P= − − × , (2.2) 
where FiO2 is the fraction oxygen in the inspired air. 
John Scott Haldane, a noted physiologist (and the pioneer of diving decom-
pression theory) commented that lack of oxygen stops the machine and wrecks the 
machinery. The response of individuals to an insufficient supply of oxygen 
(hypoxia) varies with age and fitness. Within the body the response times of 
individual tissues and organs also vary. Damage to the cerebral cortex occurs about 
one minute after the cessation of oxygen supply to it, the liver and kidneys about ten 
minutes, and skeletal muscle about two hours (Moyle 1994). J.F. Nunn (1987) thus 
modified Haldane’s quote to , lack of oxygen stops the machine and then wrecks the 
machinery.  
Haemoglobin has another important property from the point of view of blood 
oxygen measurement: the colour of haemoglobin changes when it acquires four 
oxygen molecules. Georg Gabriel Stokes first reported that the coloured substance 
in blood was the oxygen carrier in 1864. Felix Hoppe-Seyler later crystallised the 
pigment and coined the name haemoglobin (Hb). Hoppe-Seyler observed that when 
a solution of haemoglobin was exposed to air, it formed a dissociable bond with 
oxygen, and named this compound oxyhaemoglobin (HbO2). Hoppe-Seyler further 
observed that Hb was responsible for the absorption of blue and green bands of the 
solar spectrum. This is why oxygenated blood appears bright red while 
deoxygenated blood appears blue, however a more useful change in the absorption 
spectrum of Hb occurs in the near infrared portion of the spectrum (see Figure 3.7) 
where tissue is translucent—and this facilitates in vivo spectrometry and ultimately 
pulse oximetry.  
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2.1.1 DYSHAEMOGLOBINS AND FETAL HAEMOGLOBIN 
Oxygen (O2) is not the only molecule with which haemoglobin can bind, nor is 
oxygen the only binding agent with which haemoglobin forms a compound that is 
absorptive of red and near infrared light. A brief description is given here of the 
other common compounds that haemoglobin forms in blood. They are of relevance 
to oxygen transportation as these forms of haemoglobin are not able to supply 
oxygen (dyshaemoglobins), and will later be seen to be of importance in deter-
mining the accuracy of blood oxygen measurements (see Section 3.4.1).  
2.1.1.1 CARBOXYHAEMOGLOBIN (COHB) 
Carbon monoxide (CO) can also form a bond with haemoglobin to produce a 
compound Carboxyhaemoglobin (COHb), indeed the affinity of Hb for CO is about 
two hundred times greater than for O2. Once bound with haemoglobin however, 
because of its high affinity, carbon monoxide does not easily relinquish the 
haemoglobin molecule. From the point of view of oxygen transportation, COHb has 
the effect of reducing the ability of the blood to carry and supply oxygen.  
Haemoglobin bound with carbon monoxide has much higher absorptivity at 
red wavelengths of light than haemoglobin by itself, and even more so than 
haemoglobin bound with oxygen. From the point of view of oximetry, COHb levels 
in excess of those used in calibration (typically < 2% of the total haemoglobin) can 
cause a large error in the oximetry reading, the cause of which may not be 
immediately apparent to a user—victims of smoke inhalation, urban dwellers, and 
indeed heavy smokers can fall into this category (Clark 1997; Moyle 1994; Seidler, 
et al. 1993; Tungjitkusolmun 1997). 
2.1.1.2 METHAEMOGLOBIN (METHB) 
Methaemoglobin does not result from the binding of haemoglobin with another gas 
molecule, but rather, is haemoglobin that has been oxidised, that is, haemoglobin 
that has lost an electron, and as a result is no longer capable of binding with oxygen. 
The process can be described as, 
 2 3HbFe HbFe e+ +⇔ −+ . (2.3) 
Unlike COHb, MetHb occurs naturally and an enzyme system exists for 
maintaining haemoglobin in its reduced state (HbFe2+). Under normal circum-
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stances MetHb accounts for less that 0.6% of total haemoglobin, though the 
concentrations varies during the day (Tungjitkusolmun 1997). Its effect on pulse 
oximetry accuracy is generally less problematic than that of COHb, since MetHb 
tends to produce an under estimation of blood oxygen content (Moyle 1994), 
though its effects are difficult to quantify, since its absorption spectrum is strongly 
pH dependent (Bunn 1986). 
2.1.1.3 SULFHAEMOGLOBIN 
The irreversible reaction of oxyhaemoglobin and hydrogen sulfide produces 
sulfhaemoglobin. Sulfhaemoglobin has little effect on oxygen transport as its 
affinity for oxygen is about one hundred times less than that of unmodified 
haemoglobin. The absorption spectrum of sulfhaemoglobin is unreported upon, and 
hence its effects on the accuracy of pulse oximetry are not quantifiable. It is not 
included in pulse oximetry calibration calculations, though its concentrations in 
human blood are thought to be sufficiently low as to be insignificant (Clark 1997). 
2.1.1.4 FETAL HAEMOGLOBIN 
Fetal haemoglobin has a different oxygen dissociation curve compared to normal 
adult haemoglobin, appropriate to foetal oxygen requirements. It is gradually 
replaced by adult haemoglobin during the first ten to twelve weeks of life. Its 
production can be activated pharmacologically in later life, which is useful in the 
treatment of diseases such as sickle-cell disease. It has a different absorption 
spectrum to adult haemoglobin, the effects of which are not included in pulse 
oximetry calibration techniques. 
2.2 LIGHT ABSORPTION AND SCATTERING IN TISSUE 
This section describes the long established laws and observations that govern the 
absorption and scattering of light in biological tissue and form the basis of all near 
infrared spectroscopic techniques, of which pulse oximetry is a special case.  
12 
Scientific Background 
2.2.1 LIGHT ABSORPTION IN TISSUE—THE BEER-LAMBERT LAW 
Layers of a substance of equal thickness each absorb the same fraction of an 
incident beam of light. Thus in a medium consisting of three layers, if the first 
absorbs ½ of the incident light, the second will absorb ½ the remaining light, as will 
the third layer, and only ⅛ of the incident light will emerge from the third layer. 
This law, derived in the 18th century, is commonly known as the Lambert-Bouguer 
law, and describes the logarithmic attenuation of light travelling through an 
absorbing medium. The Lambert-Bouguer can be written as, 
 010log
IA
I
=  
 . (2.4) 
The dimensionless term A is the light attenuation, given nominal units of optical 
density (OD), that indicates the order of magnitude of attenuation between the 
incident light I0 and the transmitted light I.  
In the 19th century August Beer derived a law stating that the optical density of 
a non-absorbing medium, with an absorbing substance dissolved in it, is 
proportional to the concentration of the absorbing substance. The combination of 
these two laws is commonly know as the Beer-Lambert law and can be written as  
 010log
IA
I
cdα = =   , (2.5) 
where α and c are respectively, the absorptivity1 and concentration of the absorbing 
substance, and d is the distance between the points where the light enters and exits 
the medium. 
In cases where there are multiple absorbing substances dissolved in a non-
absorbing medium, the combined attenuation due to all the absorbing substance is 
given by the sum of their individual contributions multiplied by the length of the 
path travelled by the light, that is, 
 [ ]1 1 2 2 ... n nA c c cα α α= + + + d
                                                
. (2.6) 
In a typical spectroscopic application, it is required to determine the 
concentrations of a certain number of substances each of which has a different 
absorptivity at different wavelengths. The absorptivity as a function of wavelength 
 
1 Note that α is more correctly the specific extinction coefficient (with units of  
µmolar-1 cm-1) and c the concentration in µmolar. The term absorptivity is used loosely 
here since no quantitative data are discussed. 
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is known for each absorber and the distance d can be measured. Then for different 
wavelengths of light the attenuation of the medium is measured experimentally. 
Provided the number of wavelengths used is at least equal to the number of 
absorbing substances, the concentrations of each of the substances can be found by 
solving the resulting set of simultaneous equations. 
This is the basic premise of all spectroscopic methods of determining tissue 
oxygen saturation. Tissue might seem apt to this model of attenuation: it is 
composed largely of water, which can be considered non-absorbing between 
wavelengths of 200 nm to 900 nm, compared to the absorbers (or chromophores) of 
interest, Hb and HbO2. However tissue is also a highly scattering medium. The 
effect of scattering is to increase the observed light attenuation between two points 
to a level far greater than can be attributed to absorption alone. Thus the Beer-
Lambert law alone is insufficient for determining the concentration of chromo-
phores in tissue. 
2.2.2 LIGHT ATTENUATION—THE MODIFIED BEER-LAMBERT LAW 
Of the observed attenuation by tissue between two points, absorption accounts for 
only about 20%, with scattering accounting for the remaining 80% (Elwell 1995). 
The Beer-Lambert law, equation (2.5), can be modified to take account of the 
effects of scattering by including an additive term G—the attenuation due to 
scattering, and a multiplicative term B—the differential path length factor, which 
when multiplied by the geometric distance d between the source and detector, 
accounts for the increase in optical path length caused by scattering. Thus the 
modified Beer-Lambert law can be written as 
 010log
IA
I
α  cdB G= = +   . (2.7) 
The scattering loss G is usually unknown and is dependent on the relative 
positions of the source and detector, and on the scattering coefficient of the tissue 
under investigation. As a result of the unknown term, the modified law cannot be 
used in the same way as the original law, to generate simultaneous equations 
yielding quantitative values for the sought concentrations. Instead the equation (2.7) 
is used in a differential form in which the scattering loss is considered to be constant 
for a given source and detector position. A measurement is made at a particular 
wavelength yielding attenuation A1 corresponding to concentration level c1. Some 
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time later, the concentration of the chromophore has changed to c2; another 
measurement is taken yielding attenuation A2. Provided the loss due to scattering 
(G), the geometric distance between source and detector (d ), and the differential 
path length factor (B), are the same for each measurement, the change in 
concentration ∆c = (c2 – c1) can be calculated as 
 2 1( )A A A c dBα∆ = − = ∆ . (2.8) 
For multiple chromophores measured at wavelength λ, the differential 
attenuation can be written as 
 [ ]1 1 2 2( ) ( ) ( ) ... ( ) ( )n nA c c c dBλ α λ α λ α λ λ∆ = ∆ + ∆ + ∆ , (2.9) 
where αn(λ) is the absorption of nth chromophore present in the medium measured 
at a wavelength λ, and where cn is the concentration of that chromophore in the 
medium. 
Now in a typical spectroscopic application, the values of absorptivity 
(α1(λ)…αn(λ)) are known, the geometric path length (d ) is measured or 
calculated, and the differential path length factor (B(λ)) and the change in 
chromophore concentration (∆c) remain unknown. Calculation of the differential 
path length factor is not trivial; two methods are described by Elwell (1995). The 
first is a time of flight technique that uses a laser capable of generating picosecond 
duration pulses and a streak camera capable of measuring the time of arrival of a 
pulse with great accuracy. The pulse from the laser is projected on a beam splitter. 
One of the resulting beams is directed to the camera via a series of mirrors forming 
a time reference. The second beam traverses a tissue sample en route to the camera. 
The difference in the time of arrival is measured and using the speed of light in a 
vacuum, the refractive index of tissue and the geometric distance, the differential 
path length factor is calculated. The second method described by Elwell uses an 
intensity modulated optical spectrometer. A laser beam is modulated and the phase 
difference between the light entering the tissue and exiting the tissue is measured. 
This time, using the speed of light in a vacuum, the refractive index of tissue, the 
modulation frequency, and the measured phase difference, the differential path 
length factor is calculated. 
By measuring the differential attenuation at least at as many wavelengths as 
there are chromophores, a set of equations can be constructed, which can be solved 
simultaneously, to yield the time varying, relative change, in each of the 
chromophores’ concentrations. Though this does not yield the quantitative values 
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for the concentration of individual chromophores, as the unmodified Beer-Lambert 
law purported to do, the changes in chromophore concentrations over time are 
useful nonetheless, and form the basis of many spectroscopic investigations of 
tissue oxygenation and tissue oxygen consumption. See for example Cope (1991) 
who describes a spectroscopy system for monitoring cerebral oxygenation of new 
born infants, Niwayama et al. (2006) and Yuanqing et al. (2002) who describe tissue 
and muscle oxygenation measuring techniques respectively, and Coyle et al. (2004) 
who describe motor cortex oxygenation monitoring as a means of implementing a 
brain-computer interface.  
Despite the development of such techniques and devices, modified Beer-
Lambert law based spectroscopic monitoring, is in general ill-suited to routine 
clinical monitoring applications, where the need to establish an estimate of the 
differential path length, for every patient and for each measurement site, is 
impractical. Though modified Beer-Lambert based spectroscopy is extendable to 
the application of pulse oximetry (Humphreys, et al. 2005b; Rolfe 2000), in 
practice, no clinical device utilises the technique. Section 3.2.1 revisits the subject 
of light attenuation in tissue and describes how the technique of pulse oximetry 
eliminates the need to establish the optical path length in calculating arterial blood 
oxygen saturation. 
2.3 LIGHT TRANSPORT IN TISSUE 
Section 2.2 described how light travelling through tissue is attenuated by the 
combined effects of scattering and absorption. This section describes the affect of 
scattering and absorption on the propagation of light through tissue with the aid of a 
Monte Carlo simulation; specifically, the proclivity of scattering to cause the 
bending of light propagating through tissue—making possible the measurement of 
backscattered light and ultimately non-contact measurements of tissue and blood 
oxygen saturation. 
2.3.1 LIGHT ABSORPTION 
Light absorption refers to the loss of photonic energy during interaction with 
electrons, atoms, and molecules. The energy lost by photons is converted into either 
heat or into light of longer wavelengths (Splinter and Hooper 2007). Within tissue, 
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near infrared light is absorbed by molecules that posses an electric dipole moment, 
typically these are molecules composed of dissimilar atoms and they include carbon 
dioxide, carbon monoxide, nitric oxide, and water (Reddy 1997). Absorption is 
wavelength dependent. 
The absorbers of principal interest in this study are Hb and HbO2, a list of the 
other common absorbers (or chromophores) in tissue and of relevance to this study 
is given in Section 2.1.1. 
2.3.2 LIGHT SCATTERING 
Light scattering can be classified into three modes of light-particle interaction: 
Rayleigh scattering, Mie scattering, and Raman scattering. The occurrence of 
Rayleigh or Mie scattering is determined principally be the ratio of the wavelength 
of the incident light (λ) to the dimensions of the scattering particle. Rayleigh 
scattering occurs when λ is much larger than the dimensions of the scattering 
particle and Mie scattering when the dimensions are comparable. Both Rayleigh 
and Mie scattering are elastic and cause a change in the trajectory of the scattered 
photon only. Raman scattering by contrast describes a phenomenon in which the 
trajectory of the scattered photon is altered, but in addition the interaction causes the 
emission of light, usually with longer wavelength, from the scattering particle 
(Splinter and Hooper 2007). 
Mie scattering is predominant in light interaction with biological tissue. The 
interaction closely approximates geometrical optics. The cross-section of the 
scattering particle and the angle of incidence of the photon are used to determine an 
anisotropy factor g, which is the probability that the photon will be scattered in a 
solid angle θ. 
2.3.3 MONTE CARLO SIMULATION OF LIGHT PROPAGATION 
A Monte Carlo simulation of light propagation through a homogenous scattering 
medium is presented here. The simulations are instructive in establishing the most 
probable path along which a beam of photons travels between the injection point 
and the detection point. Knowledge of the likely path taken by a beam of photons is 
necessary to explain the means by which contact and non-contact pulse oximetry 
and photoplethysmography acquire pulse signals from tissue. The profile of the 
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photons path also provides rationale for design considerations pertaining to 
positioning of source and detector, and a means of explaining some of the 
phenomena associated with non-contact camera-based photoplethysmography.  
The propagation of optical radiation in tissue is most often described using 
radiation transfer theory, which ignores wave-like phenomena such as interference. 
The radiative transfer equation formulates the radiance of light in a medium in 
terms of absorption and differential scattering coefficients (the derivation of which 
has been provided by many authors—see for example Splinter and Hooper (2007)). 
The equation can be solved analytically for simple geometries, however it is most 
commonly solved by various numerical methods including, but not limited to, 
Monte Carlo analysis, random walks (Bonner, et al. 1987), and finite element 
analysis (Arridge, et al. 1993). Of these techniques, Monte Carlo analysis is perhaps 
the most versatile and commonly used, lending itself to complex tissue geometries. 
The disadvantage of the Monte Carlo method is that it is computationally intensive 
and time consuming. The technique provides a simulation of light propagation 
rather than a direct solution to the radiative transfer equation, and as such requires 
the simulation of a large number of photons to produce accurate results, with the 
accuracy increasing in proportion to the square root of the number of photons used 
(Patterson, et al. 1990). Nonetheless, Monte Carlo simulations are commonly found 
in investigations of light-tissue interaction and near infrared spectroscopy, see for 
example: Hiraoko et al. (1993) on investigations of optical path length; Okada et al. 
(1997) on investigations of light propagation in the adult head for spectroscopy; 
Fukui et al. (2003) on investigation of light propagation in both adult and neonatal 
heads; Strangman et al. (2003) on the effects of differential path length factor and 
optical cross-talk as sources of error in NIR spectroscopy; Reuss (2005) on the 
comparability of homogeneous and multi-layer models of tissue for reflectance 
pulse oximetry; and Niwayama et al. (2006) on tissue oxygen measurement. 
Figure 2.2 displays the flowchart of the Monte Carlo simulation program used 
here. The flowchart and the description of its functions that follows, are based on 
those described by Prahl et al. (1989) and Splinter and Hooper (2007). The method 
described here utilises a variance reduction technique known as implicit capture, in 
which a group or packet of photons, rather than an individual photon, is propagated 
through the medium. Upon its launch, each packet is given the same weight; at each 
tissue interaction location, a portion of the packet’s weight is lost due to absorption 
and the remainder of the packet scattered in accordance with the optical properties 
of the medium. Packets continue to propagate in the medium until their weight falls 
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below a certain threshold value, or until they are backscattered from or transmitted 
through the medium. 
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Figure 2.2 Flowchart of Monte Carlo simulation. 
Throughout the simulation each packet’s three-dimensional location is 
recorded as a Cartesian coordinate (x, y, z). The packet’s current trajectory is 
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described by three directional cosines (µx, µy, µz); the cosines of the angles made 
between the packet’s trajectory and each of the x, y and z-axes; defined as the dot 
product of the trajectory vector and a unit vector along each of the x, y and z-axes. 
The packet’s initial position is (0, 0, 0) and its initial trajectory (0, 0, 1). Thus 
packets are injected at the origin, initially travelling vertically. (When the tissue 
model comprises one or more horizontal layers, z < 0 defines air, z > 0 defines 
tissue, and z = 0 defines the air-tissue interface.) In this manner an infinitely narrow 
beam of photons is simulated. 
Attenuation coefficients due to absorption, µa, and due to scattering, µs, are 
defined respectively as the mean number of absorption and scattering events 
encountered by a photon per millimetre. A total attenuation coefficient, µ t, is 
defined as the sum of µa and µs. Thus the mean step size that a photon travels 
without interacting with the medium, the mean free-path length ∆s, is described by, 
 
1 1
t a
s
sµ µ µ
∆ = = + . (2.10) 
The discussion of the Beer-Lambert law in Section 2.2.1 noted that light 
travelling in tissue is attenuated exponentially, thus the probability density function 
that describes the distribution of ∆s is also exponential and is proportional to 
exp(−µ t∆s). A step size with such a density function is generated by, 
 
ln
t
s
ξ
µ
−∆ = , (2.11) 
where ξ is a random variable uniformly distributed between zero and one. 
Having generated an appropriate step-size ∆s, a packet is moved to its new 
location by updating its (x, y, z) Cartesian coordinates. The new coordinates 
(xnew, ynew, znew) are given by, 
 
.
new x
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new z
x x s
y y
z z
µ
µ
µ
s
s
= + ∆
= + ∆
= + ∆
 (2.12) 
At its new location the packet’s weight, w, is reduced by a fraction µa/µ t, such 
that the packet’s new weight wnew, is given by, 
 anew
a s
w
µ
µ µ= + w . (2.13) 
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The location of the absorption and the new weight of the packet are recorded. The 
remainder of the packet is scattered. 
The scattering trajectory is defined by two angles: an azimuthal angle φ and a 
longitudinal angle θ. The azimuthal angle is uniformly distributed over the range 0 
to 2π, and is hence given by, 
 2πφ ξ= , (2.14) 
where ξ is again a random variable uniformly distributed between zero and one. 
The longitudinal angle θ, is not uniformly distributed and is calculated using 
the Henyey-Greenstein phase function2 defined as, 
 
22
21 1cos 1
2 1 2
g
g
g g
θ ξ
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        
. (2.15) 
The term g, was defined earlier as the anisotropy factor. The term ξ is a 
random variable uniformly distributed between zero and one. When g = 1 scattering 
is predominantly forward, as g tends towards zero, scattering tends towards 
isotropic scattering. If scattering is truly isotropic then g = 0, and the longitudinal 
angel is instead calculated as, 
 cos 2 1θ ξ= − . (2.16) 
A photon with a current trajectory defined by the directional cosines 
(µx, µy, µz) will, after being scattered in a direction (θ, φ), have a new trajectory 
(µ'x, µ'y, µ'z), given by, 
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 (2.17) 
If the current trajectory of the photon is close to vertical, say |µz| > 0.99999, 
then equation (2.17) should be replaced by, 
 
2 Henyey and Greenstein (1941) characterised the scattering of light in interstellar dust 
clouds, by developing an expression for the angular dependence of light scattering by 
small particles. The identity they developed (which describes the probability density 
function of an angle as a function of the anisotropy of the scattering medium) is now 
commonly used to describe the scattering of light in biological tissues.  
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Where a packet’s trajectory crosses a boundary between regions of different 
refractive indices, be it tissue and air or two different tissues, there is a possibility 
that the packet will be internally reflected with a probability proportional to the 
angle of incidence. For simple models comprised of parallel layers of tissues, the 
angle of incidence θ i, of the packet can be calculated as, 
 1cosi zθ µ−= . (2.19) 
The angle of transmission, θ t, can be calculated using Snell’s law, 
 1sin sinit
t
n
n i
θ θ−=   
, (2.20) 
where ni and nt are respectively, the refractive indices of the medium from which, 
and towards which, the packet is travelling. 
The probability of internal reflection is given by the Fresnel reflection 
coefficient R(θ i), 
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Whether the packet is reflected or not is determined by a random number 
uniformly distributed between zero and one, ξ, such that reflection occurs if, 
 ( )iR θ ξ< . (2.22) 
Finally it is desirable to cease propagating packets with small remaining 
weight, as they contribute little to determining the distribution of photons within the 
medium. Eliminating all packets with less than a threshold weight violates the 
conservation of energy principle, thus packets with a weighting less than a threshold 
are subjected to a Roulette process—surviving packets have their weight reset to the 
maximum and continue propagating. 
A Monte Carlo routine based on the description given here and the flowchart 
depicted in Figure 2.2 was implemented in Matlab® (MathWorks Inc.). Figure 2.3 
displays the results of a simulation of one million launched packets through a 
homogenous medium with the optical properties described in Table 2.1. The plot 
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shows the locations where backscattered photons emerged from the medium. 
Superimposed on Figure 2.3 are circles concentred on the injection point (0, 0). 
Each annular region between adjacent circles encloses the same area as that 
enclosed by the inner circle.  
  
  
  
  
  
  
  
 
Parameter Value 
µ a 0.2 mm-1 
µ s 1.3 mm-1 
g 0.9 
Refractive index of tissue 1.3 
Minimum packet weight 0.1 
Roulette survival probability 0.1 
Table 2.1 Optical properties of tissue as used in Monte Carlo simulation. 
 
Figure 2.3 Emergence of backscattered photons injected at the point (0, 0) 
with concentric circles each enclosing equal area. 
Figure 2.4 displays a plot of the number of backscattered packets emerging in 
each annular region, versus radial distance from the injection point. Figure 2.5 
displays the cumulative weight of all packets contained in each annular region 
versus the radial distance from the injection point (where the cumulative weight is 
the sum of the variable weight that each packet retains upon its emergence from the 
tissue, which is proportional to the received light intensity). As described earlier 
(see Section 2.2) the emergent light intensity decreases exponentially in all 
directions with increasing distance from the source.  
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Figure 2.4 Number of emerging packets versus radial distance from 
injection point (one million photons launched). 
 
Figure 2.5 Cumulative weight of emerging packets versus radial distance 
from injection point. 
The probable path taken by a photon travelling between a given injection and 
emergence point, can be predicted to some degree for a medium of known optical 
characteristics and geometry. Figure 2.6 displays the path taken by all photons that 
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emerged within a radius of 10 mm of the location (15, 15, 0), in a simulation of one 
hundred thousand packets using the same optical properties given in Table 2.1.  
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Figure 2.6 Path taken by photons travelling between the injection point 
and the emergence area. 
The photons travel in an arc between the injection point and the emergence 
area, forming a three dimensional shape that is ubiquitously referred to in the 
literature as an optical banana. The proportions of this banana within a given 
medium depend on the separation of the injection and emergence point, or the 
separation of source and detector points in an actual application, with the 
penetration depth of the light increasing as the source-detector separation increases. 
Note that in order to use a Monte Carlo simulation to characterise a medium in 
terms of absorption, scattering, or light fluence, it is necessary to divide the volume 
into discrete volumes—voxels. Each time an absorption event takes place, the 
appropriate absorption quantity is added to the corresponding voxel. As the voxel 
size is reduced, the granularity of the modelled volume is increased, giving better 
resolution. However greater granularity results in smaller sampling of the photon 
distribution, and consequently greater uncertainty. Lower granularity conversely 
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provides less resolution but higher certainty of the distribution of light fluence, 
absorption, or scattering within a voxel. Thus to achieve accurate results with a 
Monte Carlo simulation, a large number of photons must be launched.  
The number of photons used to generate the optical paths in Figure 2.6 is 
insufficient to characterise the transport of light in a medium in general, and the 
photon paths are intended only to illustrate the effect. (It is impracticable to store or 
display the paths of very many photons.) 
Furthermore, the above simulations characterise the response of the medium 
to an infinitely narrow beam of photons. To simulate a realistic beam of incident 
photons one of two techniques can be employed. Either the beam profile may be 
convolved with the beam source function, or the initial location of the photons may 
be varied randomly, with a distribution defined by the source profile. 
2.4 SUMMARY 
This chapter has presented a short overview of oxygen transportation, light 
attenuation in tissue, and light transportation in tissue. The mechanism of oxygen 
transportation is important to the method of pulse oximetry and will be shown in 
Chapter 3 to affect the choice of wavelengths for a device and, in the case of 
functional and dysfunctional haemoglobins, to affect both the accuracy of the 
device and the actual measured quantity.  
The Beer-Lambert model of absorption and scattering of light in tissue (which 
are collectively observable as attenuation) is the basis of pulse oximetry and 
Chapter 3 will build on this discussion in describing the method of pulse oximetry. 
The banana-shaped path taken by light travelling between two points on the 
tissue surface has ramifications for the choice of source and detector geometry, both 
in a conventional contact device and especially in a non-contact device. Knowledge 
of the shape of this path is used in Chapter 5 as the rationale for choosing the 
relative position of the source and detector, and is referred to again in Chapter 6 to 
describe the concept of camera-based diffuse tomography. 
The Monte Carlo simulation is employed again in Chapter 5 to investigate the 
effects of tissue-detector separation on the received light intensity. 
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CHAPTER 3  
 
PULSE OXIMETRY 
 
 
 
Equation Chapter 3 Section 1 
The technique of pulse oximetry is rooted in the Beer-Lambert based spectrometry 
described in the previous chapter. This chapter details the application of the 
principles of Beer-Lambert based spectrometry to the specific application of arterial 
blood oxygen saturation monitoring. This chapter has two principal objectives. First 
it is intended to provide the reader with a thorough explanation of the principles and 
technologies that form the basis of all variants of pulse oximetry. Second, following 
this discussion, a description is given of some of the technical problems faced by 
pulse oximeter designers and manufacturers. Some solutions to common problems 
are reviewed. The prominence given to the various aspects of clinical device design 
during this discussion, is not necessarily indicative of their importance to the 
performance of clinical devices—for example, no consideration is given to the 
microprocessor, though it is arguably the most important component of a pulse 
oximeter and is the greatest variable among manufacturers. Rather, the discussion 
that follows is intended to elucidate aspects of pulse oximeter functionality, which a 
novel device must emulate comparably, and aspects of pulse oximeter operation 
that are negated, obviated, or complicated, by a non-contact implementation.  
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3.1 CONTEMPORARY HISTORY OF PULSE OXIMETRY 
An electrical engineer ultimately invented pulse oximetry, though the extent to 
which it has since been reported upon in biomedical and electronics literature belies 
the fact that pulse oximetry properly belongs to the physiological field of blood gas 
analysis. Pulse oximetry owes its existence to fundamental investigations by natural 
philosophers, physiologists and physicians over three centuries. This brief 
discussion focuses only on the recent history of the subject, and then only on the 
protagonists and their inventions, which led directly to the present day clinical 
monitoring technology. The technology used in oximetry has varied markedly with 
the era in which developments took place, and to a large extent, development in 
oximetry took place as a result of technological development in other fields. Only 
passing reference is made to those technologies here, though the concomitant 
complexities of cumbersome sources, non-linear detectors, and weak amplification, 
should be borne in mind when considering the pace and magnitude of 
achievements. 
Gas has been extracted from blood for centuries, initially by vacuum, and the 
constituent gases and their quantities identified with ever increasing precision for 
the last 150 years (Severinghaus 1987a). Though it has been possible to measure the 
tension (partial pressure) of oxygen in blood by various means for some time, the 
impetus for optical measurement was the discovery that the electron emission from 
cesium cathodes was sensitive to light. This ultimately led to the development of 
barrier layer photocells; semi-conductive barriers to electrons that become 
conductive when light is incident upon them. Ludwig Nicolai made the first steps 
towards modern oxygen saturation measurement in 1931. Using a mercury vapour 
light and a rotating filter wheel to produce blue and green light, a vacuum 
photoelectric cell detector, and a vacuum tube amplifier, Nicolai occluded the 
circulation in his hand and derived curves for the decrease of HbO2 and increase in 
Hb over time. Nicolai’s associate, Kurt Kramer, then made the first report of precise 
oxygen saturation measurement of blood both in cuvettes and flowing blood in 
1934 using an incandescent light and barrier photo cell (Severinghaus 1987a). 
Building on their work, in 1935 another German physician, Karl Matthes, produced 
the first device to continuously measure oxygen saturation in humans, by 
transillumination of the ear (Severinghaus and Astrup 1986d). 
The next important development was the outbreak of World War II in 1939. 
Military aircraft at the time were not pressurised and at high altitudes, where 
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oxygen partial pressure is low, aviators sometimes lost consciousness (see 
Section 2.1). Scientists involved in the British war effort, notably Lord Adrian, 
professor of physiology at Cambridge University, had begun developing oxygen 
delivery systems sensitive to altitude and activity. Adrian wrote to the American 
physiologist Glenn Millikan asking for help with the task. Millikan was at the time 
a lecturer at Cambridge, though had been visiting his parents in the United States at 
the outbreak of war in Europe, and had subsequently remained there. Millikan was 
well primed to take on the task; he had obtained his PhD for a thesis on a dual-
wavelength colourimeter, he had worked in Germany prior to the outbreak of war, 
and in 1936 had been visited by Kramer and adopted the use of the barrier layer 
photocell. Between 1940 and 1942, Millikan and his colleague Pappenheimer were 
principally responsible for developing a lightweight and practical aviation ear 
oximeter, which became know as the Millikan ear oximeter, and incidentally coined 
the term oximeter.3 The device was first presented in 1941 (Millikan, et al. 1941). 
Millikan and his colleagues had arranged for the device’s production and 
successfully incorporated a servo that controlled the supply of oxygen to an 
aviator’s mask. The device initially used an incandescent battery operated light, and 
red and green gelatine filters. The use of green light was common at the time due to 
the high absorption at this wavelength in the haemoglobin spectrum. Millikan had 
shown the light detected at this wavelength to be independent of oxygen saturation 
and thus useful as a reference wavelength. However just prior to publishing this in 
Review of Scientific Instruments in 1942, the device manufacturer informed 
Millikan that the ear was so opaque to green light and transparent to infrared light, 
that the green filter and its photocell had in fact, fortuitously, been responding 
primarily to infrared light. The paper was corrected in time and became the first 
report of red and infrared light in oximetry (Millikan 1942). 
Although Millikan had been working in the United States, the Unites States 
military only became interested in the technology when they learned that the 
German Luftwaffe already had such a device (Severinghaus and Astrup 1986d). 
Despite having access to much of Matthes’ work (he had been a prodigious author 
producing twenty papers on oximetry between 1935 and 1944), the United States 
had failed to produce a working device. However after V-E Day, the United States 
Army recovered Kramer (then an SS officer) from a Russian prisoner of war camp. 
                                                 
3 The term oximeter, though likely derived from the words oxygen and meter, is now 
used to refer exclusively to oxygen measuring devices based on the principle of 
spectrometry—that is optical methods of determining oxygen saturation. 
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Kramer was brought to the United States to help perfect the technology—which he 
did. 
Millikan was killed in a rock climbing accident in 1947, though the 
tremendous efforts that he and others had expended during the war found new 
application in the emerging field of respiratory physiology. By 1950 some sixty six 
publications existed that described uses of the Millikan ear oximeter (Severinghaus 
and Astrup 1986d). It is important to note, that at this point oximeters, though they 
sought to measure arterial oxygen saturation, could not discern the contributions to 
their readings from arterial blood, venous blood and scattering and absorption by 
tissue. Thus while oximeters of the time could indicate a change in saturation and 
could provide a reading proportional, even close to, the arterial oxygen saturation, 
they could not provide absolute readings. An important improvement to the 
Millikan oximeter was made by Wood and Geraci (1949), building on the work of 
Squire (1940), when they introduced an inflatable balloon with which the ear could 
be made bloodless to provide an initial zero reading. This technique removed the 
components due to scattering and absorption by tissue to the arterial oxygen 
saturation reading, though did not remove the contribution from venous blood. 
At this point the ear oximeter was still dependent on barrier layer photocell 
detector technology. It was not possible to measure the output current of these 
devices without causing a drop in voltage that decreased the devices’ sensitivity. 
Furthermore the devices’ output current varied with time and temperature 
(Severinghaus 1987a; Severinghaus and Astrup 1986d). At about this time Leland 
Clarke invented his oxygen electrode, which measured the oxygen partial pressure 
in a gaseous mixture or the oxygen tension in a solution. Soon this device made 
possible transcutaneous oxygen partial pressure measurement and as a result a 
paradigm shift occurred in blood oxygen measurement, physiologists and 
physicians began thinking of blood oxygen content in terms of partial pressure 
rather than saturation (Severinghaus and Astrup 1986b). The use of oximetry began 
to decline, a trend that continued until the development of silicon semiconductor 
detectors and high gain solid-state amplification techniques. 
The next important milestones in the development of pulse oximetry came in 
the nineteen sixties. Previous oximeters had typically used two wavelengths of 
light, one sensitive to oxygen saturation and one insensitive. In this manner it had 
not been possible to discern the contributions of the various species of haemoglobin 
to the saturation reading (see Section 2.1.1). This problem was tackled with the 
introduction of the eight-wavelength ear oximeter by surgeon and inventor Robert 
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Shaw around 1964. This device (constructed from a broadband halogen lamp, 
optical fibres and photodiode detector—though still utilising a rotating filter wheel 
to produce multiple wavelengths) was bought and marketed by Hewlett-Packard. It 
was widely used in physiological research (Moyle 1994), however due to its 
expense and the large size of the ear piece, it was seldom used for clinical 
monitoring (Severinghaus and Astrup 1986d). Though it was never intended for 
clinical monitoring, another important development at this time was the CO-
oximeter, the operation and importance of which is discussed later. 
The final step in the emergence of pulse oximetry came in the nineteen 
seventies, when the Japanese engineer, Takuo Aoyagi, realised that by isolating the 
pulsatile component of the received light intensity, the long sought oxygen 
saturation of the arterial blood could be distinguished from all the other components 
of the detected light intensity. Aoyagi had actually been trying to measure blood 
flow and was initially concerned with removing the unwanted pulsatile component 
when the realisation occurred (Aoyagi 1992, 2003; Aoyagi and Miyasaka 2002). 
Aoyagi and his colleagues built the first prototype device between 1973 and 1974. 
However prior oximeters had never been widely used in clinical applications and in 
the decade that followed, few foresaw the potential of pulse oximetry. Severinghaus 
and Honda (1987) attributed the enormous interest that eventually developed to the 
multi-qualified engineer, physician, and physiologist, William New, and engineer, 
Jack Lloyd, who together founded the company Nellcor Incorporated. New 
recognised the potential for pulse oximetry in all applications where a patient is 
unable to regulate their own oxygen supply. However with the success and 
worldwide interest that followed came a lucrative medical instrumentation market, 
and with that came patents and litigation (a decorous description of which, is 
provided by Severinghaus and Honda (1987)). 
The discussion here highlights the impetus and developments that directly 
contributed to the invention of pulse oximetry. Also of significance to the modern 
technology were the contributions to reflectance oximetry of Zijlstra (1953; 1958) 
and his mentor Brinkman. 
For an historical overview of the subject of blood oxygen measurement, and 
its parent subject, blood gas analysis, the interested reader should refer to the works 
of Severinghaus and Astrup (1985a; 1985b; 1986a; 1986b; 1986c; 1986d) and 
Severinghaus and Honda (1987). An even more comprehensive and well-narrated 
treatise of the subject is to be found in the epic, essay-style paper of Severinghaus 
(1987a). For an insight into the early development of the technology, and transcripts 
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of symposium discussions between early protagonists (including Severinghaus, 
Wukitsch, Tremper and others) the interested reader should refer to Payne and 
Severinghaus (1986). 
The taxonomy of the field of blood gas analysis is depicted in Figure 3.1. It is 
apt to think of pulse oximetry as the culmination of the development of the in vivo 
oximeters. Its displacement of all other methods of in vivo oxygen measuring in 
clinical environments, and the re-reversion of clinical and experimental thinking, 
from terms of oxygen partial pressure back to oxygen saturation, is now a matter of 
historical record. However, until the emergence of commercial pulse oximeter 
devices in the nineteen eighties, oximeter technology faced stiff competition from 
chemical methods (particularly the invasive Clarke electrode) and the trans-
cutaneous oxygen partial pressure sensor. A short discussion of the construction and 
operation of this device is included below. An appreciation of the Clarke electrode’s 
operation is instructive in understanding the revolution that pulse oximetry brought 
to clinical oxygen monitoring, and the comparative robustness of the pulse 
oximeter.  
Also included below is a short description of the aforementioned CO-
oximeter. Though the CO-oximeter is a cuvette-based technique that was neither 
intended nor used for in vivo monitoring, it has however, become the gold standard 
of laboratory blood oxygen measurement, and is central to the calibration procedure 
(see Section 3.3.5) of both conventional pulse oximeters and the novel non-contact 
technique described in this thesis. 
On the subject of the non-contact device described in this thesis and its 
classification within the taxonomy described in Figure 3.1, it could be argued that it 
is either the direct descendant of pulse oximetry or perhaps a separate genus of in 
vivo oximeters, the non-contact oximeter. 
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Figure 3.1 Taxonomy of the field of blood gas analysis. 
3.1.1 THE CLARKE ELECTRODE AND THE TRANSCUTANEOUS PO2 SENSOR 
Leland Clarke invented the Clarke electrode in October 1954, assembling the first 
electrode from glass, platinum and silver wire, and a potassium chloride solution, 
wrapped in a polyethylene film (Severinghaus 1987a). The electrode measures the 
partial pressure of oxygen (PO2) using the principles of oxidation and reduction. 
When oxygen is dissolved in an aqueous solution and exposed to a voltage of 
approximately 0.6 V the following reaction occurs (Farmer 1997), 
 2 2O 2H O 4e 4OH
− −→+ + . (3.1) 
The principle of the electrode is illustrated in Figure 3.2. Since the potassium 
chloride solution provides everything for the reaction except O2, the amount of O2 
dissolved in the solution determines the amount of current that flows between the 
anode and cathode. 
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Figure 3.2 Principle of operation of the Clarke electrode. 
The actual electrode is arranged in a cylindrical fashion, and is used to 
measure PO2 of blood solutions in vitro, and when miniaturised, can be attached to 
the end of catheter and placed inside an artery to provide in vivo measurement. 
Clarke’s electrode stills forms the basis of most laboratory blood gas analysers 
(Shapiro, et al. 1989), and is also commonly used in the food industry, beer and 
wine production, aviation, soil chemistry, and sewage management (Severinghaus 
1987a).  
The Clarke electrode, mounted upon a catheter, is however an invasive means 
of monitoring blood oxygen, and the electrode found its greatest clinical use in its 
less invasive guise, as the transcutaneous PO2 sensor. The transcutaneous PO2 
sensor is depicted in Figure 3.3. Under normal circumstances, PO2 of blood near 
the skin’s surface is atmospheric (0.21 bar or 157 mmHg), however hyperaemia 
(increased blood volume) of the skin can cause the PO2 of the blood near the 
surface to approach the arterial oxygen partial pressure, PaO2. This excess oxygen 
near the skin’s surface then diffuses out through the skin and can be detected using 
the Clarke electrode. Hyperaemia can be introduced by abrasions, drugs and 
creams, or, as in the case of the transcutaneous PO2 sensor, by heating. The 
transcutaneous PO2 sensor consists of a Clarke electrode with a heating element 
and a thermistor for temperature control. The skin is heated to between 43 °C and 
44 °C, the optimum temperature for achieving the desired transcutaneous effect 
with minimum skin damage. The sensor must be periodically moved to avoid burns, 
particularly with infants. 
34 
Pulse Oximetry 
 
 
 
 
 
 
 
 
 
 
Silver
anode
Gold 
cathodeInsulator
Polypropylene
membrane
Electrolyte 
Heating
element
Plastic
bodyThermistor
Figure 3.3 Transcutaneous PO2 sensor. 
The sensor has some advantages over a pulse oximeter; for example, it will 
continue to produce a valid output in the presence of anaemia, which a pulse 
oximeter will not do. However among its drawbacks are that it requires skin and 
electrode preparation, a warm-up time of several minutes, requires recalibration, 
reports low PO2 if poorly placed, and requires some operator skill (Barker and 
Tremper 1984; New 1985; Severinghaus 1987b). Most of these requirements are 
obviated by pulse oximetry, which despite some limitations (see Section 3.4.2) 
provides less invasive, safer, and more robust clinical monitoring of oxygen 
saturation, with the added benefits of heart rate monitoring and display of the 
peripheral arterial pressure waveform. 
3.1.2 THE CO-OXIMETER 
The term CO-oximeter was coined but not copyrighted by Instrumentation 
Laboratories Inc. who produced the first device in 1966 (Moyle 1994). CO-
oximeters are spectrometers designed to analyse haemolysed blood samples using 
the Beer-Lambert law (see Section 2.2.1) to determine the concentrations of the 
four most common species of haemoglobin; reduced haemoglobin (Hb), 
oxyhaemoglobin (HbO2), carboxyhaemoglobin (COHb), and methaemoglobin 
(MetHb).  
A typical CO-oximeter analyses small samples of heparinised and haemolysed 
blood. That is blood to which an anticoagulant has been added, and in which the red 
blood cells have been destroyed (often by ultrasound), releasing haemoglobin into 
the plasma. Blood samples are maintained at 37 °C. Placing either slits or 
interference filters in front of a broadband light source generates several 
monochromatic wavelengths of light, which are used to illuminate the blood 
sample. The light is usually in the visible range between 500 nm and 700 nm. 
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Typically a photodiode is used as a detector. Since the test solution contains only 
absorbers, the optical path length can be easily measured. The incident light 
intensity can be obtained for each wavelength by means of a reference beam. 
Determining the concentration of the absorbers is therefore, a straightforward 
matter of applying the Beer-Lambert law for the case of multiple absorbers (Moyle 
1994). 
CO-oximeters are susceptible to error. The presence of scattering impurities in 
the blood sample, such as cell fragments remaining from the haemolysis process or 
lipids, invalidate the presuppositions on which the Beer-Lambert calculations are 
based. CO-oximeters that use few wavelengths of light can be susceptible to error in 
the presence of fetal haemoglobin, in which case an overestimation of COHb is 
produced (Zwart, et al. 1981). Some CO-oximeters attempt to compensate for this 
by using as many as seventeen wavelengths (Farmer 1997). Figure 3.4 depicts a 
schematic representation of the IL-282 CO-oximeter. The IL-282 uses four 
wavelengths of light that it produces by rotating four interference filters mounted on 
a wheel controlled by a stepper-motor. 
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Figure 3.4 Schematic depiction of the Instrument Laboratories IL-282 4-
wavelength CO-oximeter. 
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3.2 THEORY OF PULSE OXIMETRY 
If red or near infrared (NIR) light is transmitted through tissue, the received light at a 
detector will capture a slowly varying attenuation due to reflection from the skin, 
scattering by tissues such as muscle, bone and fat, and absorption due to tissues 
such as muscle, bone, fat and venous and arterial blood. The received light intensity 
will also capture a faster pulsatile attenuation component that is due to the pulsation 
of arterial blood. Figure 3.5 depicts the components of light attenuation in tissue 
and indicates the relative contributions of each. 
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Figure 3.5 Components of attenuation in the detected light exiting tissue.4 
The pulsatile component of the absorption is specifically caused by the 
peripheral arterial pressure waveform, a plot of this waveform is known as a 
plethysmogram, or a photoplethysmogram (PPG) if measured by optical means. 
Figure 3.6 depicts the arrangement of erythrocytes in an artery at various stages 
during the cardiac pulse. At systole (peak pressure) the cells are packed tightly 
together and are orientated such that their long axes are perpendicular to the 
direction of flow. At diastole (low pressure), the cells are less densely grouped and 
are rotated such that their long axes are parallel to the direction of flow. These 
effects combine to produce maximum absorption (minimum transmittance) of light 
                                                 
4 Wukitsch et al. (1988) state that an arterial pulsation accounting for 3% of the signal 
amplitude can be considered normal and 10-11% considered high. Ohmeda pulse 
oximeters display a low-signal warning when the signal’s pulsatile component falls to 
0.2% (Wukitsch 1987; Wukitsch, et al. 1988). 
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during systole and minimum absorption (maximum transmittance) at diastole 
(Liebman, et al. 1962; Visser, et al. 1976). 
Tissue surface 
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Figure 3.6 Arrangement and orientation of erythrocytes (red blood cells) 
during the cardiac pulse. 
During the discussion of the modified Beer-Lambert Law (see Section 2.2.2) 
several parameters were identified that must be calculated in order to establish the 
relative concentrations of absorbing chromophores in a scattering medium. These 
parameters were enumerated: the incident light intensity at each wavelength; the 
received light intensity at each wavelength—and by implication the detector’s 
sensitivity to each wavelength; the optical path length; and the differential path 
length factor that accounts for the increase in path length due to scattering. Two 
methods of estimating the differential path length factor were described, both of 
which required a significant amount of instrumentation. The optical path length for 
a transmission geometry is relatively easily calculated, however, for a reflection 
geometry it somewhat more difficult (see Section 2.3.3 and the optical banana 
displayed in Figure 2.6). Calculation of the incident light intensity also requires 
quantification of the reflection from the surface, which is a function of the angle of 
incidence and hence also of the light source’s emission profile. A clinical oximeter 
operating on the principle of the modified Beer-Lambert law would need to 
establish each of these parameters for all wavelengths, for each patient and for each 
measurement location. If probe movement were an issue, each parameter would 
need continuous updating. Pulse oximetry however eliminates all these parameters 
from the estimation of arterial blood oxygen saturation. 
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3.2.1 LIGHT ABSORPTION FOR PULSE OXIMETRY 
Pulse oximetry is a special case of the Beer-Lambert based spectroscopy described 
in Section 2.2. This section describes the set of conditional assumptions that enable 
the technique of pulse oximetry by eliminating the incident light intensity and the 
position and wavelength dependent optical path length as variables from the Beer-
Lambert model. 
3.2.1.1 ELIMINATION OF INCIDENT LIGHT INTENSITY AND OPTICAL PATH 
LENGTH AS VARIABLES 
The level of absorption due to tissues such as bone, muscle, fat and venous blood, 
varies slowly with respect to the pulse. Let this baseline absorption have 
absorptivity α and optical path length d. Let the pulsing arterial blood have 
absorptivity αA and path length ∆d (and note that ∆d varies slightly as the blood 
pulses). The light emerging from the baseline component Ib, can be written as a 
function of the incident light intensity I0, as 
 b 0e
dI I α−= . (3.2) 
The light emerging from the pulsatile component Ip, can be written as 
 p be A
dI I α− ∆= . (3.3) 
Substituting equation (3.2) into equation (3.3) yields the light emerging from 
the pulsatile component as a function of the incident light intensity, 
 p 0
(e AdI I α α )d− + ∆= . (3.4) 
The transmittance of the arterial component can be defined as the ratio of the 
light emerging from the arterial component and the light incident on the arterial 
component; which is the light emerging from the baseline component. Therefore the 
arterial transmittance T∆ A is given by 
 p 0
b 0
( )e
e
A
A
d d
d
I IT
I I
α α
α∆
− + ∆
−= = . (3.5) 
The I0 terms cancel out leaving the arterial transmittance as a function of the 
pulsatile component’s absorptivity and path length only. 
 e AA
dT α∆
− ∆=  (3.6) 
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Note that the absorptivity of the pulsatile component is innate to the received 
light attenuation signal (refer to Figure 3.5 where Is represents the transmittance at 
systole and Id represents the transmittance at diastole). Any device employing this 
principle is unaffected by fluctuations in the incident light intensity and is 
effectively self-calibrating (Wieben 1997). It now remains to remove the variable 
∆d from the calculations. 
Taking the natural logarithm of the arterial transmittance yields 
 ln ln( ) (e )A AA
d dT α α∆ − ∆ − ∆= = . (3.7) 
Now by comparing the ratio of the arterial transmittance measured at two 
wavelengths, a ratio ROS can be calculated such that, 
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Now the variable distance ∆d (the optical path length over which arterial 
absorption takes place) can be considered independent of the wavelength at which it 
is measured if two conditions are met. First, the path of light through the artery 
should be free of scattering events, since scattering can be wavelength dependent 
and increases the optical path length beyond the geometric distance. This is not 
strictly true of whole blood. However, the diameter of arteries in the limbs are small 
(typically the radial artery is approximately 3 mm, the ulnar 2.5 mm, and the digital 
arteries 1.6 mm (Fazan, et al. 2004)), and the mean number of scattering events for 
near infrared light travelling in blood is of the order of 1 – 2 mm-1. So provided that 
the two measurement wavelengths experience a similar number of scattering events 
per millimetre, the first condition is approximately met. The second condition is that 
the geometrical distance between the source and detector is the same at each 
wavelength. In practice, both sources are located close together and at some 
distance from the artery, a common detector, also at some distance from the artery, 
is used for both sources, such that the difference in ∆d arising from source 
positioning is negligible. Thus the second condition is also met and ∆d can be 
considered approximately independent of wavelength—though the first of several 
conditions pertaining to the choice of wavelengths has been imposed. Equation 
(3.8) reduces to  
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3.2.1.2 CHOICE OF WAVELENGTHS 
It is now required to choose wavelengths λ1 and λ2 such that the ratio ROS in 
equation (3.9) is proportional to the arterial oxygen saturation. The precise 
definition of arterial oxygen saturation entails some detail and will be discussed in 
due course (see Section 3.4.1). For the present a limited but didactic definition will 
suffice. Arterial oxygen saturation, SpO2, is the ratio of oxyhaemoglobin to total 
haemoglobin. That is, 
 22
2
HbO
O 100%
HbO +Hbp
S = × . (3.10) 
Where the subscript p denotes the arterial oxygen saturation as measured by a pulse 
oximeter. 
It is now necessary to choose λ1 and λ2 such that one wavelength is most 
strongly absorbed by oxyhaemoglobin (HbO2) and the other by reduced 
haemoglobin (Hb).  
Figure 3.7 depicts the absorption of Hb and HbO2 across a portion of the 
visible and near infrared electromagnetic spectrum. It can be seen in Figure 3.7 that 
Hb and HbO2 have different absorption across the entire portion of the spectrum 
except at 805 nm, termed the isobestic point. Below the isobestic point, absorption 
is principally due to Hb, while above the isobestic point most absorption is due to 
HbO2. The most commonly used wavelengths in pulse oximetry are 660 nm (red) 
and 940 nm (infrared) (Wukitsch, et al. 1988). There are several reasons why these 
wavelengths have become prominent. The difference in absorption between Hb and 
HbO2 is greatest at 660 nm below the isobestic point, thus absorption measured at 
this wavelength will be largely proportional to the concentration of Hb only. Above 
the isobestic point the difference is greatest above 970 nm, however from 
approximately 950 nm and upwards, the absorption of light by water increases 
sharply (Elwell 1995) making the use of these wavelengths impracticable. At 
940 nm, absorption by water is sufficiently low, and both the Hb and HbO2 
absorption curves are relatively flat. Their flatness is useful. The peak emitted 
wavelength of an LED can vary somewhat from the specified value. Additionally, 
the peak emitted wavelength can drift during operation. The relative flatness of both 
the Hb and HbO2 absorption curves in this region, serves to insulate the calculations 
from variances in the peak emitted wavelength of the infrared LED, since movement 
left or right of 940 nm does not cause a significant change in absorption of either 
species of haemoglobin. Contrast this with 660 nm, where the Hb curve has a steep 
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slope. Consequently, calculations are very sensitive to variance of the red LED 
wavelength, especially at low saturations where Hb is the dominant absorber. (See 
Section 3.3.1, and refer to de Kock et al. (1991) and Pologe (1987).) There are 
reasons, discussed later, for choosing alternative wavelengths, notably in the 
presence of low oxygen saturations (see Section 3.4.1.2 and Mannheimer et al. 
(1997)), though another compelling reason to choose 660 nm and 940 nm is that 
light emitting diodes have been commonly available—and thus economical to 
purchase—at these wavelengths for some time.  
 
Figure 3.7 Absorption spectra of reduced (Hb) and oxyhaemoglobin 
(HbO2). 
3.2.2 DERIVING ARTERIAL OXYGEN SATURATION 
Having recorded the intensity of light emerging from tissue at two wavelengths, and 
establishing that each has a pulsatile component, that is a PPG, it is necessary to 
calculate the variable ROS from the two PPG signals by implementing equation (3.9). 
Though ultimately each device manufacturer implements this based on their own 
research, two methods are commonly used (Palreddy 1997). They are the peak and 
valley method and the derivative method.  
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3.2.2.1 THE PEAK AND VALLEY METHOD 
Cheung et al. (1989b) first described the peak and valley method of deriving ROS in 
a US patent application. 
Figure 3.8 depicts a red and infrared PPG signal, the signals obtained by 
monitoring the intensity of light emerging from tissue. Note that the PPG signals 
appear inverted compared to the attenuation-derived waveform depicted in 
Figure 3.5. 
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Figure 3.8 Received light intensity from the red (R) and infrared (IR) LEDs 
over time. 
Here the signal peaks correspond to diastolic pressure where the volume of 
blood between the source and detector is lowest and the erythrocytes are aligned 
with their long axes parallel to the direction of flow. Thus attenuation is at its lowest 
and transmittance at its highest. As before, RH represents the baseline transmittance 
at the red (R) wavelength, the transmittance in the presence of scattering and 
absorption by skin, muscle, bone, fat, venous blood and the absorption due the 
normal volume of arterial blood. The difference between RH and RL, represents the 
reduction in transmittance due to the pulsation of the arterial blood. The natural 
logarithm of the quotient of RL and RH, is the term defined earlier in equation (3.7) 
as the natural logarithm of the arterial transmittance, 
 ( )ln ( ) ( ) ( ) ln LA R A R R
H
R
T d
R
λ α λ λ∆ = − ∆ =    . (3.11) 
Similarly for the infrared (IR) PPG, 
 ( )ln ( ) ( ) ( ) ln LA IR A IR IR
H
IR
T d
IR
λ α λ λ∆ = − ∆ =    . (3.12) 
Equation (3.9) defined ROS as the ratio of these terms, 
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Since the numerator and denominator of the ratio ROS, are themselves, ratios 
of the valleys and peaks of the red and infrared PPG signals respectively, the variable 
ROS is commonly referred to as the ratio of ratios. 
3.2.2.2 THE DERIVATIVE METHOD 
The peak and valley method has intuitive appeal. The method closely resembles the 
reasoning used to explain the concept of pulse oximetry and to develop the ROS 
variable. The peak and valley method provides perfectly valid measurements of 
ROS, however it has limitations that make it incongruous with clinical monitoring 
requirements.  
Peaks and valleys in the arterial pressure waveform occur only once per 
heartbeat, thus ROS can be calculated only once per heartbeat by the peak and valley 
method. As heart rate varies so does the rate at which ROS is calculated. Such a 
dependency is unacceptable in a clinical monitoring device. The problem is 
compounded by signal processing requirements. To mitigate the affects of spurious 
ROS values resulting from artefacts in the PPG waveforms,5 it is desirable that the 
current displayed oxygen saturation be in some way derived from a moving 
weighted average of the previous calculated values. Under these conditions, the 
displayed output saturation value is delayed by several heartbeats, each with a 
variable period. 
Device manufacturers each implement their own particular solutions to this 
problem—some of which are to be found by searching patent claims—however the 
underlying method upon which these solutions are based in the derivative method 
(Palreddy 1997). Like the peak and valley method, the derivative method is based 
on applying the Beer-Lambert law to the PPG signals present in the detected light 
intensity, I1. I1 can be described in terms of the constant incident light intensity I0, 
as, 
                                                 
5 Artefacts in the PPG can result from motion, momentary direct coupling of the source 
and detector, ambient light interference, or any other of a number of biological factors 
such as muscular contractions in the region of the probe. 
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In this instance, α is defined as the relative (rather than specific) extinction 
coefficient and encompasses the concentration of the chromophore. L is the path 
length of the light through the arterial blood and varies as a function of the arterial 
pressure waveform, as before it will be assumed approximately equal for both 
wavelengths. The rate of change of the detected light intensity with respect to time 
is given by, 
 1 0
- ( ) ( )( ) ( )e ( )L tdI t dL tI
dt dt
α λ α λ= − 
 , (3.15) 
thererefore, 
 1
1
( ) 1 (( )dI t dL t
dt I dt
α λ= − ) . (3.16) 
The measured light intensity I1, contains both the desired PPG component and 
the large DC offset. However the derivative of I1 is equal to the derivative of the PPG 
component alone. Thus the ratio of, the ratio defined in equation (3.16), for two 
wavelengths, red (R) and infrared (IR), call it R ', is given by, 
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This is the variable defined in equation (3.13) as the ratio of ratios, that is, 
ROS. For a uniformly sampled discrete time signal, the time domain derivative of a 
signal I, is approximately given by, 
 2
( ) ( ) ( )dI t 1I t I tdt
≈ − . (3.18) 
Note that if t2 and t1 are chosen to be the peak and valley of the local PPG 
signal respectively, then the derivative method reduces to the peak and valley 
method. 
Potratz (1994) described a variation of the derivative method of calculating 
ROS in a US patent, intended for noise reduction. A limited description of the means 
by which the Ohmeda clinical pulse oximeters perform ROS calculation is provided 
by Wukitsch (1987) and by Wukitsch et al. (1988). The Ohmeda system calculated 
the change in received light intensity (∆ I ) at each wavelength thirty times per 
second. From these ∆ IR and ∆ I IR, the ratio ROS was calculated and converted to 
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instantaneous oxygen saturation values SpO2i. A moving weighted average of ten 
SpO2i values at a time is used to update the displayed SpO2 value, which is updated 
every three seconds. Wukitsch noted that the values of ∆ IR and ∆ I IR obtained close 
to the inflection points of the PPG waveforms are less accurate than those obtained 
during the rising part of the waveform, and as such are assigned a lower weighting. 
Wukitsch and his co-authors were, at the time, Ohmeda employees and did not 
describe how the device determined these weights.  
Though Wukitsch does not state the cause of the inaccuracies near the 
inflection points, they are to be expected on two accounts. First, the change in light 
intensity over a given sampling period will be least in the region of the inflection 
points, as the rising arterial pressure slows, temporarily remains static, and then 
begins decreasing, and vice versa at the next inflection. Since the device has fixed 
measurement accuracy, the error associated with very small values will be 
proportionately greater. Second, the corresponding measurements of ∆ IR and ∆ IIR 
are not made simultaneously but rather in a multiplexed fashion. While the arterial 
pressure is rising steadily, the PPG waveform has relatively fixed slope, and 
sampling the R and then the IR waveform introduces little error. This is not true at 
the inflection points, where the slope may be positive at one sample instant and 
negative at the next. (Section 5.4 revisits this in relation to the performance of the 
non-contact camera based device described later.) 
3.2.3 THE NEED FOR CALIBRATION 
The method by which pulse oximetry operates and the exclusion of the variance in 
path length and incident light intensity as variables from the calculation seem to 
obviate calibration. To a large extent this is true, the isolation of the PPG signal 
eliminates the contributions to the attenuation of the detected light that result from 
reflection from the skin’s surface, and the relatively static attenuation due to 
absorption and scattering by muscle, bone, fat, venous blood and other tissues. 
However the change in attenuation that occurs over the duration of the cardiac 
pulse, due only to arterial blood, is itself composed of both absorption and 
scattering. The varying absorption (discussed above) was attributed to a rotation of 
the biconcave erythrocytes and the increase in blood volume (that is more densely 
packed erythrocytes) at systolic pressure. The erythrocytes, on which the absorbing 
haemoglobin species are located, have a diameter of approximately 700 nm 
(Wieben 1997). This is sufficiently close to the wavelength of the interrogating light 
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to cause Mie scattering. In addition, the populous erythrocytes are suspended in 
plasma, each of which has a different refractive index, and so light is scattered by 
the erythrocyte-plasma interface. The probability of scattering occurring at the 
interface is determined not just by the respective refractive indices, but also by the 
angles of incidence and transmission of the light (see Section 2.3.3). To compound 
the complexity of this scattering, the erythrocytes and plasma are constantly pulsing 
between the source and detector with the orientation of the erythrocytes alternating 
with the pulse. In addition the magnitude of this effect varies with oxygen saturation 
as the various species of absorbing haemoglobins become more or less numerous—
not to mention patient-to-patient variances such as anaemia (deficiency of 
erythrocytes or haemoglobin) and sickle-cells (characterised by abnormally shaped 
red blood cells). A further consideration is the bandwidth of the light sources: the 
calculations assume monochromatic sources, the measurement of the emission 
spectra of the LEDs in the non-contact device (presented in Section 5.2.4.2) 
indicates the degree to which this assumption may be invalid. 
For illustrative purposes, a comparison is made here, of the theoretically 
predicted and empirically observed, variance of attenuation at two wavelengths 
with arterial oxygen saturation (SaO2). For simplicity, assume that the only species 
of haemoglobin present are oxyhaemoglobin HbO2, and (reduced) haemoglobin 
Hb. Thus when SaO2 is 100%, HbO2 accounts for all of the haemoglobin and Hb 
accounts for none; at 50% SaO2, they each account for half the haemoglobin; at 0% 
SaO2, Hb accounts for all haemoglobin and so on. Using the common red and 
infrared wavelengths of 660 nm and 940 nm respectively, the specific extinction 
coefficients (α)  of Hb and HbO2 are: αHb, 660 = 3.4408, αHb, 940 = 0.7874, 
αHbO, 660 = 0.3346, and αHbO, 940 = 1.3520, each with units mMolar-1 cm-1 (from the 
values reported by Cope (1991), see Figure 3.7). The absorption due to arterial 
blood at each wavelength can be calculated using the equations, 
 ,660 ,660660 0,660
(e )Hb Hb HbO HbCI I α α− × + ×= OC
)
, (3.19) 
 ,940 ,940940 0,940
(e Hb Hb HbO HbCI I α α− × + ×= OC . (3.20) 
The variable C denotes the relative concentrations of either Hb or HbO and varies 
between 0 and 1 as SaO2 varies. The sum of the relative concentrations of both 
wavelengths is thus always 1. The optical path length is omitted from the 
calculation using the earlier argument that it is approximately equal for both 
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wavelengths. The incident light intensity I0, is set to be the same for each 
wavelength, thus the ratio of red to infrared arterial absorbance is given by, 
 660
940
ln
ln
(
( )OS
R
)I
I
= . (3.21) 
The resulting curve is plotted in Figure 3.9 as the solid line. Also plotted in 
Figure 3.9 is the empirically observed change in the ratio of the absorbance at the 
same two wavelengths, as reported by Wukitsch et al. (1988). The empirical change 
in absorption with SaO2 is linear. The empirical and theoretical graphs are in 
relatively close agreement while oxygen saturation is above 37%, however below 
this saturation6 the empirical observation increasingly underestimates the arterial 
oxygen saturation. At high saturations, a small measurement error might be 
tolerated, since decisions regarding the patients’ management would likely not be 
affected. However at low saturations, decisions regarding a patient’s management 
are critical and device error in this region of operation could be extremely 
consequential. 
 
Figure 3.9 Deviation of theoretically predicted and empirically observed, 
red/infrared ratio variance as a function of oxygen saturation. 
                                                 
6 Wukitsch et al. do not state how data pertaining to low oxygen saturations are 
obtained. Presumably it is by extrapolation or in vitro calibration techniques, since it is 
unacceptably dangerous to desaturate a human subject below 85% due to the risk of 
hypoxic brain damage (Moyle 1994). Note that Schowalter (1997a) suggests that a 
saturation as low as 60 % is achievable. Some studies have been made of pulse oximeter 
performance at low saturations using hospitalised patients already exhibiting very low 
saturation, see Kelleher (1989) for a summary of such studies. 
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For this reason, several studies have been conducted investigating the 
applicability of various absorption and scattering models to pulse oximetry. Steinke 
and Shepard (1986) studied the multiple scattering model developed by Twersky 
(1970). Marbel et al. (1994) also studied this topic but reached the conclusion that 
such models could not replace clinical calibration studies.  
Some equations have been developed that relate measured ROS to SpO2 using 
clinically derived constants. Mendelson and Kent (1989) derived the curve, 
 1 22
3 4
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p
OS
k k R
S O
k k R
−= − . (3.22) 
Where k1…k4 are clinically determined constants. 
Fine and Wienreb (1995), report the use of a quadratic polynomial curve by 
Ohmeda and Radiometer pulse oximeters, of the form 
 . (3.23) 22 1 2 3pS O k k R k R= + +
Where k1…k3 are again, clinically determined constants 
The use of lookup tables is a popular alternative, as multiple conversion 
curves can be stored to accommodate variances in the interrogation wavelength 
(Moyle 1994; Wieben 1997). 
3.3 OPERATION OF A CLINICAL DEVICE 
3.3.1 LIGHT EMITTING DIODES 
All clinical pulse oximeters utilise light emitting diodes (LEDs) as light sources 
(Bourgeois 1997). LEDs produce light by electroluminescence, which is highly 
efficient compared to other forms of light emission such as photoluminescence or 
high-temperature emission. The fact that LEDs are so suited to the application is a 
result of the convergence of several parameters. First, LEDs emit light with 
wavelengths over a range of approximately 700 nm from violet (about 400 nm, just 
below indigo and blue) in the visible range to the near infrared. This band of 
emission overlaps the near infrared window into tissue (Jobsis-vanderVliet 1999) 
and coincides with suitable peaks in the absorption spectra of Hb and HbO2 (Elwell 
1995). 
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Manufacturers commonly specify the following parameters of LEDs: peak 
emitted wavelength, bandwidth, beam angle, forward voltage, forward current and 
corresponding emitted power, power dissipation, reverse breakdown voltage, 
reverse current, operating temperature, switching times, maximum pulse current as 
a function of duty cycle and frequency, dimensions, and finally, cost. A thorough 
explanation of all of these parameters is to be found in many electronics textbooks 
and handbooks. It is sufficient here to say that the requirements of pulse oximetry 
do not approach the limits of any of these parameters—with two caveats. First the 
specified peak emitted wavelength of a light emitting diode, can vary from one 
device to the next, by an amount sufficient to introduce a significant error in the 
calculated oxygen saturation percentage. Steps must be taken to account for this. 
Second, in pulse oximetry, LEDs are placed in direct contact with the skin, often for 
long periods. LEDs have the capacity to cause burns and their power dissipation 
must meet certain specifications.  
3.3.1.1 VARIANCE IN PEAK EMITTED WAVELENGTH 
LEDs produced in bulk from the same material should have the same characteristics 
including peak emitted wavelength. As with all manufacturing processes, 
imperfections occur. Pologe (1987) investigated the variance in peak emitted 
wavelength of LEDs produced in bulk from the same lot at the common 
wavelengths of 660 nm and 940 nm, and found that the variance can be as much as 
15 nm from the specified peak wavelength. This is particularly important at the 
lower red wavelength, where the absorption spectrum of Hb has a very steep slope.  
Figure 3.10 displays the effects on the theoretical ratio of the red and infrared 
signals, caused by a 15 nm increase in the peak emitted wavelengths of a 660 nm 
and a 940 nm LED, as the arterial oxygen saturation varies between 100% and 0%. 
(The values of the Hb and HbO2 extinction coefficients at these wavelengths were 
reported by Cope (1991) and the description of how these curves are generated was 
given in Section 3.2.3.) Note that the deviation of the empirically observed red–
infrared ratio from the theoretical variation with arterial oxygen saturation was 
discussed in Section 3.2.3.  
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Figure 3.10 Variance in red/infrared ratio caused by a 15 nm increase in 
peak emitted wavelength, in the red (660 nm) and infrared (940 nm) 
LEDs. 
To compensate for this effect device manufacturers employ one of two 
strategies. During manufacture, the peak emitted wavelength of each diode is 
measured using a spectrometer. With the first strategy the manufacturer uses only 
diodes that are extremely close to the specified wavelength, for example, Hewlett 
Packard selects diodes that are within ±1 nm of 660 nm for the red wavelength 
(Bourgeois 1997). The second strategy used by manufactures is to note the peak 
emission wavelength of each LED and then to include some way for a device to 
interrogate a probe upon connection and choose a calibration curve appropriate to 
the two wavelengths contained in that probe. A common method of performing this, 
described in patents by New and Corenman (1987; 1988), is to include a resistor in 
the probe, the resistance of which, indicates the wavelength combinations of the 
LEDs contained in that probe. When a probe is connected to a device, the device 
sends a current through the coding resistor and uses the measured voltage drop to 
determine the resistance and hence the wavelengths.  
Each method has its drawbacks—selecting only LEDs that meet the criteria 
diminishes the cost saving of bulk buying, while the addition of an extra component 
and the associated additional functionality required by the coding resistor method 
have a direct cost. Both approaches require measurement of every purchased LED. 
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3.3.1.2 DRIFT IN PEAK EMITTED WAVELENGTH 
The wavelength of light emitted from an LED is described by, 
 g
hc
E λ= , (3.24) 
where Eg is termed the band gap (or energy gap) in electron volts, h is Planck’s 
constant, c is the speed of light in a vacuum, and λ is the wavelength of emitted 
light. The physical properties of the material from which the LED is constructed 
determine the value of Eg. Materials such as gallium arsenide phosphide (GaAsP) 
and gallium phosphide (GaP) are commonly used to construct LEDs in the visible 
range with wavelengths from 380 nm to 740 nm, while gallium arsenide (GaAs) is 
commonly used to produce near infrared wavelengths. Though less common 
gallium aluminium arsenide (GaAlAs) can be used to produce both visible and near 
infrared light (Bourgeois 1997).  
Eg is also a function of the p-n junction temperature, typically decreasing as 
temperature increases (Varshni 1967), which, referring to equation (3.24), causes 
the emitted wavelength to increase. During operation, the pulse oximeter LEDs are 
alternately pulsed with duty cycles ranging from 2% to 50% depending on the 
manufacturer (Reynolds, et al. 1991). The resulting average driving current is 
usually still sufficient to cause heating of the p-n junction. Note that pulse oximeters 
typically vary the driving current to each LED in proportion to the amplitude of the 
detected PPG at that wavelength (Bourgeois 1997; Moyle 1994). 
In addition to the heating caused by driving current, the effect of ambient 
temperature can be significant. de Kock et al. (1991) investigated these effects using 
wavelengths of 660 nm and 950 nm. The maximum shift of peak wavelength due to 
driving current (at 100% of maximum rated drive current for duty cycle and 
frequency) was 8 nm for the red LED and 0 nm for the infrared LED. For an increase 
in ambient temperature from 0 °C to 50 °C, the maximum shift of peak wavelength 
was 5.5 nm for the red LED and 7.8 nm for the infrared LED. Referring again to 
Figure 3.10, though the error due to peak wavelength drift during operation is 
smaller than that resulting from device-to-device peak wavelength variance, it will 
be significant. 
Device manufacturers compensate for this by either placing a temperature 
sensor in the probe or by directly monitoring the driving current for both LEDs. In 
both cases, the information is fed back to the device’s microprocessor, where an 
estimate is made of the current LED wavelengths. The device then chooses a new 
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calibration curve appropriate to the current wavelength combination (Bourgeois 
1997). 
3.3.1.3 PREVENTION OF BURNS 
Several international and national standards have been published pertaining to pulse 
oximetry: ISO 9919 and ASTM F1415. For the most part these documents specify 
the parameters, data, and methods of calibration, which the manufacturer should 
provide or make available on request. Issues such as electrical safety and 
electromagnetic interference are also covered, as well as descriptions of alarms that 
devices should provide. For the most part these documents are of limited use to 
pulse oximeter designers. The American Food and Drug Administration requires 
that the temperature of the contact region between the probe and the skin not exceed 
41 °C. The pertinent LED parameter is the specified thermal resistance, which is 
defined as the increase in p-n junction temperature (TJ) above the ambient 
temperature (TA), per unit of power dissipation (PD), with units of °C/W. In the 
event there is no heat sink, it is given by, 
 J ATH
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Typically, LEDs used in pulse oximeters possess a sufficiently low RTH and 
low average driving current to pose no significant risk (Bourgeois 1997). Moyle 
(1994) noted that although there had, as of 1994, been several reports of pulse 
oximeter probes causing burns, especially in small children, these were most likely 
not caused by thermal emissions from LEDs; rather Moyle suggests that these were 
pressure necroses caused either, by the probe being too tight, or by poor perfusion 
of the skin under the probe. Note however that some specialised pulse oximetry and 
tissue oximetry applications utilise higher performance LEDs with highly dissipative 
metal cases, which may be necessitated by a demand for deeper tissue penetration, 
beyond the normal requirements of pulse oximetry. Such systems have the potential 
to cause thermal injuries and care should be taken to ensure compliance (see Coyle 
(2005) as an example of such a system). 
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3.3.2 PHOTODETECTORS AND AMPLIFIERS 
One of the hindrances to early oximetry was the lack of suitable detectors. While 
the photocells used by early oximeters were sensitive across the wavelengths now 
used in pulse oximetry, those devices produce a varying resistance in response to 
changes in incident light intensity. Their response is highly non-linear and slow. In 
addition they are temperature sensitive. The magnitude of the change in resistance 
produced by incident light is very large, typically between 100 Ω and 100 MΩ 
between dark and illuminated conditions (though Schowalter (1997b) states that it 
can be as large as 1014), which makes incorporating them into instrumentation 
circuitry challenging. They are also unsuitably large with diameters of 5 mm to 
25 mm.  
Modern pulse oximeters have a range of alternative devices available. Shottky 
diodes provide ultra fast response times, though are typically used in ultraviolet 
sensing applications. Avalanche photodetectors (APDs) use an avalanche 
multiplication effect to provide very high sensitivity. APDs are suited to specialised 
applications where detected light levels are low (see Coyle et al. (2004) as an 
example of such). However APD response time is comparatively slow and the large 
reverse bias required for their operation creates a large electric field that may 
preclude the use of APDs in some clinical situations (Pallas-Areny and Webster 
1991). Phototransistors possess some characteristics favourable to pulse oximetry, 
notably they can provide built-in current amplification, yielding a light-to-current 
conversion ratio that can be hundreds of times greater than a similar photodiode. 
Phototransistors were used in early pulse oximeters (Schibli, et al. 1978) though 
their comparatively large dark currents and non-linear sensitivity over the range 
useful in pulse oximetry ultimately saw them replaced by photodiodes as the sensor 
of choice (New and Corenman 1987). 
Photodiodes offer good linearity between incident light and output current 
when connected in a photoconductive mode, at a reasonable cost. The only 
challenger to their dominance is the integrated circuit (IC) detector. IC devices can 
incorporate a photodiode and transimpedance amplifier, to produce an output 
voltage that varies linearly with incident light intensity. By placing the initial 
amplification stage so close to the source, IC detectors can achieve excellent noise 
performance. The principal drawback to the IC detector is that the component itself 
is several times the price of a photodiode and requires extra wires. Its size may also 
be a limiting factor in some applications. 
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3.3.3 SIGNAL PROCESSING 
The extent and complexity of signal processing employed by individual commercial 
devices varies among manufacturers. However signal processing invariably consists 
of sampling, de-multiplexing of the signals from each channel, and analogue to 
digital conversion—each of which is also of relevance to a non-contact device. 
3.3.3.1 SAMPLING 
Device manufacturers employ various sampling and timing strategies, though 
invariably, they each contain an ambient light sample during which neither LED is 
energised. This ambient light level is later subtracted from the signal.  
Figure 3.11 depicts the output of the photodiode from an Ohmeda pulse 
oximeter. The system uses a three-state clock in which, the red LED is pulsed, 
followed by the infrared, followed by a period of the same length in which neither 
diode is energised (Pologe 1987). 
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Figure 3.11 Ohmeda timing diagram: three-state clock, adapted from 
Pologe (1987). 
Figure 3.12 depicts the output from a Nellcor device using a four-state clock in 
which, the red LED is pulsed, followed by a dark sample, following which the 
infrared LED is pulsed, followed by a second dark sample. Each period is of equal 
duration.  
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Figure 3.12 Nellcor timing diagram: four-state clock, adapted from 
Paranjape (1997). 
The comparative merits of either sampling strategy or of other sampling 
strategies are unreported in the literature.  
3.3.3.2 DE-MULTIPLEXING 
The photo diode detector of the pulse oximeter probe produces a continuously 
varying output current that is sampled by a sample-and-hold circuit. Since the 
photodiode’s output current contains information from both the red and infrared 
channels, the signal is first de-multiplexed to produce two separate red and infrared 
signals. Each signal is then low-pass filtered to remove any high frequency 
switching noise (Paranjape 1997). 
3.3.3.3 ANALOGUE TO DIGITAL CONVERSION 
Note that the detected light intensity consists of a pulsatile, and non-pulsatile 
component that varies slowly compared to the pulsatile component. Recalling the 
discussion of Section 3.2, both of these components are required for the calculation 
of the arterial oxygen saturation. However it is also important to measure the 
pulsatile PPG component as accurately as possible (see Section 3.2.2.2 on the 
inaccuracy of ROS readings obtained near the inflection points). Thus the maximum 
utility of the analogue to digital conversion (ADC) quantization range would not be 
obtained were the captured light intensity signals to be quantized directly, since a 
large part of the quantization range would be used up by the almost stationery DC 
offset. Therefore, prior to ADC the DC component is removed, its magnitude 
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digitised and stored, such that it can be added back to the signal prior to later 
calculations where it is required. The matter was first described in a US patent by 
Cheung et al. (1989a). (Whether this remains a problem for contemporary clinical 
devices, with access to modern ADCs, is questionable, it is however pertinent to the 
camera-based device described later, where limited quantization range will be 
shown to be consequential.)  
3.3.4 PROBES 
The discussion so far in this chapter has alluded principally to transmission of light 
through tissue, in practice, pulse oximeter probes can operate by transmittance or 
reflectance—though the use of the word reflectance is a little misleading as the 
sensor is actually detecting what is more accurately described as backscattered light. 
The term reflectance is an anachronism that dates from the nineteen fifties, prior to 
studies of light propagation in tissue, it remains in use in relation to pulse oximetry 
(see Section 2.3.3). Within the category of reflectance probes, probes may also be 
reusable or disposable. 
3.3.4.1 TRANSMITTANCE PROBES 
In the case of a transmittance probe, the two LEDs and the photo diode are housed in 
a clip designed to fit around a finger or toe, the bridge of the nose, or the earlobe. 
The photodiode is located on one side of the clip with the two LEDs side by side on 
the other side of the clip directly opposite the detector. The clip itself serves to 
shield the detector from ambient light and to maintain good contact between the 
optical elements and the tissue. The only significant variable in transmission probes 
is the force applied by the clip. This varies with manufacturer and model. If the 
force exerted by the probe is significant, the blood underneath the probe may clot 
and if the force is insufficient motion artefacts may increase (Reddy 1997). 
The advantage of transmittance probes is that they are reusable indefinitely 
and have the lowest associated cost per usage. Their disadvantages include the 
aforementioned risk of clotting, their tendency to reduce circulation in the region of 
the probe over time, and the risk of cross contamination. Indeed cleaning of the 
probe is required between patients, and their use in not recommended for infectious 
patients or patients with high risk of infection, such as neonates or immuno-
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suppressed patients. As such, transmittance probes are best suited to short term 
monitoring, typically less than four hours (Reddy 1997). 
3.3.4.2 REFLECTANCE PROBES 
Early investigations into measurements in a reflection geometry were conducted by 
Brinkman and Zijlstra, who produced a commercially available reflectance 
oximeter for measurements from the forehead—the Cyclops—as early as 1950. 
Detailed studies were subsequently published by Zijlstra (1953; 1958). The idea of 
reflectance (backscatter) based oxygen saturation measurement marked a significant 
advancement in non-invasive measurement, ultimately making possible measure-
ment from any part of the body surface.  
In the case of disposable probes, which are invariably reflectance probes, the 
probe is adhesive. For reusable reflectance probes some variety of adhesive wrap is 
used (Reddy 1997). 
The mechanisms of back scattering of light in tissue were discussed in 
Chapter 2. The two variables of concern in the design of reflectance probes are the 
source and detector separation and the photosensitive area of the detector—or 
indeed the number of detectors and their arrangement. 
As the source and detector separation increases, so does the penetration depth 
of the detected light. A greater penetration depth and longer optical path, illuminates 
a larger vascular bed, and increase the likelihood of detecting a suitable PPG. 
However, for a given incident light intensity, as the source and detector separation 
increases the detected light intensity decreases. 
Mendelson and Ochs (1988) investigated the effect of using three photodiode 
detectors, arranged symmetrically around the two LEDs. This effectively tripled the 
photosensitive area of their detector and allowed proportionately larger PPG signals 
to be detected for a given source and detector separation. Reddy (1997) stated that 
the same effect could be obtained by using a photodiode with three times the area. 
This is likely inaccurate, as a single detector with an enlarged area could not be 
positioned such that the extra area is equidistant from the source. Since the detected 
light intensity decreases with increasing radial separation of the source and detector, 
the extra area of the larger photodiode would receive increasingly less back 
scattered light as it becomes distant from the sources, compared with the case of 
three detectors arranged symmetrically. However, a case will be presented later in 
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this thesis, for favouring one large continuous detection area rather than multiple 
symmetrically arranged discrete locations (see Section 5.5.2), particularly where the 
source and detector separation is considerable. 
3.3.5 CALIBRATION OF PULSE OXIMETERS 
Recall from the discussion in Section 3.2.3, that while the technique of pulse 
oximetry removes the unwanted contributions of absorption and scattering by 
tissues other than the arterial blood, scattering by the arterial blood itself, causes the 
empirically observed ratio of absorption at two wavelengths to differ from that 
predicted by theory (see Figure 3.9). For this reason it is necessary to derive 
empirical calibration curves that map the observed ratio of absorption at two 
wavelengths to the actual value of arterial oxygen saturation. Calibration can be 
performed in vivo or in vitro.  
3.3.5.1 IN VIVO CALIBRATION 
In vivo calibration was until 1993 the only method used to calibrate pulse oximeters 
(Moyle 1994). In vivo calibration typically takes place in a hospital environment 
using informed and consenting, non-smoking, healthy volunteers as human test 
subjects. Subjects are fitted with an indwelling arterial cannula placed in the radial 
artery. An initial arterial blood sample is taken and tested to ensure that only normal 
adult haemoglobin is present and that each subject’s background levels of 
carboxyhaemoglobin and methaemoglobin are within normal limits. Typical values 
are MetHb < 1% and 1% < COHb < 2% (Moyle 1994; Schowalter 1997a; 
Wukitsch, et al. 1988). A CO-oximeter is used to determine the oxygen saturation of 
the blood samples precisely. The subjects breathe air or oxygen-enriched air until 
their arterial blood samples show 100% saturation. The subjects’ arterial oxygen 
saturation is gradually and incrementally reduced by replacing the oxygen in their 
breathing gas with nitrogen, and pausing at each step to allow time to equilibrate. 
When the device under test indicates a stable reading, an arterial sample is 
immediately taken and analysed by the CO-oximeter. The data from each device are 
plotted against each other to yield a graph with oxygen saturation on the vertical 
axis and ratio of absorption at two wavelengths on the horizontal axis (see 
Figure 3.9). A lookup table is then constructed to perform an exact mapping of the 
ROS readings from the device under test to the corresponding SaO2 level, or, a 
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transform equation is constructed that generates a best fit to the plotted graph. This 
process must be repeated for every LED wavelength combination that the 
manufacturer intends to use in their probes. 
There are several reasons why in vivo calibration is unsatisfactory. The 
principal reason is that because it is unsafe to desaturate a human test subject below 
85% (due to the aforementioned risk of hypoxic brain damage), the data that result 
from in vivo calibration pertain only to high oxygen saturations—where the need to 
ascertain accurate oxygen saturation readings is least. The mapping of ROS to SaO2 
for lower saturations must be extrapolated. 
3.3.5.2 IN VITRO CALIBRATION 
In vitro calibration methods can be divided into those that use blood or 
haemoglobin solutions and those that do not. Methods that do not use blood or 
haemoglobin solutions can generally provide only one reference saturation point, 
which limits their utility. Though the appeal of a blood free device is such that 
several attempts have been published—see Munley (1989) for a pragmatic 
example—the consensus however, is that versatile in vitro methods require a blood 
or haemoglobin solution (Reynolds, et al. 1992).  
Several blood-based in vitro techniques have been described in the literature 
and in patents, ranging in complexity from Yount’s (1989) wedge-based technique 
to the comprehensive system described by Reynolds et al. (1992). The system 
described by Reynolds et al. is depicted in Figure 3.13. It serves as a good example 
of the tasks and components involved. 
The system uses whole blood to which the anticoagulant heparin has been 
added. A computer controlled peristaltic pump circulates the blood around a closed 
loop with minimum damage to the erythrocytes, mimicking the pulsatile blood flow 
of the arteries. A gas-mixing pump provides a mixture of O2, N2 and CO2, in user 
defined proportions. The CO2 is necessary to maintain the correct pH and realistic 
carbon dioxide partial pressure. Gas diffuses into and out of the blood through an 
oxygen membrane, which provides a large permeable interface area with gas on one 
side and a thin film of blood on the other, mimicking the alveolar function of the 
lungs. The probe of the pulse oximeter under test is attached to a phantom finger in 
which the blood is circulating. A sample port provides an extraction point for blood 
samples, which are subsequently analysed by a CO-oximeter. The computer, using 
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parameters fed-back from a second, modified pulse oximeter, varies and controls 
the gas mixture and rate of peristaltic displacement, to simulate the desired heart 
rate and arterial oxygen saturation. 
Gas supply 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Probe of device
under test
Phantom 
finger 
Circulating 
blood 
Sample port to 
CO-oximeter 
Membrane
oxygenatorComputer 
controlled 
peristaltic 
pump 
Reservoir
Mixing Pump 
CO2 NO2O2
Figure 3.13 Apparatus for in vitro calibration of pulse oximeters 
(Reynolds, et al. 1992). 
The construction of the phantom finger, to which the probe of the device under 
test is attached, is an important factor. The phantom should possess similar 
absorptive and scattering properties to a real finger and in addition, should exhibit a 
similar variance in volume to a real finger, when exposed to the artificial pulse. A 
system similar to that of Reynolds et al. was developed by Vegfors et al. (1993), 
though with a greater emphasis on the phantom finger. 
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3.4 LIMITATIONS AND APPLICATIONS OF PULSE OXIMETRY 
3.4.1 ACCURACY AND ERRORS 
In Section 3.2.1.2 the saturation quantity, SpO2, displayed by a pulse oximeter was 
defined as the ratio of oxyhaemoglobin to total haemoglobin. This definition is 
imprecise and in need of revision. The quantity defined in equation (3.10) is in fact 
the functional arterial oxygen saturation, defined as, 
 22
2
HbO
Functional O 100%
HbO + Hba
S = × . (3.26) 
The functional oxygen saturation ignores species of haemoglobin that are 
present in the blood but not available for oxygen transportation. The percentage 
oxygen saturation of all haemoglobin in the blood is termed the fractional oxygen 
saturation, and is given by, 
 22
2
HbO
Fractional O 100%
HbO + Hb + HbCO + MetHba
S = × . (3.27) 
It is important to note that pulse oximeters measure neither of these quantities, 
but rather measure the absorption of light at two wavelengths and use empirically 
derived calibration tables to map the ratio of the absorption at each wavelength to 
either the fractional or functional saturation. Since pulse oximeters are calibrated 
using a CO-oximeter, which measures at least the four quantities in the denominator 
of equation (3.27), CO-oximeters can measure either functional or fractional 
saturation. Thus a pulse oximeter can display an estimate of either the fractional or 
functional oxygen saturation; it is up to the manufacturer to explicitly state which 
parameter their particular device is estimating.  
It is important to remember that regardless of the manufacturer’s goal to 
measure fractional of functional saturation, the device will display neither of these 
quantities, since, invariably, the patients’ blood pH and background levels of 
dyshaemoglobins will differ from those of the calibration subjects’—and perhaps 
significantly since a patient is presumably in a state of illness when monitoring 
commences. Moyle (1994) stated that the quantity displayed by a pulse oximeter, 
SpO2, is best thought of and referred to, as the oxygen saturation as displayed by a 
pulse oximeter, since it is variable between devices and unavoidably inaccurate in 
either case to a varying degree. 
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With this in mind, how good is a pulse oximeter’s estimation of arterial 
oxygen saturation, and how useful is it?  
Pulse oximeter performance is rated by its accuracy; the systemic error or bias 
associated with the method; and, its precision; the reproducibility of the 
measurement or the variation of the random error associated with the 
measurements. The CO-oximeter is the gold standard against which pulse oximeter 
performance is calibrated and compared. (CO-oximeter manufacturers (IL 482) 
report precisions as high as 0.5% (Tungjitkusolmun 1997).) It is obviously desirable 
that the magnitudes of these parameters are as small as possible—however in 
clinical practice it is generally acceptable for a device to exhibit a 95% confidence 
limit of ±3% (Tungjitkusolmun 1997), though its accuracy will be determined by 
several factors relating to the patient’s condition. 
Some of the other factors affecting pulse oximeter accuracy are summarised 
below. They are naturally of great interest to clinicians and competing device 
manufacturers alike. 
3.4.1.1 DYSHAEMOGLOBINS AND FETAL HAEMOGLOBIN 
The affects of dyshaemoglobins and fetal haemoglobin beyond their normal 
background levels are multifarious. Any increase in their levels causes an increase 
in the denominator of the fractional saturation defined in equation (3.27). Their 
overall effect on the displayed SpO2 value is determined by the haemoglobin 
specie’s absorption spectrum and the wavelengths of light used by the pulse 
oximeter.  
A discussion of their individual affects on SpO2 is to be found in Moyle 
(1994), Reynolds et al. (1993), and Tungjitkusolmun (1997). 
3.4.1.2 SATURATION, PERFUSION, AND OTHER FACTORS 
Perhaps the most crucial relationship to quantify is the variance in pulse oximeter 
error as a function of oxygen saturation. This is typically specified for regions of 
oxygen saturation. In the region of high saturation (greater than 97.5%) the 
statistical parameters pertaining to a pulse oximeter’s performance are difficult to 
establish accurately. Since pulse oximeters never display saturations greater than 
100% the accuracy and precision of their measurements in this region are biased 
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(Clayton, et al. 1991a). However patients in this saturation range are in no 
immediate danger. 
Pulse oximeters have reliable performance in the region of normal saturation 
(90% to 97.5%). This is the easiest region in which to obtain in vivo calibration 
data. In a study of thirteen commercial devices Webb et al. (1991) found that eight 
devices had absolute mean errors of less that 1% and a standard deviation of less 
that 2%, while in the remaining five devices these figures were 2% and 3% 
respectively. Taylor and Whitman (1988), reported a mean bias of +2.8% for five 
commercially available devices in the saturation range 80% to 100%. 
At low saturations (less than 80%) pulse oximeters are most susceptible to 
errors. Recall from Section 3.3.5 on calibration that it is unethical and dangerous to 
repeatedly desaturate volunteers to these levels during in vivo calibration. Thus 
many of the calibration curves are extrapolated in this region. The absorption 
spectrum of the most abundant absorber at these saturations, Hb, is steep at the 
common red wavelength of 660 nm, making devices particularly susceptible to 
wavelength variances at these saturations (see Section 3.3.1). Webb et al. (1991) 
also reported the use of intensive care patients exhibiting low saturations to test the 
same thirteen devices. The results varied among manufacturers, though absolute 
values of bias and precision decreased in all devices. Two devices, a Datascope 
Accusat and a Nonin 8604, had biases within 1.7% of each other for normal 
saturations, which increased to 15.9% for low saturations. 
Mannheimer et al. (1997) conducted the first study aimed at improving pulse 
oximeter performance in the crucial low saturation range. They used both Monte 
Carlo and photon diffusion numerical models to simulate the affect of wavelength 
on oximetry accuracy at low saturations. They concluded that wavelengths of 
735 nm and 900 nm provide the best trade-off between low saturation accuracy and 
the need to equilibrate the fractional change in path length experienced by both 
wavelengths (see Section 3.2.1.1).  
Since pulse oximeters require an arterial pulse, low perfusion can be 
problematic. Poor perfusion and a concomitant reduction in peripheral arterial 
pulsations can result from hypothermia, vasoconstriction, hypotension, or cardiac 
arrest. Another interesting complication can result from venous congestion, where 
blood is accumulated within an organ. The resulting backpressure can introduce 
pulsations into the venous blood, which cause that blood to contribute to the pulse 
oximeter reading. Since venous blood is considerably less rich in oxygen, the 
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resulting SpO2 values are lower than the true value (Tungjitkusolmun 1997). This 
phenomenon is also the basis for venous oximetry, in which, an artificial pulsation 
that is discernable from the natural arterial pulsation, is introduced to the venous 
blood. When combined with pulse oximetry, venous oximetry has the potential to 
yield local tissue oxygen consumption data in a relatively non-invasive manner 
(Chan, et al. 2003). 
Some further factors that can introduce error are: motion artefacts, optical 
interference, intravenous dyes, nail polish, activity, and the presence of dried blood. 
3.4.1.3 ACCURACY AND PROBE LOCATION 
Some consideration should also be given to the location of the pulse oximeter 
probe. Under certain conditions, principally rapid desaturation, the accuracy can 
vary with probe location. It has been known for some time that PPG signals captured 
from the finger differ significantly compared to those captured from the ear. Nijboer 
and Dorlas (1985) demonstrated that changes in pressure during induction, 
maintenance, and recovery from anaesthesia, are greater when recorded from the 
finger, and hence should preferably be measured from the finger.  
In relation to pulse oximetry, Severinghaus et al. (1989) found that ear and 
forehead probes generally had a much faster response to changing SaO2 values than 
finger probes. Young et al. (1992) conducted a significant study of this phenomenon 
at the Royal Air Force Institute of Aviation Medicine. They measured the response 
times of thirteen pulse oximeters from ten manufacturers using twenty-six probes 
(thirteen ear and thirteen finger probes) to a 10% step reduction in arterial oxygen 
saturation. Ear probes showed a faster response than finger probes. 
In relation to poor perfusion, Clayton et al. (1991b) showed that finger probes 
have superior performance to either ear, nose or forehead probes, and recommended 
their use in poor perfusion situations.  
3.4.2 LIMITATIONS 
J. Severinghaus at the conclusion of a considered history of the entire field of blood 
gas analysis (to which he himself made significant contributions in carbon dioxide 
measurement) said of pulse oximetry:  
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Pulse oximetry is arguably the most important technological 
advance ever made in monitoring the well-being and safety of 
patients during anesthesia, recovery and critical care. 
(Severinghaus 1987a) 
J. Moyle however, promulgated this caveat, enjoining users against complacency: 
The reputation of the technique of pulse oximetry can be 
maintained only if its limitations are always borne in mind. 
Currently this in not the situation and the indicated value of 
SpO2 is relied on totally by most users. 
(Moyle 1994) 
Beyond the technical and circumstantial constraints discussed above, two 
inherent factors largely account for the limitations of the technique. They should be 
borne in mind equally by the clinician managing a patient and by the researcher 
seeking to find new applications. 
The first is pulse oximetry’s ability to monitor oxygen delivery, be it too much 
or too little. Lack of oxygen at a cellular level is termed hypoxia. Hypoxia can be 
further categorised into four groups: hypoxic hypoxia (arterial Hb oxygen saturation 
is low), anaemic hypoxia (Hb concentration is low—but may be well saturated), 
stagnant hypoxia (low cardiac output or vessel occlusion), and histotoxic or 
cytotoxic hypoxia (oxygen is delivered but cells are unable to utilise it). Of these 
categories, pulse oximetry can measure and indicate only one—hypoxic hypoxia—
though a device may produce readings during instances of other types of hypoxia. 
Thus a patient may be globally or locally hypoxic despite SpO2 readings to the 
contrary. 
Also on this point, pulse oximetry is insensitive to the delivery of too much 
oxygen—hyperoxia. Excess oxygen can be toxic, leading to either central nervous 
system (CNS) toxicity (that can result immediately upon exposure to very high 
oxygen partial pressure, typically greater than 1.6 atm (United States Navy 1994)), 
or pulmonary oxygen toxicity (that can result from prolonged exposure to oxygen 
partial pressures above 0.5 atm (Moyle 1994), common in intensive care). This 
limitation of pulse oximetry is important in monitoring patients receiving 
supplementary oxygen, particularly premature babies and neonates, who can suffer 
retinopathy, resulting in blindness, if their arterial oxygen saturation is allowed to go 
too high (Moyle 1994). 
The second limitation of pulse oximetry is that it requires a pulse. Though it is 
desirable to monitor the oxygen saturation of a patient experiencing cardiac arrest, 
or, exhibiting an irregular pulse, low perfusion, or low blood volume (hypo-
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volaemia), this is exactly when pulse oximetry either, is precluded in the case of 
cardiac arrest, or should be treated sceptically in the remaining cases. Indeed Moyle 
(1994) states that all pulse oximeters should display a PPG, and that the indicated 
SpO2 value should not be relied upon unless the displayed PPG bears a strong 
resemblance to an arterial pressure waveform complete with dichrotic notch.7 
It is worth noting that the limitations of the technique of pulse oximetry apply 
equally to both existing clinical devices and to any future non-contact device that is 
based on the principle. 
3.4.3 APPLICATIONS 
The clinical applications of pulse oximetry in medicine are as 
important as oxygen is to life. This may seem an overstatement, 
but as more and more pulse-oximeters are coming into use, 
more and more hypoxaemic events are being seen as precursors 
of pathological events.  
(Moyle 1994) 
The scientific and medical literature is filled with examples of studies in which 
pulse oximetry has been either the subject or an investigative tool. There are 
numerous calls for, and statements that, pulse oximetry should become a standard 
technique in monitoring patients where their own ability to regulate breathing is 
diminished by either illness or medical treatment. However, the volume of 
publications on the subject, suggests that pulse oximetry has already been adopted 
as a standard in these situations. Indeed it has been suggested in several fields of 
medicine that pulse oximetry should become, or is already being used as, a fifth 
vital sign (Mower, et al. 1998; Mower, et al. 1997; Neff 1988). 
In addition to its common functions pulse oximetry has been used surgically to 
assess the viability of bowel tissue and in so doing, to discern recoverable from 
irrecoverable levels of ischaemia of bowel tissue (DeNobile, et al. 1990). A list of 
other uses to which pulse oximetry has been put since its inception, includes but is 
not limited to the following: 
- Assessing the perfusion of extremities and transferred tissue during 
illness, after injury or surgery, and after reattachment (Lindsey, et al. 
1991). 
                                                 
7 The dichrotic notch is the inflection in the falling edge of the PPG that results from a 
momentary back flow of blood caused by the abrupt closure of the aortic valve. See 
. Figure 3.5
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- In emergency medicine as a quick indicator of the likelihood of 
desaturation as a cause of malaise and to monitor the effectiveness of 
cardio pulmonary resuscitation. 
- In dentistry where sedation or anaesthesia is used and to indicate the 
perfusion and viability of dental pulp (Schmitt, et al. 1991). 
- In monitoring sleep apnoea and generally in sleep studies. 
- In continuous assessment of sick neonates—to whom high saturation 
may also be dangerous. 
- In monitoring the health of pilots of high performance aircraft and in 
monitoring the effects of commercial aircraft cabin pressure on 
passengers. 
- Monitoring both mother and child during childbirth. 
- Computer controlled oxygen weaning. 
- Cerebral oxygen measurement through the eye and measurement of the 
saturation of the retina—which is important in monitoring the progress 
of diseases such as diabetes. 
- Veterinary medicine.  
Key to many of these applications, for example, monitoring the saturation of 
mother and child during childbirth (Chung and McNamara 1993), measuring retinal 
and cerebral saturation (de Kock, et al. 1993) (which unlike peripheral circulation is 
not affected by shock, hypothermia, or haemorrhage), and measuring oesophageal 
saturation (Kyriacou, et al. 2002; Kyriacou, et al. 2003) in patients under going 
thoracic surgery (and who consequently have very low peripheral circulation), has 
been the development of new and different probes apt to the particular needs of the 
monitoring situation.  
It should also be noted that many applications of pulse oximetry are in fact 
utilising only the ability of a pulse oximeter to a display a PPG. For example, 
compromised extremities or transferred tissue (such as skin, muscle flaps, and 
digits) can be assessed using two probes, one on a healthy limb and the other on the 
compromised extremity or transferred tissue.  
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3.5 CHAPTER SUMMARY 
This chapter has reviewed the principles of pulse oximetry and highlighted some 
aspects of commercial device design and construction. Commercial devices employ 
numerous sophisticated digital signal-processing techniques and are comprised of 
both a microprocessor and specialised instrumentation electronics. Though the 
degree of sophistication varies among commercially available devices, the process 
of capturing two PPG signals simultaneously at two different wavelengths is 
fundamental to all conventional pulse oximeters, and equally so to a non-contact 
device. As a further point on the importance of capturing a PPG, while this chapter 
has emphasised how a PPG signal is captured by a pulse oximeter and how arterial 
oxygen saturation is subsequently determined, the ability of a pulse oximeter to also 
display a PPG signal is an integral part of the device’s clinical usefulness. The pulse 
rate (which is determined from the PPG signal) and the profile of the waveform 
itself, when interpreted in conjunction with the arterial oxygen saturation, greatly 
enrich the capabilities of a pulse oximeter, as both a monitoring and diagnostic tool. 
The aspects of clinical device design that have been highlighted—particularly 
choice of source and detector, source and detector separation, reflection-based pulse 
oximetry, and sampling strategy—will be prominent themes in the design 
considerations for a remote non-contact device (Chapter 4), and will be shown to 
have a strong bearing on the performance of such a device (Chapter 5).  
Additionally this chapter has highlighted some of the uses and inherent 
limitations of the technique of pulse oximetry, as well as the importance of the 
technique in its primary application. The current diversity of applications in which 
pulse oximetry is employed and particularly its use in anaesthesia, surgery and 
patient monitoring (with which it has become synonymous), are in stark contrast to 
the needs that spurred its development—an example of Diamond’s adage that in 
contradiction to the popular saying, invention is often the mother of necessity 
(Diamond 1997).  
Together these areas of discussion provide a useful insight into the 
functionality that a novel device must posses as well as defining the levels of 
accuracy and precision that a novel device must approach. The description of the 
limitations of pulse oximetry is instructive in delineating the capabilities and desired 
functionality of a remote camera-based pulse oximeter from existing camera-based 
tissue oxygenation monitoring techniques utilising similar technologies, however 
with markedly different design requirements. 
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DESIGN CONSIDERATIONS 
 
 
 
Equation Chapter 4 Section 1 
This chapter outlines considerations pertaining to the choice of source and detector 
in a remote non-contact pulse oximetry (or photoplethysmography) application. 
This chapter is concerned primarily with identifying suitable technologies for use as 
a source and detector, while the details of the system used in this study are 
presented in Chapter 5, along with analyses of both the components’ performance 
and the system’s performance. This chapter also summarises the existing safety 
guidelines pertaining to exposure to near infrared light. 
4.1 CHOICE OF SOURCE 
Section 3.2.1.2 described the three constraints on the choice of illumination 
wavelength imposed by the technique of pulse oximetry. They were that the 
wavelengths should fall within the optical window into tissue, that the two 
wavelengths should be on opposite sides of the Hb/HbO2 isobestic point, and that 
each wavelength should have a similar differential path length factor.  
In addition the nature of a remote camera-based system requires that the 
optical density of the tissue and the emitted power at each wavelength should be 
sufficient to allow the detection of PPG signals at each wavelength, while 
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maintaining an illumination intensity that is safely within the maximum permissible 
exposure for that wavelength.  
The formulation of the theory describing light attenuation by tissue assumed 
monochromatic light sources. In practice monochromatic light is difficult to 
produce within the power, size, and safety constraints of a clinical environment—as 
is very narrow-band light. While some light emission at wavelengths other than the 
desired wavelength can be accommodated, it is required as a minimum that the two 
sources have no significant emission at common wavelengths, which can lead to 
cross talk between the haemoglobin species.  
There are three categories of light sources that meet these criteria: light-
emitting diodes (LEDs), laser diodes, and broadband sources (used in conjunction 
with optical filters).  
Lasers meet all of the criteria except safety, where their coherent light makes 
them hazardous particularly to the eyes and especially in the near infrared where the 
projected light is invisible to the naked eye.  
Broadband sources (such as tungsten or halogen lamps) used in conjunction 
with optical filters do not easily lend themselves to quickly alternating the emitted 
wavelength (though such a source was utilised in the earliest reported studies of 
camera-based non-contact photoplethysmography by Blažek et al. (2000) while an 
annular ring of LEDs was used by Hülsbusch and Blažek (2002)).  
Laser diodes are generally suitable though they are relatively large and often 
require optical fibres to couple them to the tissue. By comparison LEDs are small 
and relatively inexpensive. When used with inbuilt lenses LEDs can be arranged to 
create various illumination patterns. The only drawback of LEDs in their application 
to non-contact pulse oximetry is that light from an LED is emitted over a wide angle. 
Even with the incorporation of a lens this limits the distance at which the light 
source can be located from the tissue under investigation. 
Other than the choice of illumination method the only other design 
consideration pertaining to the light source is safety.  
4.1.1 SAFETY GUIDELINES 
The mechanisms by which light can cause damage to biological tissue include 
thermal, acoustic, optical (electric breakdown), and photochemical interactions 
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(ICNIRP 1996). The occurrence of each type of interaction is governed by the 
wavelength of light and the duration of the exposure. For example, pulses less than 
approximately 0.1 ms can lead to acoustic damage caused by rapid local expansion 
of heated tissue, pulses of less than a nanosecond can cause optical breakdown and 
plasma formation, while lengthy exposures (greater than 10 s) to very short 
wavelengths can cause photochemical damage (ICNIRP 1996)—sun burn being an 
example. The wavelengths used in pulse oximetry fall into the category visible and 
IRA light, defined by the International Commission on Non-Ionizing Radiation 
Protection (ICNIRP) as 400 nm to 1400 nm.  
Although there are no definite boundaries between injury mechanisms, certain 
mechanisms predominate according to the spectral region and exposure duration 
(ICNIRP 1997). The pulse durations used in pulse oximetry (see Section 3.3) are 
considerably longer than the threshold at which tissue damage can occur either by 
acoustic or optical breakdown mechanisms. Within the visible-IRA range, 
photochemical damage is predominant over thermal damage only in the wavelength 
range 400 nm to 700 nm. Above 700 nm thermal damage is predominant with 
injury to the skin resulting from temperature rises exceeding 45 °C (ICNIRP 1997). 
LEDs in pulse oximeters are widely considered safe from a radiation perspective; 
most absorption in tissue at these wavelengths is due to blood, which is constantly 
circulating. Indeed the primary cause of heating of the skin in pulse oximetry is heat 
conduction from the p-n junction, discussed in Section 3.3.1.3. Bozkurt and Onaral 
(2004) conducted a study of skin heating resulting solely from semiconductor 
junction heating. They found the temperature increase in skin due to the 
semiconductor junction to be in the range 1 °C to 10 °C. Both Bozkurt and Onaral 
and Ito et al. (2000) place the temperature increase due to near infrared light 
absorption alone at less than 0.5 °C. The risk of burns caused by semiconductor 
junction heat conduction is obviated by a remote non-contact application.  
Guidelines exist for both incoherent broadband light sources (ICNIRP 1997) 
and coherent monochromatic laser sources (ICNIRP 1996, 2000), though narrow-
band LEDs belong to neither category. With the advent of high power LEDs and their 
widespread use have come calls for the development of safety standards specific to 
LEDs (Horak 1999). ICNIRP (1997) recommends adherence to broadband safety 
guidelines when evaluating the safety risk posed by LEDs; in contrast, the 
International Electrotechnical Commission (IEC) includes LEDs in its safety 
guidelines for laser products (British Standards 1994). The IEC guidelines are more 
conservative and specify the following maximum permissible exposure (MPE) of 
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skin to coherent light in the range 700 nm to 1400 nm (exposure time t, 
103 s < t < 3×104 s), 
 . (4.1) 20.002 ( 700)MPE = 2000 10 [W/m ] λ× −×
Individual LEDs generally do not exceed this exposure limit—though an array 
of high power LEDs utilising lenses may have the potential to do so. The compliance 
of the array used in this study is discussed in Section 5.2.2.3.  
4.2 CHOICE OF DETECTOR (CAMERA TECHNOLOGY) 
Various silicon semiconductor based detectors are used in near infrared spectro-
scopy applications. The band gap of silicon (the energy required by an electron to 
move from the valance band to the conduction band) is approximately 1.12 eV. 
Thus incident light with a wavelength shorter than approximately 1107 nm has 
sufficient energy to induce conduction, making such detectors well suited to tissue 
oximetry and pulse oximetry applications. 
Within tissue oxygenation studies and particularly imaging based studies, the 
charged coupled device (CCD) is the detector of choice. A CCD is effectively an 
array of either photodiodes or photogates. In dedicated near infrared spectroscopic 
systems, tissue is illuminated by a broadband source. Detected light is coupled to 
the spectrometer by a fibre bundle where it is projected at a prescribed angle of 
incidence onto a diffraction grating (or prism). Light is diffracted from the grating 
(or refracted from the prism) at an angle that is a function of its wavelength; thus 
different wavelengths of light fall on different parts of the CCD array and the 
intensity of each can be measured separately (Lerner 2006). Such systems are suited 
to measuring the oxygenation of small regions of immobile tissue. Two such 
techniques are described by Irwin (1995) and Stranc (1998), which describe the use 
of tissue oxygenation and perfusion monitoring to assess the viability of tissue 
during plastic surgery. 
CCDs have also been employed as detectors in camera-based systems to 
measure regional variation in tissue oxygenation. Sowa et al. (1997), Sowa et al. 
(1999a; 1999b), Sowa et al. (2001), and Attas (2001), present studies on tissue 
hydration and oxygenation during surgical procedures and following burns using 
both a spectrometer and a non-contact CCD-camera-based system. To acquire 
images at various wavelengths, broadband sources were used to illuminate the 
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tissue and either fixed wavelength or liquid crystal tuneable filters of variable centre 
wavelengths were placed in front of the camera lens. The studies were interested in 
establishing the value of tissue oxygenation and hydration monitoring as indicators 
of tissue viability. 
The development of non-contact camera-based tissue oxygenation imaging 
systems seem—in name at least—similar to the goal of non-contact camera-based 
pulse oximetry. However unlike tissue oxygenation, arterial oxygen saturation does 
not vary regionally, thus there is little merit to arterial oxygen saturation imaging 
with the intent to observe variation (refer to the discussion of oxygen transportation 
in Section 2.1). A camera-based system does however, through its optics, offer the 
ability to observe a significant area of tissue, while preserving the possibility of 
compensating for motion. 
Though a camera-based approach is suited to the task of non-contact pulse 
oximetry, the nature of pulse oximetry, as opposed to tissue oximetry, places 
significantly different demands on the camera. Changes in tissue oxygenation occur 
over several minutes (Sowa, et al. 1997); arterial oxygen saturation changes are 
more rapid (see Section 3.3.4) and the technique of pulse oximetry requires the 
capture of two pulse signals simultaneously. Non-contact camera-based pulse 
oximetry requires that near infrared spectroscopy be performed at faster frame rates 
than are necessary in camera-based tissue oximetry. The technique of pulse 
oximetry also requires narrow band (ideally monochromatic) light sources. Neither 
the frequency response nor the time-domain response of the liquid crystal tuneable 
filters used in the above studies is sufficient for use in pulse oximetry. Since a 
silicon-based camera sensor has no inherent means of differentiating the intensity 
due to incident light of different wavelengths, a camera-based system must resort to 
the conventional pulse oximetry method: alternately illuminate tissue with two 
separate sources at different wavelengths and construct a multiplexed output from 
the detector.  
The requirements of a camera for use in remote non-contact pulse oximetry 
are thus: that it be sufficiently sensitive to measure the difference in absorption 
(received light intensity) at two wavelengths of light (detector quantum efficiency 
and signal to noise ratio); that it be capable of capturing frames at a rate sufficient to 
monitor the pulse component of the change in absorption at both wavelengths in a 
multiplexed fashion (frame rate); that it be capable of quantizing these data to a 
useful resolution (bits per pixel); that it have sufficient dynamic range; and that it be 
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capable of imaging a sufficiently large region of tissue that the observation of a PPG 
signal at each wavelengths is probable (frame size).  
Collectively these requirements can be grouped into two conflicting demands 
of the imaging sensor: high sensitivity and accuracy, and high data rate. Although 
CCD sensors have been the incumbent technology in scientific digital imaging 
applications since its inception, the conflicting requirements of sensitivity and speed 
that arise here, warrant the inclusion for consideration of CCD’s competing 
technology—complimentary metal oxide semiconductors (CMOS). 
4.2.1 CCD IMAGE SENSORS 
Figure 4.1 depicts three common CCD sensor architectures: full frame, interline 
transfer, and frame transfer. The full frame CCD sensor is the original format and 
consists of an array of adjacent pixels. Each pixel consists of one photodiode or one 
photogate. During an exposure incident photons with sufficient energy cause 
photoelectrons to accumulate in the pixels upon which they are incident. At the end 
of the exposure the charge from every pixel in the array is readout sequentially via a 
buffer row in a process that manufacturers often refer to as a bucket brigade. The 
charges from the last row of the array are transferred to the buffer row by reducing 
the voltage in the last row and simultaneously increasing the voltage in the buffer 
row. The charges in each of the above rows are moved to the row directly beneath 
in the same manner. The charges in the buffer are then shifted horizontally towards 
the amplifier. This coupling of charges is what gives the technology its name. At the 
amplifier the charges from the accumulated photoelectrons are converted to 
voltages. When each column of the buffer row has been emptied the next row from 
the array is moved down. The arrows in Figure 4.1 depict the path taken by the 
charge collected in one pixel on its way to the amplifier.  
The sequential manner in which charge is read from a full frame CCD array 
means that the readout time is long, and during readout the pixels are still 
accumulating charge from the incident light. This causes the appearance of vertical 
stripes in the captured image, emanating from bright parts of the image, known as 
smearing, which can only be avoided through the use of a mechanical shutter that 
halts exposure almost simultaneously across the array. This is of no concern in still 
photography but is impractical in video applications. 
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Smearing can be avoided by the use of an interline transfer layout. In such 
schemes a small channel of light-shielded pixels are placed between each column 
on the array. At the end of an exposure the accumulated charge in each pixel is 
transferred to the adjacent shielded pixel thus ending the exposure. In addition it is 
possible to conduct the readout of the previous frame during the exposure of the 
current frame, thus increasing frame rate. The impunity from smearing and 
increased frame rate however come at the expense of fill factor—that is the ratio of 
the optically sensitive area to the total area of each pixel is reduced. By reducing the 
fill factor the sensitivity of the array is reduced. 
Full frame Frame transfer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amplifier 
Charge movement 
Light shielded area 
Light sensitive area 
Interline transfer 
Figure 4.1 Three common CCD image sensor architectures. 
An alternative is the frame transfer CCD architecture, in which a second array 
of light-shielded pixels is attached to the sensing array. At the end of an exposure 
the charge from the sensing array is transferred to the shielded array. During the 
next exposure the charge from the shielded array can be readout in the conventional 
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way via a buffer row. Frame transfer architectures achieve frame rates and levels of 
smearing mitigation higher than those of full frame architectures but lower than 
those of interline transfer architectures. Their advantage over interline transfer 
architectures is that fill factor and thus sensitivity is not compromised—their 
disadvantage is that they require almost twice as much space and power. 
An important characteristic of an image sensor’s performance that 
incorporates several physical characteristics of the sensor itself is its dynamic 
range—the ratio of a pixel’s saturation level (its full-well capacity) and its threshold 
level (the minimum incident light required to produce an output signal in excess of 
the noise floor). The threshold is determined by the characteristics of the material 
from which the sensor is constructed, the fill factor, and the amount of noise 
producing circuitry surround the image sensor. Saturation level is determined by the 
size of the pixel and in the case of CCDs, the penetration depth of the electric field 
that couples the pixels. When a CCD pixel becomes saturated any additional 
accumulated charge spills over into adjacent pixels, an effect known as blooming. 
Unlike smearing, which is characterised by vertical stripes, blooming causes streaks 
to spread out radially from bright points in the image. 
All forms of CCD sensor read every pixel in the array serially, thus charge to 
voltage conversion and amplification are performed by a single amplifier. Large 
array sizes and high frame rates place a heavy burden on this amplifier, which must 
have an extremely high bandwidth. The amplifier’s bandwidth is a limiting factor in 
some CCD applications.  
4.2.2 CMOS IMAGE SENSORS 
Figure 4.2 depicts a schematic of a CMOS image sensor. Each pixel of a CMOS 
sensor is composed of an optical sensing area (photodiode or photogate) and an 
optically insensitive area comprised of between one and five transistors. Between 
each row and column of a CMOS sensor are optically insensitive metal tracks. The 
fill factor of a CMOS sensor is thus always less than 100%.  
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Figure 4.2 Schematic of generic CMOS image sensor architecture. 
CMOS sensors also contain a row and column decoder. During the readout 
process any pixel or any group of pixels can be selected arbitrarily by their row and 
column address. Unlike CCD sensors, the accumulated charge in each pixel of a 
CMOS sensor is converted to a voltage and possibly amplified within the pixel. 
The original CMOS sensors contained only one transistor per pixel and were 
referred to as passive or 1T sensors. With just one transistor per pixel, 1T devices 
could provide arbitrary readout from the array but no amplification and thus 
suffered from low signal to noise ratios. Additionally they are subject to the same 
smearing effects during readout as full frame CCD sensors. They are now obsolete. 
Modern CMOS sensors have active pixels containing a minimum of three 
transistors (3T). Charge collection and accumulation, charge to voltage conversion, 
and amplification all occur within the pixel. Immediate amplification of the signal 
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improves their SNR, though at the expense of fill factor and thus sensitivity and 
dynamic range. To reduce the impact of extra components per pixel on fill factor 
manufacturers switched to finer lithography wafer fabrication processes (typically 
0.25 µm, 0.18 µm, or less). This increased cost and ultimately lead to the need for 
manufacturing processes dedicated to CMOS image sensor production; CMOS 
imagers had originally shared production processes with standard memory and 
logic production processes giving them a cost advantage over CCD sensors, which 
have always required customised processes. (Indeed the erudite reader may have 
already noted the similarity between dynamic random access memory and the 
CMOS sensor depicted in Figure 4.2.) 
In-pixel amplification also gives rise to a phenomenon known as fixed pattern 
noise. This results from slight variations in the amplifiers across the array. Fixed 
pattern noise must be corrected by image processing. 
Though 3T devices offer acceptable SNR for many applications they are 
subject to smearing of the image during readout in video applications. A certain 
amount of smearing is acceptable in some consumer applications though not in 
most scientific or industrial applications. The addition of a fourth of fifth transistor 
per pixel (4T and 5T) can provide such functions as electronic global shuttering and 
correlated double frame shuttering (in which the dark current or pixel thermal noise 
is subtracted from the recorded value for each pixel). 
4T and 5T devices have significantly better SNR and dynamic range than 3T 
devices. 
4.2.3 CHOOSING BETWEEN CMOS AND CCD 
CCD sensors have traditionally offered good sensitivity, good SNR, good 
uniformity, and good dynamic range by virtue of their inherently high fill factor and 
full well capacity. CMOS sensors have typically lagged CCD in each of these areas 
but have traditionally been capable of higher frame rates and lower power 
consumption. Figure 4.3 depicts the relative positions of the various CCD and CMOS 
architectures in relation to some of these parameters.  
Manufacturers are constantly improving the performance of both technologies 
within both of their traditionally strong and weak areas. Many manufacturers 
provide highly specialised devices that utilise cooling of the sensor, anti-reflective 
coatings to minimise reflection losses, rear illumination to minimise transmission 
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loss, micro-lenses over each pixel to mitigate the effects of diminished fill factor, 
and various other techniques.  
Though both technologies have become associated with various specialised 
applications, for example CCD with spectroscopy and CMOS with machine vision, 
non-contact pulse oximetry is a new application and the choice of technology is not 
obvious, requiring both sensitivity and speed. 
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Figure 4.3 Comparison of the characteristics and tradeoffs associated 
with various CCD and CMOS architectures. 
CCD undoubtedly provides the greater sensitivity; the quantum efficiency of a 
CCD pixel benefits from the larger fill factor. The sensitivity of a sensor is also a 
function of the SNR. CMOS sensors have a greater amount of noise producing 
circuitry mounted on the chip. Sensitivity is important to this application as tissue is 
optically dense and light may have to traverse several centimetres before re-
emerging at greatly reduced intensity. 
Quantization range and dynamic range are also important to non-contact pulse 
oximetry. In conventional contact pulse oximetry the variation in received light 
intensity due to the pulse may under normal circumstances be as little as 1% of the 
total received light intensity (see Section 3.2). The camera’s ability to record such a 
variation in both brightly and dimly illuminated areas of the image is determined by 
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its dynamic range. CCD sensors provide better dynamic range by virtue of higher 
sensitivity during low levels of illumination and larger full well capacity during 
high levels of illumination. Both technologies can provide sufficient quantization 
levels for non-contact pulse oximetry—that is sufficient to characterise the profile 
of the PPG waveform.  
To choose between CCD and CMOS it is necessary to prioritise the camera 
requirements of non-contact pulse oximetry. Sensitivity is a desirable characteristic 
of all detectors, however pulse oximetry does not require the sensitivity of tissue 
oximetry methods, which endeavour to quantify the concentrations of individual 
chromophores. Provided the tissue is sufficiently well illuminated either CCD or 
CMOS cameras can provide sufficient sensitivity to detect a PPG waveform by non-
contact means. Thus the overriding consideration in choosing an image sensor is the 
ability to achieve a frame rate sufficient to sample two PPG waveforms in a 
multiplexed fashion while providing a suitable frame size. 
As a constraint on the minimum frame size, a suitable size means that the 
combination of the number of pixels per frame and the magnification produced by 
the system’s optics, provide sufficient sensitivity to capture a PPG signal, while 
imaging an area of tissue sufficiently large that the observation of a PPG signal is 
probable. As a constraint on the maximum frame size, suitable size means that the 
achievable frame rate should not be unduly diminished by an excessive number of 
pixels per frame.  
CMOS sensors generally offer higher frame rates than comparable CCD 
sensors and crucially, posses the capability of varying the frame size—allowing 
even higher frame rates. 
This capability is paramount in non-contact pulse oximetry, in both offline 
processing and especially in real-time processing. For this reason a CMOS image 
sensor was adopted in this study. 
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Equation Chapter 5 Section 1 
This chapter is intended to serve two purposes. First, the chapter details the 
construction and operation of a novel non-contact remote camera-based device; 
capable of capturing two PPG signals simultaneously—the prerequisite for pulse 
oximetry. The non-contact system described here is based on the principles and 
methods of conventional pulse oximetry, described in detail in Chapter 3. The 
components of the system, principally an array of LEDs and a CMOS camera, were 
designed and chosen respectively, in accordance with the considerations, 
constraints, and requirements that were discussed in Chapter 4. The second purpose 
of this chapter is to present a methodical investigation of the comparability of 
measurements from the non-contact camera-based device with those from a 
conventional contact device. Conventional devices perform three core functions: 
monitor SpO2, monitor pulse rate, and display a plethysmogram; the comparability 
of the camera-based device is examined in regard to each of these functions. The 
examination is intended to establish both the feasibility of such a device and to 
identify important inherent differences between conventional pulse oximetry and a 
camera-based technique. 
Additionally this chapter presents an investigation of some aspects of photo-
plethysmography that are unique to a non-contact implementation. The observation 
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of inverted PPGs by non-contact means is described, a phenomenon that is, in the 
least a curiosity, and may be a hint to the potential utility of a non-contact device 
beyond that of a conventional device. A possible explanation of the phenomenon is 
formed from the known characteristic path of light propagating in tissue (described 
in Chapter 2) and from the absorptive characteristics of the pulsing arterial blood 
(described in Chapter 3). 
Finally this chapter attempts to address the effect of increasing distance 
between the device and the tissue under investigation. The achievable tissue-device 
separation is ultimately a function of the system’s optics, the camera’s character-
istics, and the type of source and its characteristics. However some predictions of 
the decrease in detected light intensity with increasing separation can be made, with 
knowledge of the characteristics of the backscattered light emerging from the tissue. 
A simplified probabilistic model of the effect of tissue-camera separation is 
developed here, based on a priori knowledge of the distribution of photon 
trajectories emerging from the region of interest. The prediction by the model is 
compared to results from a Monte Carlo simulation (described in Chapter 2) of a 
three-layer tissue model and is shown to provide a prediction comparable to the 
simulation results. 
5.1 SYSTEM OVERVIEW 
The principal components of the device are illustrated in Figure 5.1, in an 
arrangement that is indicative of a typical experimental set-up. The main 
components of the system are the camera, the array of LEDs, and the optical filter. 
Also depicted in Figure 5.1 is the relative timing of the system, and the arrangement 
of the two wavelengths of LEDs relative to each other on the illumination array. 
Light from the LED array alternately illuminates the tissue under investigation at 
wavelengths of 760 nm and 880 nm. By monitoring the backscattered light 
emerging from the tissue using the camera, through image analysis, a PPG signal 
can be obtained at each wavelength. The two resulting multiplexed PPG signals are 
then separated and processed by a personal computer (PC) off line (not shown) to 
yield the desired physiological measurements (the pulse rate and the shape of the 
peripheral arterial pressure waveform) and to measure the ratio of arterial 
absorption at each wavelength of light.  
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Figure 5.1 Overview of the principal components of the non-contact 
system. 
5.2 HARDWARE DESCRIPTION 
5.2.1 THE CAMERA 
In accordance with the design specifications pertaining to the sensor, enumerated in 
the previous chapter (see Section 4.2), a CMOS camera was chosen for this 
application. The camera (PixeLINK PLA-741, IIDC 1.3/DCAM compatible) utilises a 
⅔ inch monochromatic CMOS sensor (8.576 mm × 6.912 mm, 11.01 mm diagonal). 
The sensor has 1280×1024 square pixels of length 6.7 µm. 
The camera uses an IEEE 1394-interface connection. Pixels can be encoded 
using 8 bits or 10 bits. 
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The camera is configured to operate using a global or synchronous shutter, 
such that, upon generation of an internal trigger, or upon receipt of an external 
trigger, the camera exposes the entire sensor for a predefined amount of time—the 
exposure time. At the end of the exposure, the camera simultaneously reads out the 
charge accumulated by each pixel, within a user-defined region of interest (ROI), 
thus ensuring that each pixel has been exposed for precisely the same duration, and 
for precisely the same period of time.  
5.2.1.1 SENSITIVITY 
Silicon is sensitive to wavelengths between approximately 1100 nm (in the near 
infrared) and 400 nm (violet in the visible spectrum). At wavelengths longer than 
1100 nm, incident photons lack sufficient energy to overcome the silicon energy 
band gap, while wavelengths shorter than 400 nm do not penetrate silicon 
sufficiently deeply to produce photoelectrons.  
Manufacturers often specify their detector’s sensitivity using a graph of 
quantum efficiency (QE) as a percentage versus wavelength. The QE parameter 
incorporates other attributes of the sensor such as pixel area and fill factor, however 
it excludes the SNR performance of the chip. A more useful figure of merit, which 
incorporates the sensor’s SNR, is the amount of charge produced in excess of the 
device’s noise floor per unit of incident light—usually expressed in units of A/W. 
The CMOS detector used in this application has a sensitivity of 0.091 A/W at 760 nm 
and 0.055 A/W at 880 nm. 
5.2.1.2 MAXIMUM ACHIEVABLE FRAMERATE  
The IEEE 1394 standard specifies a maximum data rate of 400 Mbits/s. This sets an 
upper limit for the maximum achievable frame rate. For raw data the camera’s 
output data rate is given by, 
 Bits per second = (Bits per frame)  (Frames per second)× , (5.1) 
where the number of bits per frame is given by, 
 Bits per frame = (Frame Width  Frame Height)  (Bits per pixel).× × (5.2) 
Thus for a given frame size and number of bits per pixel, the maximum 
achievable frame rate is limited by the IEEE 1394 maximum data rate. However 
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equations (5.1) and (5.2) do not take account of the readout time associated with 
each frame. The maximum achievable frame rate of the camera is a function of 
readout time, which in turn is proportional to the frame size (or the user defined 
ROI). The inclusion of the readout time imposes a lower limit on achievable frame 
rate than the IEEE 1394 bandwidth. The maximum achievable frame rate FM, is thus 
given by, 
 M
1
F  (frames/second)
Exposure time + Readout time
 = . (5.3) 
Thus the camera’s maximum data rate DM, is given by, 
 , (5.4) M MD  = (Bits per frame)  F (bits/second) ×
which, due to readout time, is always less than 400 Mbits/s. 
Operating at frame rates approaching the maximum achievable rate can result 
in dropped frames, which are difficult to detect during operation, and can go 
unnoticed during image analysis. A dropped frame has the potential to critically 
impair the de-multiplexing of the PPG signal from each wavelength during the 
image analysis process. It is desirable to avoid dropped frames completely, or at 
least to detect them in the event of their occurrence. 
In an attempt to eliminate dropped frames, a safe maximum frame rate FSM, 
was empirically established for several frames sizes. To accomplish this, two LEDs 
were placed side by side within the camera’s field of view. LED1 received a square 
wave driving current, with period T1and 50% duty cycle. LED2 received a square 
wave driving current, synchronised with LED1, but with period T2 = 2×T1, also with 
50% duty cycle. The camera was externally triggered by a square wave voltage 
signal, to capture a frame upon receiving a rising edge. The rising edge of the 
voltage signal was synchronised with the rising edge of the driving current to LED1. 
In this manner the two LEDs flash in a four-state binary sequence. The camera was 
fixed in place such that the LEDs always flash in the same place in each of the 
recorded frames. A dropped frame is observable as it causes the LEDs to flash out of 
their correct binary sequence. In this manner up to four sequential dropped frames 
can be detected. The resulting values of safe maximum frame rate for pixel 
resolutions of 640×480 and 320×240 are tabulated in Table 5.1 and Table 5.2 
respectively. 
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  Exposure Ideal maximum Maximum achievable 
Resolution  time (ms) frame rate (frame/s) frame rate (frames/s) 
640×480  10 100 49 
  12 83 45 
  14 71 41 
  16 62 38 
  18 55 35 
  20 50 33 
  22 45 31 
  24 41 29 
  26 38 27 
  28 35 26 
  30 33 25 
Table 5.1 Empirically derived maximum achievable frame rates at a pixel 
resolution of 640×480 with global shutter. Defined as the maximum 
frame rate that resulted in 0 dropped frames per 10,000 captured frames. 
  Exposure Ideal maximum Maximum achievable 
Resolution  time (ms) frame rate (frame/s) frame rate (frames/s) 
320×240  10 100 76 
  12 83 66 
  14 71 58 
  16 62 52 
  18 55 47 
  20 50 43 
  22 45 40 
  24 41 36 
  26 38 34 
  28 35 33 
  30 33 30 
Table 5.2 Empirically derived maximum achievable frame rates at a pixel 
resolution of 320×240 with global shutter. Defined as the maximum 
frame rate that resulted in 0 dropped frames per 10,000 captured frames. 
5.2.2 ILLUMINATION 
Illumination is provided by an array of thirty-six GaAlAs LEDs—eighteen with a 
peak emission wavelength of 760 nm and eighteen with a peak wavelength of 
880 nm. The 880 nm LEDs (Opto Diode Corp. OD880-L) emit 17 mW at a forward 
current of 100 mA. The 760 nm LEDs (Opto Diode Corp. custom wavelength L-
package) emit 10 mW at the same forward current. Both types of LED are housed in 
a TO-46 gold-plated casing, with in-built glass lenses and a specified full width half 
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maximum (FWHM) beam angle of 30°. The LEDs are mounted on a printed circuit 
board (PCB) along with two transistors that activate each wavelength of LED. A 
schematic of the array showing the relative positioning of the two wavelengths of 
LEDs is depicted in Figure 5.2. The various aspects of the array’s design and 
operation are discussed separately below. 
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Figure 5.2 Schematic of the illumination array showing the arrangement 
of the 760 nm LEDs (surrounded by dotted outline) and the 880 nm LEDs, 
along with ancillary components. 
5.2.2.1 CHOICE OF WAVELENGTH 
The criteria for choosing the wavelengths of the two light sources were enumerated 
in Section 3.2.1.2 and extended in Section 4.1: one wavelength either side of the 
Hb/HbO2 isobestic point; each wavelength should have a similar differential path 
length factor; and, the optical density of the tissue at each wavelength should be 
sufficient to allow the detection of signals at each wavelength, without exceeding 
the maximum permissible exposure for that wavelength. 
The wavelengths selected for this application were 760 nm and 880 nm. This 
choice was based in part on the prior work of Coyle et al. (2003) and Coyle et al. 
88 
Instrument Description and Performance 
(2004), which demonstrated the capture of PPG signals by contact reflectance over 
several centimetres of tissue using these wavelengths. Early investigations of the 
feasibility of a camera-based approach (Humphreys, et al. 2005a; 2005b; 2005c) 
further indicated the suitability of these wavelengths for use with the camera 
described earlier (Section 5.2.1). 
In particular, the choice of 760 nm as opposed to the more conventional pulse 
oximetry wavelength of 660 nm, places the lower wavelength just inside the near 
infrared band, making the use of a commonly available band pass filter possible, 
and thus excluding much unwanted ambient light. Within the region of the near 
infrared spectrum that lies below the Hb/HbO2 isobestic point, the region in the 
vicinity of 760 nm is particularly apt to the technique of pulse oximetry due to a 
hump in the Hb extinction curve, which causes a marked and desirable difference in 
the absorption by Hb and HbO2 (refer to Figure 3.7). The total absorption by blood 
at this wavelength is considerably less than at 660 nm. Note however that by 
selecting a wavelength at the peak of the hump in the Hb extinction curve, 
quantitative measurements of oxygen saturation are made vulnerable to error. Any 
drift in the peak emitted wavelength of the 760 nm LEDs or deviation among 
individual components would significantly alter the relative absorption by Hb and 
HbO2 (see Section 3.3.1). The performance of the LEDs in this regard is described in 
Section 5.2.4. 
The difference in absorption by Hb and HbO2 at 880 nm is broadly similar 
to—though less than—the difference at the conventional wavelength of 940 nm. 
The sensitivity of the camera’s CMOS sensor however is approximately 45% less at 
940 nm than at 880 nm.  
5.2.2.2 ILLUMINATION PATTERN 
Various illumination patterns were tested, including an annular pattern of LEDs 
directed circumferentially around the camera’s field of view, and a small bright spot 
adjacent to the camera’s field of view (see Humphreys et al (2005b; 2005c)). The 
most successful pattern for obtaining signals from deep tissue, proved to be a large, 
brightly illuminated area, adjacent to the camera’s field of view.  
There are compelling reasons for preferring a small brightly illuminated spot 
(ideally a point source) to any other illumination pattern and in particular the 
technique of pulse oximetry implicitly precludes the use of an annular light source. 
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However an explanation of this point is deferred until the conclusion of this chapter 
(Section 5.7), at which point it is discussed in conjunction with several other aspects 
of the device’s performance and some aspects of photoplethysmography and pulse 
oximetry that are unique to a camera-based implementation.  
The illumination pattern created by the array depicted in Figure 5.2 varies with 
distance from the array. The manufacturer specifies a FWHM beam angle of 30° for 
both types of diode. Measurements of this parameter suggested a FWHM beam 
width of 32° for both wavelengths of LEDs. Using the FWHM parameter, the 
diameter of a diodes’ half-maximum intensity beam d, at a distance x from the 
diode, is given by, 
 FWHM22 tan(d x
∠= ) . (5.5) 
Using the measured FWHM angle of 32°, and the geometry of the array 
specified in Figure 5.2, the illumination pattern of the 760 nm LEDs, at a distance of 
15 cm, from a flat surface, was computed, as the superposition of the illuminated 
spot from each of the eighteen individual 760 nm LEDs. The resulting illumination 
pattern is illustrated in Figure 5.3. At a distance of 15 cm, each diode projects a 
half-maximum intensity spot of diameter 8.6 cm. The brightness of the image in 
Figure 5.3 is proportional to the number of diodes coincident on that region. The 
maximum height and width of the illuminated area is 131.10 mm. The illumination 
pattern generated by the 880 nm LEDs is identical but rotated by 90°. 
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Figure 5.3 Computed illumination pattern resulting from the superpos-
ition of the eighteen 760 nm LEDs depicted in Figure 5.2, at a distance of 
15 cm from the array. 
It is important to consider the profile of the illumination pattern when further 
evaluating aspects of the system’s performance.  
5.2.2.3 COMPLIANCE WITH MAXIMUM PERMISSIBLE EXPOSURE 
The compliance of single LEDs in conventional contact pulse oximetry is well 
established (see Section 3.3.1), however this study utilises an array of LEDs and it is 
the compliance of the array as a whole that is investigated here. The various 
standards pertaining to LED safety and maximum permissible exposure (MPE) were 
discussed in Section 4.1.1. The most conservative applicable limit for skin 
exposure, specified by the International Electrotechnical Commission (IEC), for 
coherent light sources in the range 700 nm to 1400 nm (British Standards 1994) was 
given in equation (4.1), 
 . 20.002 ( 700)MPE = 2000 10 [W/m ] λ× −×
The limit is applicable for exposure durations between 1000 s to 30000 s. 
For 760 nm, equation (4.1) imposes a limit of 2.6 KW/m2, or 260 mW/cm2. 
For 880 nm, the imposed limit is 450 mW/cm2. In evaluating the compliance of the 
illumination array with the MPE limits, the effects of multiple LEDs coincident on 
the same region of tissue should be taken into account. The intensity profile of the 
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illumination pattern created on a flat surface, parallel to the array, at a distance of 
15 cm, is depicted in Figure 5.3. Taking 15 cm as the nominal distance from tissue 
under investigation, at which the array will be placed during operation, a contour 
map of the intensity profile depicted in Figure 5.3 was computed, and is depicted in 
Figure 5.4. 
 
Figure 5.4 Contour map of illumination pattern intensity profile depicted 
in Figure 5.3. Contour lines mark regions where the specified numbers of 
LEDs are coincident—that is where their FWHM spots overlap at a distance 
of 15 cm from the array. 
The entire illuminated area fits inside a square of dimensions 132×132 mm—
an area of 174.2 cm2. However within that area, the intensity is non-uniform—
indeed 30 cm2 receive no illumination (that is less than half the maximum intensity 
of one LED). The intensity of only one LED illuminates a continuous region around 
the edge of the pattern, while moving towards the centre of the pattern, the 
projected spots of several LEDs begin to overlap. There is a region in the centre of 
the pattern where all eighteen 760 nm LEDs are coincident. The tissue in this central 
region experiences the greatest exposure.  
Using the data mapped in Figure 5.3 and Figure 5.4, the area of the central 
region where all 760 nm LEDs are coincident, was calculated to be 4.7158 cm2. The 
specifications for the 760 nm LEDs, state a typical power output of 10 mW. 
Assuming the worst case, in which all LEDs are located centrally over the region, at 
a distance of 15 cm, for a FWHM beam angel of 32°, each diode could provide a 
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radiant power density of 172.1524 µW/cm2. The entire region in Figure 5.4 upon 
which all eighteen LEDs are incident, would therefore receive a collective exposure 
of 14.6130 mW, or an exposure per unit area of 3.0987 mW/cm2. The 880 nm LEDs 
have a specified typical emitted power of 17 mW, and under the same conditions 
would deliver a collective exposure of 24.8241 mW, to the central region of 
Figure 5.4, and an exposure per unit area of 5.2678 mW/cm2. 
Thus the maximum possible radiant power delivered by the LED array per 
square centimetre at 760 nm and 880 nm, represent just 1.19% and 1.17% 
respectively, of the maximum permissible exposures at those wavelengths.8 As was 
discussed earlier, the actual emitted power of the array will be mollified by the 
requirement of pulse oximetry that both wavelengths of LEDs operate on a 50% 
duty cycle or less (see the discussion of signal processing by a clinical device in 
Section 3.3.3). Furthermore, the LEDs are not monochromatic; their maximum 
emitted power is not in fact concentrated at one wavelength but rather spread over a 
range of wavelengths (see Figure 5.8 and Figure 5.9 below), further diminishing the 
hazard. Finally the MPE limit recommended by the IEC refers to coherent light 
exposure, while LEDs produce incoherent light. 
5.2.2.4 LED DRIVING 
The LEDs are placed in series in groups of three, each group in series with a small 
value resistor to limit the current. Both wavelengths of LED are limited to a 
maximum driving current of 100 mA. The 880 nm LEDs have a forward voltage of 
1.54 V at a forward current of 90 mA. Owing to their shorter emission wavelength 
(see Section 3.3.1), the 760 nm LEDs have a forward voltage of 2.01 V at the same 
forward current. Figure 5.5 depicts a schematic of the LED driving circuit. The LEDs 
are arranged in the same pattern as that indicated in Figure 5.2. 
                                                 
8 In Section 5.2.4.2 it will be shown that the actual peak emitted wavelength of the 
880 nm LEDs is closer to 860 nm. Recalculating the MPE at 860 nm, the array is found to 
produce 1.26% of the MPE. 
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Figure 5.5 Schematic of LED driving circuit. VCC is set at +6 V, R1 is 14 Ω 
and R2 is 4.7 Ω. The two transistors are n-channel enhancement type, 
power MOSFETs, with a maximum drain current rating of 2.5 A. 
A suitable signal applied to the gate of either transistor energises the eighteen 
diodes at that wavelength. The transistors used are metal-oxide semiconductor field-
effect transistors (MOSFETs), rated to a maximum continuous drain current of 2.5 A. 
The MOSFET channels are fully conductive when their gate-source voltage exceeds 
3.7 V. Since the MOSFETs are alternately activated with 50% duty cycle, the 
maximum instantaneous current due to either wavelength of LED is 1.8 A. The 
circuit’s rail voltage VCC, is +6 V, thus the circuit requires a maximum continuous 
power of 10.8 W. 
This circuit is intended exclusively for use in non-contact illumination. The 
outer metal case of the LEDs is electrically connected to the anode, thus for safety, 
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where contact illumination is required, these diodes should be driven between 
ground and a negative cathode voltage. 
5.2.3 TIMING SIGNALS 
Section 3.3.3 described the use by clinical devices of dark samples to determine 
ambient light levels. As will be discussed later, the frame rates achievable with a 
camera-based device do not permit the inclusion of dark frames in the sampling 
pattern. Therefore the LEDs are pulsed in a simple alternating fashion in which, each 
wavelength is on for one period and then off for the next period. The camera is 
triggered to capture a frame when either wavelength of diode is energised. The 
circuit used to generate the triggering signals is depicted in Figure 5.6. Logic gates 
driven between +5 V and ground provide sufficient signal levels to drive the 
MOSFETS and the camera.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 KΩ 
S’
S
Signal to 880 nm 
indicator LED 
4 
6
5
Signal to 760 nm LEDs 
3 2
114 
4 7 8
5
3
6
2
1
CD4027BE
VSS
VDD
16
CLK
K 
J 
7 CD4081BE
Pin 3 
Pin 2 
+ 5V 
Signal Generator 
Signal to 880 nm LEDs 
CD4081BE 
Camera internal circuitry 
Figure 5.6 Logic circuit used to generate triggering signals to LED array 
and to camera. 
A JK flip-flop is used to half the frequency of a square wave from a signal 
generator, providing a signal S at half the frequency of the input clock. The rising 
edges of S are synchronised with every other rising edge of the clock. The flip-flop 
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also produces a signal S’ that is the inverse of S. The signal S is used to activate the 
880 nm LEDs and the signal S’ to activate the 760 nm LEDs. The 880 nm signal is 
also fed to an AND gate acting as a buffer, which drives an 880 nm indicator LED, 
the purpose of which is discussed below.  
The camera is triggered by the clock signal after it has been fed through an 
AND gate. The gate serves two functions: first when connected as shown in 
Figure 5.6 it isolates the camera from fluctuations in the clock signal level; and 
second the connection from the AND gate to V + can be replaced by a connection to 
a master trigger step that synchronises the initiation of a capture sequence by the 
camera with a second device. 
Figure 5.7 depicts the relative timing of the various signals. The response time 
of the camera, the LEDs, the transistors, the flip-flop, and the AND gates, are all of 
the order of microseconds, whereas a typical frame length is of the order of tens of 
milliseconds. Thus the response times of all the components are negligible 
compared to the duration over which a frame is integrated. In the event that a 
master control signal is required, to either initiate a capture sequence by the camera 
or to synchronise the system with another measurement device, the rising edge of 
the master control step acts as the initial trigger. During such operation, the clock 
signal AND the master control step signal, forms the trigger signal to the camera. 
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Figure 5.7 Relative timing of triggering signals to the camera, the 
indicator LED, and to both wavelengths of LEDs on the illumination array. 
5.2.4 REPLICATING ASPECTS OF A CLINICAL DEVICE 
In Section 3.3 several aspects of a conventional contact device’s operation were 
emphasised; among them were: ambient light interference; compensation for the 
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variance in the peak emitted wavelength of LEDs; compensation for drift in peak 
emitted wavelength of LEDs caused by increased p-n junction temperature; 
obtaining maximum utility from the analogue to digital quantization process; and 
maintaining a sufficient signal level at the detector. These topics are revisited here 
and the practicability of the conventional contact device’s countermeasures and 
solutions to each are evaluated in the context of the non-contact camera-based 
device. 
5.2.4.1 AMBIENT LIGHT INTERFERENCE 
Section 3.3.3.1 described the approach of clinical pulse oximeters to mitigating the 
effects of ambient light. This invariably comprises sampling the ambient light while 
the LEDs are off and subtracting the level from the adjacent samples during which 
the LEDs are on. The ratio of ambient samples to data samples and the sampling rate 
vary widely among manufacturers, though all clinical devices sample at a rate far 
greater than the frame rates achievable with a camera-based non-contact device.  
The camera-based system’s susceptibility to ambient light interference can 
however be mitigated to some degree by the inclusion of a bandpass filter. 
Figure 5.1 depicts such a filter placed directly in from of the camera’s lens. The 
filter used is a Hoya RT830 near infrared glass band pass filter, centre wavelength 
830 nm, half maximum pass band 570 nm to 1090 nm.  
The inclusion of a dark frame in the camera-based system’s sampling 
sequence is of course possible, however as will be discussed in Section 5.4, 
achieving the maximum possible frame rate is paramount to a camera-based 
device’s accuracy—at least within the range of frame rates currently achievable. 
5.2.4.2 VARIANCE IN LED PEAK EMITTED WAVELENGTH 
Limitations of the manufacturing process cause the actual peak emitted wavelength 
of LEDs to differ from the design wavelength, even among components produced 
from the same lot. The accuracy of the technique of pulse oximetry is conditional 
on the use of two precisely known monochromatic wavelengths. In practice two 
narrow-band light sources with precisely known peak emission wavelengths suffice. 
Manufacturers compensate for inter-device variation in peak emitted wavelength by 
either selecting only LEDs with specific wavelengths or noting the actual 
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wavelengths and compensating for the discrepancy during the calibration process 
(see Section 3.3.1).  
The non-contact technique requires multiple LEDs of both wavelengths to 
provide sufficient illumination. Thus the possibility of compensating for 
discrepancy in peak emitted wavelength between LEDs is precluded. The 
remaining—more costly—option for the non-contact device is ensuring each 
individual LED used has the correct peak emitted wavelength, for both wavelengths. 
Figure 5.8 displays an overlay of the normalised emission spectra of the 
eighteen 760 nm LEDs used in the illumination array. (Measured using Ocean 
Optics Inc. S2000 spectrometer.) The vertical dashed line at approximately 758 nm 
indicates the mean peak emission wavelength. 
Figure 5.9 displays the same data from the 880 nm LEDs. The mean peak 
emitted wavelength for the 880 nm LEDs is 858 nm.  
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Figure 5.8 Normalised peak emitted wavelength of the eighteen 760 nm 
LEDs. (Mean peak emission wavelength 758 nm.) 
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Figure 5.9 Normalised peak emitted wavelength of the eighteen 880 nm 
LEDs. (Mean peak emission wavelength 858 nm.) 
In comparing the characteristics of the two types of LED, the 880 nm LEDs can 
be seen to exhibit a much greater deviation from their design wavelength as well as 
a greater variance in peak emitted wavelength between individual diodes than the 
760 nm diodes. (Indeed the continued use of the label 880 nm LED is questionable.) 
Owing to the profiles of the HbO2 and Hb extinction curves (Figure 3.7), pulse 
oximetry is more sensitive to deviation in the peak emitted wavelength of the 
760 nm LEDs; where the Hb curve exhibits a large inflection. Referring to 
Figure 3.7, the 2 nm deviation in peak emitted wavelength of the 760 nm LEDs 
would correspond to a change in the absorptivity of Hb and HbO2 of +0.45% and  
–2.07% respectively. The 22 nm deviation in the 880 nm LEDs would correspond to 
a change in absorptivity of Hb and HbO2 of –5.49% and –6.77%. Since it is the 
change in the ratio of absorption of the two haemoglobin species that is 
consequential, the 2 nm shift in the 760 nm LEDs would in fact be more detrimental 
to quantitative estimates of SpO2 than the 22 nm shift in the 880 nm LEDs. 
5.2.4.3 DRIFT IN PEAK EMITTED WAVELENGTH 
The causes of drift in peak emitted wavelength during operation were described in 
Section 3.3.1.2. Both ambient temperature and driving current affect the p-n 
junction temperature of the diode, altering the amount of additional energy required 
by an electron to cross the junction and hence altering the emitted wavelength.  
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To quantify the drift in peak emitted wavelength of the LEDs during operation, 
two sets of spectra were obtained. The first set was measured immediately after the 
array had been energised, at a driving current of 60 mA with a 50% duty cycle to 
each diode. The driving current was then increased to 110 mA and the spectra 
measured again after ten minutes of continuous operation at 50% duty cycle. The 
results are plotted in Figure 5.10. The 760 nm LEDs exhibited a shift in mean peak 
emitted wavelength of 3.5 nm and the 880 nm LEDs 0.7 nm. These observations are 
similar to those reported by de Kock et al. (1991). 
Commercial pulse oximeters compensate for drift in peak emitted wavelength 
by either placing a temperature sensor in the probe or by monitoring the LED 
driving current. In either case the peak emitted (red and infrared) wavelengths’ 
dependence on either parameter is predetermined and the appropriate calibration 
tables are chosen by the device during operation to match the current estimate of 
peak emitted wavelengths. 
Either approach is applicable to a non-contact device, though as will be 
discussed in the next section, LED driving current need not be variable in the case of 
a camera-based system.  
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Figure 5.10 Drift in peak emitted wavelength of all LEDs on the 
illumination array after ten minutes at high driving current.  
5.2.4.4 OPTIMISING PULSE SIGNAL LEVEL AND QUANTIZATION 
At start up a conventional clinical pulse oximeter incrementally increases the 
driving current to the LEDs until a sufficient pulse signal is detected at each 
wavelength. This enables identical pulse oximeter probes to be used on the entire 
range of subjects, regardless of an individual’s size or skin colour, and without ever 
saturating the photodiode detector. During operation the LED driving current is 
continually adjusted to maintain signal level and prevent saturation.  
Control of the signal level in the camera-based system need not be limited to 
control of the light source. The combination of the digital camera and its optics 
form a highly configurable detector. While providing a constant illumination level, 
sufficient to detect signals across a broad range of subjects, saturation of the 
detector can be avoided by varying the lens aperture and the duration of the camera 
exposure. Amplification of weak signals is made possible by the CMOS chip’s in-
built circuitry.  
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Having obtained suitable pulse signals commercial devices also attempt to 
maximise the utility of the ADC process by removing the DC offset from the 
analogue signal prior to quantization (see Section 3.3.3.3). This makes the full 
quantization range available to encode the important pulse component of the 
received light intensity.  
Since a camera produces a digital signal in response to a continuously varying 
light intensity, there is no opportunity to remove the resulting DC component prior 
to quantization by signal processing means. However the offset can be reduced 
somewhat by carefully varying the camera’s lens aperture such that the mean 
received light intensity is just below the current intensity at the troughs of the PPG 
waveform (Wieringa, et al. 2005). If employed in conjunction with the sensor’s 
onboard amplifier the technique has the potential to improve the quantization of the 
PPG signal.  
In the experiments that are described below (Section 5.4) this technique is not 
employed however; since the base level of the PPG signal can vary significantly 
over relatively short observation periods, it would be necessary that the lens 
aperture be continuously varied to maintain the effect. 
5.3 IMAGE ANALYSIS 
Image analysis takes place offline using Matlab®. Successive frames of the tissue 
under investigation, illuminated alternately by light with wavelengths of 760 nm 
and 880 nm, are saved to a PC in Full Frame (uncompressed) Audio Video 
Interleave (AVI) media container format—the merits and demerits of which are 
discussed shortly. Image analysis comprises: separation of the multiplexed frames 
into two separate sequences of frames, one illuminated at 760 nm and one at 
880 nm; and the division of each frame, from both sequences, into smaller 
rectangular regions apt to searching for PPG signals. 
Synchronisation between the camera and the illumination array is maintained 
by means of an 880 nm indicator LED that pulses synchronously with the 880 nm 
LEDs on the array, with reduced intensity. The indicator LED is coupled to an optical 
fibre, the other end of which is positioned in a corner of the camera’s field of view.  
102 
Instrument Description and Performance 
5.3.1 EXTRACTING AVI FILES 
Since it is not required to play back the recorded video file the utilisation of the AVI 
format is an inefficient use of storage resources compared to a raw data format. The 
uncompressed or Full Frame AVI format stores each frame in truecolor format, in 
which three numbers are used to represent every pixel in a video frame. These 
numbers indicate the red, green, and blue colour intensities of that pixel. However 
the camera, being monochromatic, produces only one 8-bit number per pixel that 
represents the intensity of each pixel on a grey scale with 256 levels. The truecolor 
format triplicates the 8-bit number produced by the camera and saves it to each of 
the red, green, and blue fields of that pixel. Thus for a grey scale image, the 
truecolor format is three times as large as the raw data. For small numbers of 
frames, the AVI structure also produces a header chunk that is significantly larger 
than the collective size of the individual raw data headers, making AVI less than 
three times as efficient for small numbers of frames. For larger numbers of frames, 
the AVI format converges towards three times the size of the raw data. The 
advantage of the AVI format is that it collects all the data from a period of 
monitoring into just one file—rather than thousands of small files. At the start of 
image analysis only one of the identical red, green, or blue fields need be processed 
while the rest are discarded. This is simple matter of indexing in Matlab and need 
not add to the processing delay. So long as memory and storage space permit, the 
use of the AVI format in offline processing is not restrictive. 
Figure 5.11 depicts the structure of the resulting frames. One of the red, green, 
or blue layers of each frame is selected, and by identifying the state of the indicator 
LED, on or off, the illumination wavelength of each frame is determined. The frames 
are then divided into two separate sequences for further processing. To decide 
whether the indicator LED is on or off, the mean value of intensity of that corner of 
the video is determined over ten frames. If the intensity of that region in any 
individual frame then exceeds a certain threshold, say 1.25 × mean value, the 
indicator LED is determined to be on, and if it is less than a low threshold, say 0.8 × 
mean value, the LED is determined to be off. If neither threshold is passed, the mean 
is recalculated using a different region of the video, or the thresholds moved closer 
together.  
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Figure 5.11 Depiction of the identical, red (R), green (G), and blue (B) 
layers of successive frames in the AVI file—only one of which need be 
selected per frame. The status of the indicator light indicates the 
wavelength at which the tissue was illuminated during that frame.  
5.3.2 BOXES AND THEIR ANALYSIS 
After generating a sequence of frames illuminated by the same wavelength, each 
frame is analysed by dividing it into boxes, or rectangular regions comprised of 
adjacent pixels. The mean values of these boxes are determined for every frame, 
and a matrix constructed such that each frame adds a new row to the matrix, while 
the mean value of each box within a frame resides in a column of the matrix. Thus a 
particular column of the matrix records the time-varying mean value of the pixels in 
a particular box, as they vary from frame to frame. Where backscattered light 
emerging from the tissue and captured by the camera, has traversed an artery, a PPG 
may be detectable. Where a PPG is detectable at both wavelengths, within the same 
box, over the same period of time, the prerequisite for pulse oximetry is met. 
Figure 5.12 depicts a sample PPG signal obtained in this manner during an early 
trans-illumination experiment at one wavelength (805 nm). 
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Figure 5.12 Sample PPG obtained by transmission illumination of the 
index finger at 805 nm. The white square of dimensions 20×20 pixels in 
the left image indicates the area of the video where the signal was 
observed. (Note the PPG signal has been inverted.) 
5.3.3 IDENTIFYING PPG CONTAINING REGIONS 
A PPG signal can be observable in a single pixel or in the sum or average of a group 
of pixels. Regardless of the area of the region of interest (ROI) most ROIs in the 
video frame will not posses a strong PPG signal at both wavelengths (some portions 
of the video will contain the indicator LED signal and some others may not be 
displaying tissue). It is desirable to have an automatic means of identifying ROIs 
with strong PPGs at both wavelengths. Two methods of identifying PPG containing 
ROIs were used during this study; both assume the average pulse rate during the 
observation window is known, either from a second device or from pre-processing. 
The first method takes the signal from each ROI and identifies all the inflection 
points. This can be efficiently achieved by differencing adjacent samples of the 
signal x to form an approximate derivative x , 
 [ ] [ 1] [ ]x n x n x n= + − . (5.6) 
Each place where the sign of [ ]x n  differs from the sign of  signifies 
an inflection point at the n
[ 1]x n +
th sample. The number of these inflection points is 
counted. Referring to Figure 5.12, a PPG signal free from noise and other artefacts 
has four inflection points per pulse (or two per pulse if the dichrotic notch is not 
visible in the waveform). When the number of counted inflection points per second 
is within a certain threshold of four times the pulse rate, that ROI is deemed to 
contain a PPG at that wavelength. Noisy signals have many more inflection points 
and are rejected. 
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Though this method is simple, it is computationally efficient and is not prone 
to false positives. Figure 5.13 displays an image of the index and middle finger 
from the right hand of twenty-six year old male subject. Each finger is trans-
illuminated by an 805 nm LED. Superimposed on the frame are 20×20 pixel ROIs in 
which PPG signals were detected using the inflection point method (from 
Humphreys et al. (2005a)). 
 
Figure 5.13 ROIs containing PPG signals identified by the inflection point 
method. 
The inflection point method is however susceptible to false negatives in the 
presence of noisy signals. As such it is most suited for use with transmission 
illumination schemes.  
PPG signals at multiple wavelengths, obtained in a multiplexed fashion, from 
deep tissue, and in a non-contact reflection geometry, are weaker, sampled at a 
lower rate (because of both multiplexing and the need for a longer exposure time), 
and are consequently less well defined than that depicted in Figure 5.12. To identify 
ROIs containing PPG signals in such videos a simple spectral method was developed 
and employed during this study. 
A matrix containing the time-varying signal from each ROI is constructed as 
described in Section 5.3.2. The mean value of the signal from each ROI is subtracted 
to remove the DC offset and its Fourier spectrum calculated. A region of the 
spectrum is defined from 0.2 Hz up to 1.9 times the pulse rate (in Hertz), which 
excludes the low frequency Mayer wave and vasomotion, and the first harmonic of 
the pulse frequency. Within this region a smaller region is defined from 0.5 times 
the pulse rate up to 1.5 times the pulse rate that allows for pulse rate variability over 
the observation window. A figure of merit is then calculated for each ROI, defined as 
the area under the Fourier spectra in the smaller pulse-rate-centred region, divided 
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by the area under the Fourier spectra in the larger region. The process is depicted in 
Figure 5.14, which shows data from a thirty-three year old male subject with a 
mean pulse frequency of 1.2 Hz (72 pulses per minute). 
Figure 5.14 depicts a portion of the Fourier spectrum indicating the two 
previously defined regions (top plot). The figure of merit is calculated as the area of 
the black portion divided by the sum of the areas of the black and grey portions. 
The figure of merit for all ROIs is plotted in the bottom plot of Figure 5.14, with a 
circle marking the merit value for this example. The middle plot shows the PPG 
signal associated with this ROI. 
 
Figure 5.14 Spectral method of identifying ROIs containing PPG signals—
depicting a good PPG signal.  
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Figure 5.15 depicts the spectrum, figure of merit, and resulting PPG from an 
ROI with a poor associated figure of merit. In this instance though a small 
component is visible at the pulse frequency in both the time-domain and the 
frequency-domain, in both domains the signal exhibits greater energy at predomin-
antly lower frequencies. 
 
Figure 5.15 Spectral method of identifying ROIs containing PPG signals—
depicting a poor PPG signal. 
ROIs with strong PPG signals tend to be spatially grouped in certain regions of 
the video frame (discussed later in Section 5.5). Thus the figure of merit from each 
ROI, when converted to a 1D vector from its 2D matrix form, exhibits a periodicity 
that corresponds to the spatial location of signal containing ROIs. The decrease in 
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magnitude of the figure of merit with increasing ROI number in Figure 5.14 and 
Figure 5.15, is a result of increasing distance from the light source and the 
concomitant decrease in received light intensity. 
Neither of these methods is suited to a real-time implementation—the former 
being too susceptible to false negatives in the presence of noise and the latter being 
too computationally intensive—they are however well suited to off-line processing 
of videos. The task of quickly and accurately identifying ROIs is key to a real-time 
implementation and is deserving of further investigation. 
5.4 TESTING AND PERFORMANCE OF DEVICE 
This section describes the apparatus and experimental protocol used to test the non-
contact device. For the non-contact device to provide an acceptable substitute for a 
conventional device in any application, it must provide comparable measurements 
to a conventional device. Comparable, from a clinical perspective means that 
decisions regarding the management and treatment of a patient would not alter 
depending on the instrument used to assess the patient. For the case of a pulse 
oximeter, the three primary indicators of a patient’s health provided by the device 
are the patient’s arterial oxygen saturation SpO2, the patient’s pulse rate, and a 
display of the patient’s peripheral arterial pressure waveform—a PPG. Collectively 
these parameters are used to assess the effectiveness of the patient’s cardio 
pulmonary system, the oxygen content of the arterial blood being indicated by the 
SpO2 value, and the combined effectiveness of the cardiac pump and arterial 
delivery system, being indicated by the pulse rate and PPG waveform (see 
Chapter 3). Any novel non-contact pulse oximeter should provide comparable 
measurements of all of these parameters. Furthermore though a non-contact device 
will undoubtedly be subject to extra constraints by virtue of its position, remote 
from the tissue under investigation, the device should nonetheless be capable of 
obtaining measurements from a broad subject base and under realistic operating and 
environmental conditions.  
5.4.1 EXPERIMENTAL PROTOCOL 
Experiments were conducted using ten informed subjects (ten Caucasian, nine 
male, and one female) aged between 21 and 45 years (mean 31.70 years and 
109 
Instrument Description and Performance 
standard deviation 6.37 years). Subjects were seated in an upright position with 
their right arms resting, volar side upwards, on a cushioned bench. A conventional 
reflection mode PPG sensor with a wavelength of 805 nm (BioPac UIM100C) was 
connected to the subjects’ right index fingers. A conventional contact pulse oximeter 
(Nellcor 660 nm/940 nm probe – Welch Allyn device) was connected to the 
subjects’ left index fingers. 
The camera was positioned and focused manually such that an area of the 
volar side of the forearm close to the wrist was occupying most of the image. The 
LED array was positioned so as to illuminate an area on the proximal side of the 
imaged area, at a distance of approximately 15 cm from the tissue surface. 
Figure 5.16 illustrates the relative position of the illuminated and imaged area. 
Overhead fluorescent lighting was present during all of the experiments (mains 
supply 50 Hz). 
Over several sets of preliminary experiments on small numbers of test 
subjects, using both the system described here and variations of the system 
(described in Humphreys et al. (2005a; 2005b; 2005c)), PPG signals were captured 
from various parts of the body surface. Reflection mode PPG signals were obtained 
from the sole of the foot, the palm of the hand, the fingertips, the ankle, the forearm, 
and the neck. The forearm was chosen as the region of interrogation for this 
experiment because of the ease with which the apparatus can be repeatedly 
positioned to obtain similar measurements from multiple test subjects of varying 
physical size. Whilst other observation sites on the body and are undoubtedly of 
interest, as are other observation positions, for example a reclined and supine 
position, observing the forearm in a seated position represents a more practical and 
comfortable protocol from the point of view of the volunteers, given the decidedly 
experimental rather than clinical environment in which the experiments took place. 
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Figure 5.16 Relative position of the imaged and illuminated regions of 
tissue. 
Once stable and normal pulse rate and SpO2 readings were indicated by the 
pulse oximeter, a trigger was sent to the camera-based system and the PPG data 
acquisition system, simultaneously initiating a 20 s capture of data by both devices. 
The camera was configured to capture 640 frames, at resolution of 640×480 
pixels, with a 20 ms exposure time. The camera was triggered externally at a rate of 
32 frames/s (refer to the maximum achievable frame rate data in Table 5.1). The 
LED array was correspondingly switched at 16 Hz (see Figure 5.7).  
The LED array was activated for several minutes prior to each experiment to 
allow the LEDs reach their stable operating temperature and wavelength (see 
Section 5.2.4 for timing signals). 
All subjects were asked to sit motionless and to breathe normally during the 
experiments.  
5.4.2 DISPLAYING A PPG 
Early commercially available pulse oximeters used in clinical monitoring incor-
porated an electro cardiograph (ECG)—as do many patient-monitoring suites 
available currently. Though the pulse period could be and indeed was estimated 
from the PPG waveform, the heart rate was also calculated from the distinctive R-
peak of the QRS complex of the ECG waveform. Both of these measurements of 
heart rate were displayed and users often employed a rule of thumb: the displayed 
SpO2 values should only be relied upon if the heart rate indicated by the electrical 
ECG signal and the pulse rate indicated by the PPG signal were within one to two 
beats per minute of each other (Wukitsch, et al. 1988). This rule of thumb served to 
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alert users of instances where a PPG signal was poor; likely due to probe placement 
but possibly due to a serious deterioration in the patient’s condition; pulse oximetry 
requires only a weak pulsatile signal rather than a pulse to produce some SpO2 
value, though it is likely erroneous in the former case.  
The need for an extraneous corroboration of the validity of the pulse signal, on 
which the SpO2 values are based, is obviated if the device is capable of displaying 
the arterial pressure waveform on which it is currently basing its calculations. Thus, 
by a pulse oximeter displaying a PPG waveform, the experienced user can evaluate 
the validity of the current pulse rate and SpO2 values.  
In addition, the displayed PPG trace gives the user a quick indication of the 
cardiac rhythm and of any changes in its regularity. When the PPG trace is not 
normalised, it will indicate any sudden changes in cardiac output or hypovolaemia. 
Furthermore, the shape of the peripheral arterial pressure waveform, and 
notably the prominence of the dichrotic notch, can provide diagnostic information 
about the health and compliance of the vasculature (Joyce, et al. 1990).  
For these reasons it is important that the camera-based device be capable of 
capturing a suitable PPG signal. (Separate to the pursuit of pulse oximeter 
functionality the ability to capture spatially resolved PPGs is important to the 
device’s independent investigative capabilities.) 
Figure 5.17 displays non-contact PPG signals captured at 760 nm and 880 nm 
by the remote camera-based system, and also a contact PPG signal captured using a 
finger probe at 805 nm (200 Hz sampling rate).9 The signals were captured from a 
45-year-old male test subject imaging an area similar to that depicted in Figure 5.16 
with a tissue-camera separation of approximately 30 cm. Note that although clear 
pulses are visible, the dichrotic notch is not well defined in either of the non-contact 
signals, and not discernable in the contact signal. For this subject, a 0.5 Hz high 
pass filter has been applied to the contact PPG signal, while the non-contact PPG 
signals are the result of the image analysis described in Section 5.3.2 only, to which 
no further signal processing has been applied. 
                                                 
9 The non-contact PPG signals in  and  have been orientated such 
that their amplitude is proportional to light absorption rather than received light 
intensity. The contact device utilises this format by default—the non-contact signals are 
orientated such for ease of comparison only. 
Figure 5.17 Figure 5.18
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Figure 5.17 PPG signals captured simultaneously by the camera-based, 
non-contact device at 760 nm and 880 nm, and from the conventional 
contact probe (on the finger) at 805 nm, from a 45-year-old male test 
subject. 
Figure 5.18 displays the same data captured from a 21-year-old male test 
subject, in which the pulses complete with dichrotic notch are clearly visible in all 
three signals. The contact PPG signal, for this subject, is unfiltered. The non-contact 
PPG signals again, represent the output of the image analysis described in 
Section 5.3.2. 
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Figure 5.18 PPG signals captured simultaneously by the camera-based, 
non-contact device at 760 nm and 880 nm, and from the conventional 
contact probe (on the finger) at 805 nm, from a 21-year-old male test 
subject. 
In addition to the pulse component, a lower frequency oscillation can be seen 
in the PPG signals (except the high pass filtered contact PPG in Figure 5.17). This 
component is partially due to respiration. The component is more clearly visible in 
the frequency domain. Figure 5.19 displays the Fourier spectra of the PPG signals 
plotted in Figure 5.18. The component due to respiration can be seen in each of the 
spectra as a peak at 0.35 Hz, prominent in both the camera PPG signals, though less 
so in the contact signal. The pulse component is visible as the distinctive peak at 
1.5 Hz and its first harmonic can be seen at 3 Hz. The low frequency Mayer waves 
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and vasomotion can be seen between 0 Hz and 0.1 Hz 10 (it is particularly evident in 
the time-domain contact PPG plot as the smooth undulation with a period slightly 
longer than 10 s in Figure 5.18). 
 
Figure 5.19 Fourier spectra of the PPG signals plotted in Figure 5.18, from 
a 21-year-old male test subject. 
5.4.3 MEASURING PULSE RATES 
The next important purpose of a commercial pulse oximeter is to measure the pulse 
rate, a vital sign (Mower, et al. 1998; Mower, et al. 1997). In Section 5.4.2 reference 
                                                 
10 The Mayer waves are oscillations in arterial pressure at frequencies lower than 
respiration that are coupled with the activity of the sympathetic nervous system (Julien 
2006). Vasomotion refers to small and slow changes in vascular diameter generated 
within the vascular wall. Though both phenomena are well documented their respective 
physiological causes remain elusive.  
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was made to early clinical devices that incorporated an ECG. The ECG signal can 
provide a measurement of heart rate, while a pulse oximeter—utilising a photo-
plethysmograph—provides a measurement of the pulse rate. These two parameters 
should agree closely, but may vary a little, since the rate at which pulses pass by a 
sensor in the peripheral arterial vasculature is affected by the transit time, the 
compliance of the vasculature, and the musculature that lies between the probe site 
and the heart. The need to ensure close agreement between the ECG indication of 
heart rate and the pulse oximetry indication of pulse rate, as an indication of the 
validity of SpO2 values, was ultimately obviated by the incorporation of a plethys-
mographic display. It is thus necessary to ensure that a measure of pulse rate 
provided by the non-contact device agrees sufficiently closely with that produced 
by the conventional contact plethysmogram, that the two devices can be used inter-
changeably for this purpose. 
A useful method of assessing the agreement between two devices or 
techniques is the Bland-Altman method (Altman and Bland 1983; Bland and 
Altman 1986). The Bland-Altman method is a particularly popular tool for 
assessing agreement between two clinical devices, where both devices exhibit a 
certain amount of measurement error.11 It is preferable to other commonly 
employed methods, for example Student’s t-test, in that it is fundamentally a 
graphical method, which can compare the accuracy, precision, and bias between 
two devices or methods, without requiring assumptions to be made about the 
normality of the data’s distribution. Indeed insufficient data are available here to 
reliably ascertain the normality of their distribution by usual means (for example a 
Shapiro-Wilk or Kolmogorov-Smirnov test). The Bland-Altman method is to be 
preferred to the use of a correlation coefficient, as it inherently identifies bias 
between the devices.  
To obtain a pulse rate measurement for each of the test subjects over the 20 s 
observation window, the Fourier spectra of the contact, and 760 nm and 880 nm 
non-contact, PPG signals were calculated and the peak frequency of the cardiac 
component noted. Figure 5.20 shows a scatter plot of the pulse rate measurement 
from the conventional contact finger probe, versus the measurement from the 
camera-based non-contact device. The non-contact 760 nm measurements are 
                                                 
11 On a serendipitous note: the second paper Bland and Altman published on this 
method (1986)—which appeared in the Lancet and can be credited with bringing the 
technique to the attention of the clinical community—assessed, as an example, the 
agreement between the new technique of pulse oximetry and the established CO-
Oximeter, as a means of determining arterial oxygen saturation. 
116 
Instrument Description and Performance 
plotted as circles and the 880 nm measurements as crosses. Where the circles and 
crosses align the non-contact measurements agree at both wavelengths for that 
subject. Also plotted in Figure 5.20 is the line x = y, where data points lie along this 
line, there is perfect agreement between the two devices. Deviation from the line 
indicates disagreement, an underestimation of pulse rate by the non-contact device 
when the plotted point is to the left of the line, and an overestimation when the 
point is to the right of the line. 
It is worth noting that the measurements by the two devices will be perfectly 
correlated if the points in the scatter plot lie along any straight line; only along the 
line x = y however, do the two devices agree. 
 
Figure 5.20 Scatter plot showing the non-contact device’s measurement 
of pulse rate at two wavelengths, versus the contact device’s measure-
ment, for each subject. Also plotted is the line x = y, where both devices 
are in perfect agreement about the measurement. From Humphreys et al. 
(2007). 
Examining Figure 5.20 it can be seen that for eight subjects, both devices are 
in perfect agreement. However, for two subjects the non-contact device recorded a 
lower pulse rate than the conventional device. Since the two devices are in 
agreement for higher, intermediate, and lower pulse rates, and since both devices 
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agree for other measurements in this range, it is reasonable to presume that the 
disagreement for these two subjects is not systemic to either device.  
Having established that both devices produce largely agreeable pulse rate 
measurements over the range of pulse rates exhibited by the test subjects, it remains 
to establish if the two devices agree sufficiently closely that one device is substitut-
able for the other in making clinical measurements. This can be assessed using a 
Bland-Altman plot and analysis. 
Figure 5.21 is a Bland-Altman plot, showing the mean of the measurements 
by the two devices on the horizontal axis, versus the difference between the meas-
urements by the two devices (contact – non-contact) on the vertical axis. 
 
Figure 5.21 Bland-Altman (mean versus difference) plot showing the 
mean pulse rate measurement by the two devices versus the difference 
between their measurements. Non-contact measurements at 760 nm are 
plotted as circles and 880 nm as crosses. Also shown are the mean  
(–0.0150 Hz) and ±1.96 standard deviations (0.0337 Hz) about the mean. 
From Humphreys et al. (2007). 
The utility of the Bland-Altman plot is that unlike the scatter plot, it displays 
disagreement between the two devices as a vertical displacement from the mean 
measured value of the parameter—which is unknown; the mean of the two 
measurements is the best available estimate. The mean value of the difference 
between the two devices is –0.0150 Hz and the standard deviation is 0.0337 Hz. If 
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the two devices exhibited greater disagreement, Figure 5.21 would make any bias 
plainly evident. 
Assuming that the mean difference between the devices is normally 
distributed, the 95% confidence interval can be calculated as ±1.96 standard 
deviations. (It would take several more samples to establish if the difference is 
normally distributed; a histogram would quickly show that these samples are not.) 
Converting the 95% confidence limits from Hertz to pulses per minute, the non-
contact camera-based device should be expected to provide a measurement of pulse 
rate that is within 4.8687 pulses/minute above or 3.0687 pulses/minute below the 
contact device, for 95% of measurements. This is sufficiently close that the two 
devices could be used interchangeably, since an indicated pulse rate 5 pulses/minute 
above or 3 pulses/minute below the estimation of a currently accepted clinical 
monitoring device, would not affect decisions regarding patient management 
(Humphreys, et al. 2007). 
In practice the pulse period can vary significantly from pulse to pulse, and 
pulse oximeters use a weighted moving average of the peaks of the PPG waveforms 
to calculate the displayed pulse rate (Wukitsch, et al. 1988). The use of the peaks of 
the Fourier spectra in the above analysis has the effect of averaging the individual 
pulse periods. This does not invalidate the analysis—the analysis is applied to the 
contact and non-contact device alike—though it limits the number of sample points 
on which the analysis is based to ten (the number of test subjects). It also limits the 
range of pulse periods across which the two devices are compared, since the 
variance in pulse rate of healthy resting adults is conceivably less than the variance 
in the pulse-to-pulse period of an individual. 
To analyse the comparability of the contact and non-contact devices in this 
regard, the data pertaining to two test subjects were selected. Figure 5.17 and 
Figure 5.18 depict the slowest and fastest recorded pulse rates among the test 
subjects respectively. The data from these subjects were further processed to 
determine the pulse periods of corresponding pulses as measured by the contact 
device and the camera-based device, at both 760 nm and 880 nm. The pulse period 
was measured as the distance between adjacent systolic peaks. Analysis of the data 
pertaining to the two subjects exhibiting the maximum and minimum values of the 
parameter of interest should identify any relationship that might exist between the 
bias of the measurement and the value of the measured parameter.  
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Figure 5.22 depicts a Bland-Altman plot of the contact device’s measurement 
of pulse period versus the non-contact device’s measurement at 760 nm. Intuitively, 
it might be expected that the measurements exhibit greater disagreement at higher 
pulse rates—since the camera achieves a comparatively low 16 samples per second 
compared to the contact devices 200 samples per second. The analysis shows the 
opposite trend—disagreement between the contact and non-contact devices 
increases with increasing pulse period. Figure 5.23 shows that the non-contact 
measurements at 880 nm exhibit the same trend.  
 
Figure 5.22 Bland-Altman plot of the contact device’s measurement of 
pulse period versus the non-contact device’s measurement at 760 nm. The 
data pertain to the two subjects that exhibited the fastest and slowest 
pulse rates during the experiments. (Mean 0.0043 s and standard 
deviation 0.0742 s.) 
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Figure 5.23 Bland-Altman plot of the contact device’s measurement of 
pulse period versus the non-contact device’s measurement at 880 nm. 
(Mean 0.0043 s and standard deviation 0.0510 s.) 
For pulse period measurements at 760 nm, the 95% confidence interval is 
between +0.1497 s and –0.1411 s. (For 880 nm it is +0.1043 s and –0.0957 s.) If 
this magnitude of disagreement were present between the conventional and camera-
based devices, for every pulse measurement, the resulting difference in the reported 
pulses per minute, for a subject with a pulse rate of 72 beats per minute, would be 
63.9931 – 86.6760 beats per minute. This is a significantly greater level of 
disagreement between the conventional and camera-based technique than was 
suggested by the analysis of the Fourier spectra measurement of all subjects’ pulse 
rate. With this level of disagreement between the two devices, they could likely not 
be considered comparable from a clinical perspective. However, some caution 
should be exercised when interpreting these results. 
The disagreement between the devices for large pulse periods is likely a result 
of the differences in the shape of the contact and non-contact PPG waveforms for 
this subject (refer to Figure 5.17). The non-contact PPG signals each display pulses 
in which the systolic peak is consistently to the left of the pulses, which have a 
sharp profile. The contact PPG signal for this subject exhibits pulses with a more 
curved profile, on which the position of the systolic peak varies a little from pulse to 
pulse—in addition to the normal pulse period variation. In addition to being 
obtained by two different methods, the contact and non-contact PPG signals were 
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captured from different locations. The effects of probe location on the shape of the 
PPG waveform and its affect on pulse oximetry were discussed in Section 3.4.1.3, 
while the combined effects of low sampling rate and camera-based detection on the 
PPG waveform are the subject of the next section. 
There is also a positive aspect of the pulse period analysis that deserves 
mention. Referring again to the Bland-Altman plots depicted in Figure 5.22 and 
Figure 5.23, it can be seen that the measurement difference between the two devices 
does not exhibit a static bias or a varying bias across the pulse period’s range. This 
bodes well for the inherent accuracy of the camera-based technique compared to the 
contact technique—that is the measure of systemic error or bias. The absolute mean 
error of the camera-based device is small (0.0150 Hz and 0.0043 s), and correct to 
four decimal places, both wavelengths yielded the same mean error in both 
analyses. The standard deviation of the measurement differences from both 
analyses can be interpreted as an indication of the precision of the non-contact 
technique compared to the contact technique—that is the degree of reproducibility 
of the measurements. The analysis of the pulse period measurements suggests the 
camera-based technique to be less precise for low pulse rates, though as mentioned 
the shape of the non-contact PPG waveforms likely bear some culpability for this 
precision. In general, the precision of the system can be improved by higher 
sampling rates (yielding greater time resolution) and a camera with higher dynamic 
and quantization ranges. 
5.4.4 DERIVING SPO2 FROM A CAMERA-BASED DEVICE 
As discussed in Section 3.2 pulse oximeters estimate arterial oxygen saturation 
SpO2, by means of an interim variable ROS, the ratio of arterial absorption at two 
wavelengths, obtained from the PPG waveforms, and then employ empirically 
derived calibration curves to convert ROS to SpO2. The procedure and apparatus of 
in vivo calibration and the principle of in vitro calibration were described in 
Section 3.3.5; both in vivo and in vitro calibration are beyond the purview of this 
research; this thesis instead focuses on evaluating the suitability of non-contact 
photoplethysmography to existing calibration methods. In addressing the suitability 
of non-contact PPG signals for use with existing methods of determining ROS (see 
Section 3.2.2) two points about camera-based systems should be noted. They are 
the effects of low sampling rates and the integrative effect of camera-based 
sampling of waveforms (Humphreys, et al. 2007). 
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Pulse oximeters typically sample at hundreds of Hertz, allowing over 
100 samples per second per wavelength, as well as the sampling of ambient light 
levels. Camera-based systems will likely never enjoy these frame rates, however at 
low frame rate (Wieringa et al. (2005) reported frame rates as low as 6.7 frames/s) 
the error in estimating the instantaneous amplitude of the PPG waveforms can be 
significant. This is especially true of the peak and valley method (Section 3.2.2.1) 
where sampling before or after the true peak or troughs in the waveform yields a 
smaller peak-to-peak amplitude than the true value. Low frame rates will also affect 
the accuracy of derivative type algorithms (Section 3.2.2.2). Recall that derivative 
methods calculate ROS many times per pulse, though the values calculated in the 
vicinity of the inflection points are inaccurate and need to be weighted as such to 
prevent spurious values of SpO2. At low frame rates the number of estimates 
possible during the most reliable, diastolic to systolic rise in the pulse waveform, 
will be reduced. The problems of low frame rates are compounded by the manner in 
which a camera samples a time-varying waveform. 
The photodiode in a contact device produces a continuously varying output 
current proportional to the instantaneous incident light intensity, which is converted 
to a voltage and sampled by a sample-and-hold circuit, as often as once every 2 ms 
(Section 3.3.3.1). A camera by contrast, exposes its CCD or CMOS sensor for 
typically tens of milliseconds and then has a short readout time before beginning the 
next exposure. The value readout at the end of the exposure is however, not an 
instantaneously sampled value, but rather a charge proportional to the sum of all 
photons received during the exposure—that is, the camera-derived signal is 
proportional to the mean light intensity observed during the exposure. Thus none of 
the points in a camera derived PPG signal are actual sample values of the true signal, 
but rather they are all values proportional to the sum of the true signal, as observed 
over several almost contiguous windows. The effect of this integrative sampling on 
a sinusoidal waveform is illustrated in Figure 5.24.  
Since the frame duration is constant, the mean value of the integration window 
is plotted rather than the sum in Figure 5.24, which maintains the scale of the 
integrative waveform. The dashed vertical lines indicate the end of a frame, at 
which point the mean value of the true waveform (continuous line) between the 
current vertical line and the vertical line immediately to the left is readout. During 
periods of increasing amplitude, the mean value is always less than the 
instantaneous value, and the converse is true during periods of decreasing 
amplitude. The combined effect of low sampling rate and integrative sampling is to 
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cause the observed waveform to exhibit reduced peak-to-peak amplitude and to 
appear to lag the sample-and-hold waveform. Figure 5.25 illustrates one period of 
the synthetic pulse waveform (generated by summing three sinusoids at typical 
cardiac, vasomotion, and respiratory frequencies and amplitudes) and the corresp-
onding integrative waveform. The circles mark the inflection points of the sample-
and-hold waveform and the crosses the inflection points of the integrative 
waveform. 
 
Figure 5.24 Result of camera-based integrative sampling (dashed line) at 
16 frames per second on a synthetic pulse waveform (continuous line) 
with 160 samples per second.  
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Figure 5.25 Combined effect of low frame rate and integrative sampling 
on the peak-to-peak amplitude of a sample-and-hold synthetic pulse 
waveform.  
The affect that this waveform distortion would have on a derivative based 
method of calculating ROS would depend on the characteristics of the moving 
weighted averaging of the instantaneous red/infrared ratios employed by the 
manufacturer (see Section 3.2.2.2). It is reasonable to presume that it would not be 
beneficial to accuracy. The affect of the waveform distortion on a peak and valley 
based method of calculating ROS can be more readily quantified. 
By again constructing a synthetic pulse signal composed of three sinusoids at 
the typical vasomotion, respiratory, and cardiac frequencies, and with typical 
proportionate amplitudes, the percentage error in the calculation of ROS values 
using the peak and valley method, was determined for varying oxygen saturation 
levels and pulse rates. The effect of varying oxygen saturation levels was emulated 
by varying the ratio of the infrared and red PPG amplitudes linearly between 
approximately 2.3 and 0.5, which for a red wavelength of 660 nm and an infrared 
wavelength of 940 nm, correspond approximately to SpO2 values of between 100% 
and 60% (see Figure 3.9 and refer to Wukitsch et al. (1988)). ROS was calculated 
using equation (3.13): 
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The results of the simulation are summarised in Table 5.3. The discrepancy 
between the ROS values obtained from the sample-and-hold waveform and the 
integrative waveform vary with both pulse rate and oxygen saturation. The 
percentage error is largest when both the saturation and pulse rate are at their 
highest.  
The dependence on pulse rate exhibited by the simulation results should be 
interpreted with some caution. The likely cause of the increased error with 
increased pulse rate, is the increased slope of the rising (diastolic to systolic) portion 
of the synthetic PPG waveform, which causes the integrative waveform to further 
lag the sample-and-hold waveform and consequently to underestimate the true 
peak. In an actual PPG waveform, the slope of the rising edge is proportional to the 
force of contraction of the heart, which is not particularly dependent on pulse rate—
compare the PPG signals plotted in Figure 5.17 and Figure 5.18.  
  
  
  
  
  
  
  
  
  
  
Pulse rate Approx. 
SPO2 
(%) 
IR:R PPG 
scaling 
factor 50 72 100 
100 2.32 1.3 1.69 2.58 
 1.66 0.69 0.9 1.35 
85 1 0 0 0 
 0.81 -0.2 -0.28 -0.4 
60 0.47 -0.51 -0.73 -1.09 
Table 5.3 Simulated percentage error in calculation of ROS due to 
integrative sampling at a frame rate of 16 frames/s, compared to a 
sample-and-hold waveform sampled at 160 samples/s (Humphreys, et al. 
2007). 
More credence can be given to the error’s oxygen saturation level dependence. 
As the magnitudes of the red and infrared PPG signals vary with oxygen saturation, 
so too do the magnitudes of the integration error associated with each. At high 
saturations the infrared PPG has much larger amplitude than the red PPG, 
consequently its associated error is larger too. Equation (3.13) defined ROS as the 
quotient of the red and infrared PPG signals. Thus for high saturations the error 
associated with the numerator (the red PPG) is comparatively small and the error 
associated with the denominator (the infrared PPG) is comparatively large. Since a 
larger error means greater underestimation of the peak-to-peak amplitude, at high 
saturations ROS is overestimated by a small fraction. At low saturations, the red PPG 
has larger amplitude than the infrared, thus the reverse is true and ROS is under 
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estimated by a small fraction—though the comparative difference in the PPG 
amplitudes is slightly less at low saturations and so the underestimation has smaller 
magnitude than the overestimation at high saturations. At some saturation level the 
red and infrared PPG signals will have equal magnitude (approximately 85% for 
660 nm and 940 nm), at this saturation level the error associated with each signal is 
the same and their quotient does not introduce error into the ROS calculation. 
Within the range of pulse rate and oxygen saturation level simulated, 
compared to the contact technique, the camera-based technique produced a 
maximum overestimation in ROS of 2.6% and a maximum underestimation of  
–1.1%. If the differences in ROS values summarised in Table 5.3 were translated 
directly in to SpO2 errors, for high saturations, the bias resulting from the camera’s 
integrative sampling would cause an over estimation of saturation that is of 
comparable size to the current clinically accepted accuracy of the contact method: 
±3% (see Section 3.4.1). Such an additional error might be of clinical significance. 
Fortuitously, the simulation results suggest that integration error decreases 
with saturation, providing an underestimation in low saturation regions where a 
patient would be danger.  
5.5 ANALYSIS OF ASPECTS OF DEVICE’S PERFORMANCE 
A further consideration should be made in performing camera-based non-contact 
photoplethysmography for pulse oximetry: choosing the size of the region of 
interest (ROI) within the imaged frame from which the PPG signal is obtained. The 
size of the ROI and its position relative to the tissue under investigation influences 
the characteristics of the derived PPG signal. 
Section 3.3.4.2 reviewed the design considerations pertaining to reflectance 
probes in conventional pulse oximeters. In summary, those parameters were the 
source and detector separation and the surface area of the detector, or in the case of 
multiple detectors, their arrangement. Mendelson and Ochs (1988) concluded that 
in the case of contact reflectance pulse oximetry, summing the signals from multiple 
detectors arranged symmetrically around the sources provided the best PPG signals. 
Reddy (1997), in reviewing Mendelson and Ochs’ work, suggested that a detector 
with enlarged area would achieve the same results.  
In a camera-based system the active area of the detector—the regions of 
interest within each frame—are almost arbitrarily variable in shape, number, 
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arrangement, and area. This section investigates the effectiveness of enlarged 
detector area and multiple detection sites in the camera-based device.  
5.5.1 EFFECT OF ROI SIZE ON PLETHYSMOGRAPH CHARACTERISTICS 
Unless the PPG signal is obtained from just one pixel a camera-based system 
inherently utilises multiple detectors, combining their surface area to either sum or 
average the intensity of the emitted light in the search for PPG signals. For 
convenience in addressing pixels within the frames, the regions of interest are 
chosen as contiguous pixels grouped into rectangles, which thus far, have also been 
square. The shape and size of this area is naturally a variable of interest. 
During investigations of the effects of the region of interest’s size and shape, 
some interesting size dependent phenomena were observed, which hint at the 
additional unforeseen complexity and indeed potential of camera-based photo-
plethysmographic investigation. For illustrative purposes, a comparison is provided 
here of the PPG signals that are obtained from one twenty second AVI file, when 
image analysis is performed using three different sized regions of interest.  
Figure 5.26 depicts a sample frame from the 880 nm sequence on which are 
imposed the square outlines of ROIs with dimensions, 20×20, 40×40, and 80×80 
pixels respectively. Also visible in each image is the 880 nm indicator light in the 
top right hand corner. The imaged area corresponds approximately to that depicted 
in Figure 5.16 (though the orientation is upside down compared to Figure 5.16) and 
the separation of the camera and tissue is approximately 30 cm. The actual area of 
tissue that is imaged is a function of the system’s optics though the image in 
Figure 5.26 depicts approximately 16 cm2. 
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Figure 5.26 A sample frame from the 880 nm sequence showing the 
locations of a 20×20, 40×40, and 80×80 pixels regions of interest. 
Each ROI is centred on approximately the same region of the frame. The PPG 
signals obtained from each of these regions, at both 880 nm and 760 nm, are plotted 
in Figure 5.27. Note that in previous plots, the PPG signals have been reorientated 
such that increasing PPG amplitude corresponds to increasing absorptivity (see 
Figure 5.17 and Figure 5.18 above). In Figure 5.27 the PPG signals are plotted in 
their received form; PPG amplitude—the average pixel value within the region of 
interest—is proportional to received light intensity and inversely proportional to 
absorptivity. The mean value of each PPG signal has been subtracted so that the 
pulsatile components of the signals are directly comparable. 
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Figure 5.27 PPG signals obtained from similarly positioned regions of 
interest of different sizes for both wavelengths. 
The three PPG signals obtained using different size regions of interest are 
broadly similar for both wavelengths. They are well aligned during the diastolic to 
systolic portion of the pulse (the peaks and troughs respectively in Figure 5.27). 
However the magnified view of the waveforms depicted in Figure 5.28 shows that a 
significant difference exists in the peak-to-peak amplitude of the PPG signal 
depending on the size of the region of interest. Converse to the findings of 
Mendelson and Ochs (1988) and the predictions of Reddy (1997) pertaining to 
contact reflectance PPG measurement, the detected PPG amplitude diminishes as the 
area of the detector, the region of interest (the boxes) in this case, increases. 
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Figure 5.28 Magnified portion of the three 880 nm PPG signals plotted in 
Figure 5.27, depicting variation in PPG peak-to-peak amplitude due to 
different size regions of interest.  
The magnitude of the effect can be more clearly observed in the frequency 
domain. The Fourier spectra of the PPG signals plotted in Figure 5.27 are plotted in 
Figure 5.29. All three spectra share similar peaks, though the amplitudes vary. At 
the pulse frequency (approximately 0.7 Hz) the enlarged regions of interest result in 
a reduction of amplitude of approximately 25% at 880 nm and approximately 50% 
at 760 nm, compared to the peak resulting from the 20×20 pixel region of interest. 
The reduction that occurs at the pulse frequency is disproportionately large 
compared to the other peaks, for example the respiratory peak at approximately 
0.4 Hz, which is not affected by region of interest size at 880 nm and minimally 
affected at 760 nm.  
The cause of the PPG amplitude reduction with increasing region of interest 
size in this instance is a phenomenon that is largely unreported upon in the 
literature: PPG inversion. In some regions of the imaged tissue, the camera-based 
device captures signals that are the precise inverse of the expected PPG signal. When 
a region of interest becomes large enough to encompass both a normal PPG and an 
inverted PPG, the two signals interfere destructively, resulting in a reduction of the 
detected PPG amplitude.  
An examination of the PPG inversion phenomenon and a hypothesis as to the 
cause are the subjects of the next section. 
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Figure 5.29 Fourier spectra of PPG signals obtained from different size 
regions of interest.  
5.5.2 DETECTION OF INVERTED PPG SIGNALS 
When making remote non-contact observations of deep tissue in a reflection 
geometry the camera-based system routinely detects inverted PPG signals. That is, 
signals where the peak in the detected light intensity occurs at the systolic peak of 
the pulse waveform, and the trough at the diastolic trough of the pulse waveform. 
This is the reverse of the normal situation, where high absorptivity during systole 
causes low transmittance and a trough in the detected light intensity, the reverse 
being true of the diastolic portion of the waveform (refer to Section 3.2.1). 
Figure 5.30 displays a normal waveform captured by the camera system. The 
vertical axis displays the average pixel value within the region of interest, which is 
proportional to the received light intensity.  
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Figure 5.30 Normal PPG waveforms captured from a 40×40 pixel region 
of interest. 
Figure 5.31 displays an inverted PPG waveform captured from a different 
region of the same AVI file. It can be seen that at both wavelengths the signals share 
common inflection points, though the signals in Figure 5.31 appear to be the inverse 
of those in Figure 5.30. 
 
Figure 5.31 Inverted PPG waveforms captured from a 40×40 pixel region 
of interest within the same AVI as Figure 5.30. 
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The inverted signals are not subjected here to the scrutiny that the normal PPG 
signals received earlier; that they are indeed inverted PPG signals seems a reason-
able postulation given their similarity to the normal signals (note also the inversion 
of the dichrotic notch). 
Figure 5.32 displays an overlay of the Fourier spectra of the normal and 
inverted PPG signals at both wavelengths. 
Both signals have distinct peaks coincident at the pulse frequency (0.7 Hz) and 
at its first harmonic. The inverted 760 nm spectrum exhibits a larger peak at the 
pulse frequency than the normal PPG spectrum and a similar peak at the respiration 
frequency (0.4 Hz). The inverted 880 nm spectrum has a comparable peak at the 
pulse frequency and a reduced peak at the respiratory frequency compared to the 
normal PPG spectrum.  
 
Figure 5.32 Fourier spectra of the inverted and normal PPG signals at both 
wavelengths.  
The inverted PPG signals are most often detected from contiguous regions of 
the frames. Figure 5.33 displays a sample frame from the 880 nm sequence of an 
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AVI file. Boxes are superimposed indicating the regions where PPG signals were 
clearly discernable at both wavelengths. Also indicated in Figure 5.33 are the boxes 
in which inverted PPG signals were detected at both wavelengths.  
Figure 5.34 displays the results obtained from the same AVI file when image 
analysis is performed using a box size of 40×40 pixels and Figure 5.35 the results 
from analysis at 80×80 pixels. Note that for the most part between areas with 
normal and inverted PPG signals, there is region in which no signals are detected. 
Where light emerging from those regions contains both inverted and normal signals 
the resulting destructive interference cause no pulsatile component to be detected. 
Note from Figure 5.30 and Figure 5.31, and from the spectra in Figure 5.32, that the 
inverted and normal PPG waveforms have comparable pulsatile amplitudes, 
accounting for typically less than 1% of the quantization range. With reference to 
the spectra in Figure 5.32 and the spectral method of identifying PPG containing 
ROIs in Section 5.3.3, inverted PPG signals frequently produce the highest spectral 
figure of merit for a video file. 
 
Figure 5.33 Outline of 20×20 pixel regions from which PPG signals 
(continuous line) and inverted PPG signals (broken line) were discernable 
at both wavelengths. 
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Figure 5.34 Outline of 40×40 pixel regions from which PPG signals 
(continuous line) and inverted PPG signals (broken line) were discernable 
at both wavelengths. 
 
Figure 5.35 Outline of 80×80 pixel regions from which PPG signals 
(continuous line) and inverted PPG signals (broken line) were discernable 
at both wavelengths. 
This phenomenon is unreported in the literature pertaining to either reflective 
or transmissive contact pulse oximetry. The phenomenon was reported by Maguire 
(2004), who encountered it but did not explain it, during a study of reflectance 
photoplethysmography based pulse transit-time measurement. In the experiment 
described here in Section 5.4.1, data from three of the ten test subjects exhibited the 
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phenomenon. The phenomenon was not observed in earlier experiments using a 
camera-based system to perform detection by either transmissive illumination and 
detection (Humphreys, et al. 2005a; Humphreys, et al. 2005b), or reflective 
illumination and detection of small extremities (Humphreys, et al. 2005c). 
Figure 3.6 depicted the arrangement of erythrocytes during the various stages 
of the pulse cycle. At systolic pressure the erythrocytes are densely grouped and 
orientated such that their long axes are perpendicular to the direction of blood flow. 
At diastole the erythrocytes are least densely grouped and are orientated such that 
their long axes are parallel to the direction of blood flow. The direction of arteries 
within small extremities means that transmission probes cannot be orientated other 
than to have the path between the source and detector perpendicular to the direction 
of the artery. Thus for a transmission geometry maximum absorption (minimum 
transmittance) of light occurs at systole and minimum absorption (maximum 
transmittance) at diastole. The position of a transmission source and detector and 
the optical path between them are depicted in Figure 5.36. 
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Figure 5.36 Depiction of the arrangement and orientation of erythrocytes 
in a peripheral artery during the cardiac pulse. Also depicted are the 
outline of the optical paths between source and detector for a transmiss-
ion and non-contact reflection geometry (dashed lines). (Not to scale.) 
Also depicted in Figure 5.36 are the relative locations of the source and 
detector for the camera based device. The source and detector separation are 
significantly greater for the non-contact device and since the signals are obtained 
from backscattered light, the possibility exists that the optical path between the 
source and detector will pass axially through an artery, rather than diametrically as 
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in the transmission case. In this case, during diastole, the erythrocytes are orientated 
such that their long axes, while still parallel to the direction of blood flow, are 
perpendicular to the optical path. During systole, the erythrocytes present their short 
axes to the optical path. This situation results in maximum transmittance (minimum 
absorption) at systole and minimum transmittance (maximum absorption) at 
diastole—resulting in a signal that is the inverse of a conventional PPG. The 
proclivity of camera-based system to capture such signals may be due, in general to 
the larger source and detector separation than is present in contact probes, and in 
this instance in particular to the region of tissue being imaged; the forearm is 
imaged with the axis of alignment between the source and detector parallel to the 
major arteries (see Figure 5.16). The fact that such inverted signals have not 
previously been observed with conventional contact reflectance probes might be 
explained by the smaller source-detector separation. In conventional reflectance 
contact probes the source-detector separation is limited to just a few millimetres. 
This has the effect of limiting the penetration depth of the light so that absorption is 
due to a shallow vascular bed, in which the directions of the smaller arteries do not 
follow the orientation of the limb. Where the propagation path does intersect axially 
with arteries, the short source-detector separation limits the axial absorption. 
5.6 ACHIEVABLE SEPARATION OF TISSUE AND CAMERA 
Naturally a question of interest to remote non-contact pulse oximetry or photo-
plethysmography, is how far can the light source and detector be located from the 
tissue under investigation? The achievable separation may determine the uses to 
which the technique can be put. 
Experimentally testing the achievable separation of one particular camera and 
source combination would be somewhat meaningless. The achievable separation of 
the system is ultimately a function of the combined characteristics of the system’s 
optics, source, and detector. To experimentally investigate the affect of tissue-source 
separation would require several types of light source—since LEDs or arrays of 
LEDs are unsuited to illuminating tissue from distances of more than a few 
centimetres. Equally to investigate the achievable detector-tissue separation 
experimentally would require at least a selection of lenses of suitable magnification 
and optical format for the camera. These results would then pertain only to that 
camera—which is in itself arguably the most variable component. 
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Rather than collecting empirical data pertaining to the system described in this 
thesis, a simplified probabilistic model is developed here. The model attempts to 
predict the decrease in the number of photons striking the detector as a function of 
tissue-detector separation and detector area, in response to a monochromatic point 
source. The prediction by the model is compared to data from a Monte Carlo 
simulation (see Section 2.3.3) of a three-layer tissue model.  
During the course of the discussion that follows, knowledge of the distribution 
of the photons’ trajectories as they emerge from the tissue under investigation, will 
be seen to be crucial to the accuracy of the prediction by model. As such two 
models are developed here, one based on a normal distribution and the other based 
on a uniform distribution. 
5.6.1 MONTE CARLO SIMULATION 
The Monte Carlo simulation of tissue-detector separation is described first as 
knowledge of the characteristics of photons emerging from the tissue model is 
instructive in describing the rationale for the probabilistic models that follow.  
A Monte Carlo simulation was conducted using a simple three-layer model of 
tissue, consisting of parallel layers of skin and fat, with respective thicknesses of 
2 mm and 5 mm, and an infinitely deep layer of muscle. Niwayama et al. (2006) 
describe the optical properties of such a model for similar purposes, which are 
given in Table 5.4. The same Cartesian coordinate system is used here as that 
described in Section 2.3.3. The tissue surface is assumed to be the flat x-y plane 
defined as z = 0. Positive values of z denote a position inside the tissue, negative 
values a position outside the tissue, and z = 0 the air-tissue interface. The refractive 
indices of all tissues are assigned the value 1.3. 
 
  
  
  
  
  
Tissue µ's (mm-1) 
µa 
(mm-1) 
Skin 1.3 0.02 
Fat 1.2 0.002 
Muscle 0.6 0.02 
Table 5.4 Values of bloodless scattering coefficients (µ's) and absorption 
coefficients (µa) for three-layer Monte Carlo model (Niwayama, et al. 
2006). 
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One million photon packets were injected vertically at location (0, 0, 0) 
constituting a point source. The detector area (with dimensions in millimetres) was 
defined as the circular region centred at (15, 15, z), with radius 10 mm, where the 
value of z denotes the separation of the tissue and detector (with z = 0 being 
contact).  
At this point a simplifying assumption is made that the detector area, which in 
practice is the lens face, is a flat surface, and that all incident photons striking the 
detector surface are detectable (by the camera). This assumption ignores several 
important physical attributes of both the system’s optics and the camera’s detector 
(be it a CMOS or CCD sensor). Firstly the lens will present a convex parabola rather 
than a flat surface towards the tissue surface, which itself is likely uneven and not 
parallel to the detector surface. Secondly the glass lens will have a critical angle of 
incidence, beyond which incident photons will be reflected from the surface rather 
than refracted by the lens. Thirdly the lens will have a limited ability to focus light 
from a wide numerical aperture onto the camera’s detector. Fourthly, assuming the 
lens has focused light from a wide numerical aperture onto the camera’s detector, 
the detector may yet be insensitive to light focused from such angles depending on 
the geometry of the detector and the lens aperture. This may be particularly 
prevalent in 4/5T CMOS devices, where a stack of optically insensitive components 
can cast a shadow on the optically sensitive area of each pixel. The problem can be 
compounded with either CMOS or CCD technology by the presence of micro-lenses 
over the pixels (refer to the discussion in Section 4.2). The collective affect of these 
assumptions is to overestimate the number of detectable photons at small tissue-
detector separations (since at larger separations photons travelling on wide 
trajectories will likely not strike the detector area). 
Thus under the contact condition (z = 0) a detectable photon is considered to 
be any backscattered photon emerging from the tissue within a 10 mm radius of the 
point (15, 15, 0). 
Once a photon emerges from the tissue its trajectory in air remains unchanged. 
Thus, using the photon’s point of emergence and its directional cosines (defined in 
Section 2.3.3), a second point on each photon’s trajectory can be calculated by 
equation (2.12), where ∆s is now an arbitrary distance, 
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From the two points along each photon’s trajectory a parametric equation is 
formed. For each parametric trajectory the point of intersection with each plane to 
which the detector is moved is calculated, as well as the angle each trajectory makes 
with the normal to the tissue plane (and all parallel detector planes). Where the 
point of intersection of a trajectory and the current detector plane is less than 10 mm 
from the point (15, 15, z), that photon is considered detectable at that distance from 
the tissue. 
Figure 5.37 displays the diverging trajectories of photons emerging from the 
defined detector region, resulting from the Monte Carlo simulation. The points of 
intersection of the trajectories with detector planes at 50 mm and 100 mm from the 
tissue surface are marked by dots. Note that the rectangles imposed on the planes in 
Figure 5.37 have dimensions of 100 mm by 100 mm. 
 
Figure 5.37 Diverging trajectories of photon packets emerging from 
circular region of three-layer tissue model. Dots mark the points of 
intersection with parallel planes to the tissue at z = −50 mm and 
z = −100 mm. 
Figure 5.38 depicts the results of the Monte Carlo simulation showing the 
decrease in number of detectable photons as a function of tissue-detector separation. 
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Figure 5.38 Decrease in the number of detectable photons with increasing 
tissue-detector separation, from Monte Carlo simulation. 
The angle that a photon’s trajectory makes with a normal vector to the tissue 
plane φ, is in the range 0 ≤ φ < π/2. The angle φ is constrained to be less than π/2 
since the photon’s final trajectory is the result of the last scattering event before 
emerging from the tissue. This event takes place a small distance beneath the tissue 
surface (determined by the mean free path length defined in Section 2.3.3) and thus 
a trajectory must make an angle greater than zero with the tissue surface (less than 
π/2 from the normal) to escape the tissue. Within the tissue, both the uniform 
azimuthal scattering and the anisotropic forward scattering determine the final 
trajectory assigned to the photon. The distribution of the trajectories of photons that 
actually emerge from the tissue is governed by the probability of internal reflection 
from the air-tissue boundary, which is a function of the refractive index of the 
medium’s final layer, and the Fresnel reflection coefficient (see Section 2.3.3). Thus 
while it is possible that the angle φ take on any value in the range 0 ≤ φ < π/2, the 
distribution of the continuous random variable φ is not uniform. Furthermore 
whatever the distribution of all emergent trajectories, the distribution of detectable 
trajectories will be skewed in favour of smaller angles from the normal, since larger 
angles from the normal will be detectable only if they emanate from a very shallow 
point in the tissue or from a point located centrally under the detector. 
Figure 5.39 displays the probability density function of the angle φ for all 
detected photons from the Monte Carlo simulation, constructed from a frequency 
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distribution with ninety bins, such that the magnitude of the nth vertical line in 
Figure 5.39 gives the probability  
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Figure 5.39 Probability density function showing the distribution of the 
angle between the photon trajectories and the normal to the tissue plane 
φ. 
As expected, the distribution can be seen to tail off more gradually to its left 
side—favouring trajectories that make small angles with the normal to the tissue. 
The next section describes two probabilistic models to predict the decrease in 
the number of detectable photons as a function of tissue-detector separation and 
detector area. 
5.6.2 PROBABILISTIC MODEL OF TISSUE-CAMERA SEPARATION 
Predicting the relative number of detectable photons at a given height above the 
tissue surface, for a given detector area, depends upon correctly modelling the 
distribution of the detectable photons. Two simplified geometric models are 
developed here based on a uniform trajectory distribution and a normal trajectory 
distribution. The predictions by both models are then compared to data from Monte 
Carlo simulations. 
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5.6.2.1 UNIFORM CONIC MODEL 
Consider an infinitely tall inverted cone, perpendicular to the tissue surface, defined 
by an angle θ, and emanating from a point p some distance below the tissue 
surface. The cone is constructed such that its circular cross-section at the tissue 
surface coincides exactly with the circular area of the detector of radius r, as 
depicted in Figure 5.40. The angle θ is defined to be the maximum angle that a 
photon trajectory (φ) makes with a normal vector to the tissue plane. Since the 
cone’s surface coincides with the detector area at the tissue surface, the volume of 
the cone encloses the trajectories of all photons that are detectable under contact 
conditions. The point p, the apex of the cone located a distance z beneath the tissue 
surface, is the geometrical projection of where the scattering appears to have taken 
place when viewed from outside the tissue. In fact the photons are only collinear at 
the injection point on the tissue surface, and after travelling through the region 
indicated in Figure 5.40, acquire their ultimate trajectory only a fraction of a 
millimetre beneath the tissue surface. 
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Figure 5.40 Conic model of decrease in number of detectable photons as 
a function of tissue-detector separation and detector area. 
Two assumptions are now made about the distribution of photons emerging 
from the region of interest. First it is assumed that the points of emergence of the 
backscattered photons are uniformly distributed throughout the region of interest. In 
Chapter 2 it was established theoretically and by simulation that the number of 
backscattered photons emerging from the tissue decreases exponentially with 
increasing radial distance from the injection point. Thus the assumption that photon 
emergence points are uniformly distributed over the detector area may be invalid 
close to the injection point where the exponential profile is steep (refer to 
Figure 2.4). However referring to Figure 2.4 (which depicts the number of 
backscattered photons versus radial distance from the source), the assumption 
144 
Instrument Description and Performance 
appears reasonable for larger source-detector separations (say greater than 50 mm). 
Second it is assumed that the angle φ itself is uniformly distributed about the 
normal to the tissue plane. (The invalidity of this assumption can quickly be 
ascertained with reference to the actual distribution of φ depicted in Figure 5.39.) 
Now having assumed that the photon trajectories are uniformly distributed 
about the normal vector to the tissue, and that the emergence points are uniformly 
distributed over the detector area, the probability of detecting any given photon at a 
height h' above the tissue surface is given by the ratio of the detector area to the 
area of the cone’s face at h', 
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Thus if N photons are detectable when the detector is in contact with the 
tissue, the number of photons detectable at a height h' above the tissue surface 
n(h'), is given by 
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The angle θ is bounded between the same limits as the photon trajectory angle 
φ, thus 0 ≤ θ < π/2. In practice, the assumption of a uniform distribution greatly 
exaggerates the divergence of the photons (see Figure 5.39) and predicts far fewer 
detectable photons than the simulation suggests. The inaccuracy of the assumption 
that the distribution is uniform can be reduced by limiting the range of θ to 
0 ≤ θ < π/4. Imposing such a limit on θ excludes many photons emerging on 
trajectories that form a large angle with the normal—indeed from Figure 5.39 
Prob (0 ≤ θ < π/4) is calculated to be 0.4376. However trajectories with a large 
divergence from the normal to the tissue quickly become undetectable in any event, 
and the exclusion of such trajectories produces significant prediction error only at 
small tissue-detector separations. The prediction by the conic model as compared to 
the Monte Carlo simulation results can be seen in Figure 5.41. 
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Figure 5.41 Comparison of uniform conic model prediction and Monte 
Carlo simulation data, showing decreasing number of detectable photons 
with increasing tissue-detector separation. 
The uniform conic model forms its prediction based on assumptions about the 
distribution of backscattered photon trajectories and on the area of the detector’s 
lens. For a given system the model may be a useful predictor of achievable tissue-
lens separation, however it can also serve as a quick indicator of the effect of 
varying the lens size. Figure 5.42 displays the predicted effect of increasing lens 
radius from 5 mm to 50 mm on the relative number of detectable photons. 
 
Figure 5.42 Uniform conic model prediction of effect of increasing lens 
radius on the relative number of detectable photons as a function of 
tissue-lens separation. 
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The prediction of the effect of increased lens radius by the uniform conic 
model was tested against the Monte Carlo simulation data. For a common injection 
point defined at (0, 0, 0), data were collected from two detector areas, both centred 
at (30, 0, z) with radii of 10 mm and 20 mm. The results are displayed in 
Figure 5.43. The model can be seen to have a comparable prediction error for each 
radius, and converges on the simulation data for separations greater than approxim-
ately 60 mm. This result in conjunction with that displayed in Figure 5.41 is 
significant, as collectively they evaluate the model for varying detector areas, both 
close to, and at some distance from the injection point. This gives some validity to 
the first assumption of the uniform conic model that (despite being known to have 
an exponential distribution) the emergence points of photons within the detector 
area can be considered uniformly distributed. 
 
Figure 5.43 Predicted and actual effect of increasing lens radius on the 
number of detectable photons. 
A point worth noting about the relationship between the number of detectable 
photons and the tissue-detector separation is that the curve is particularly steep for 
small separations and almost flat beyond a few centimetres. Operating at distances 
of several centimetres from the tissue surface, the detectable light intensity can be 
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expected to vary little with small changes in the tissue-detector separation. However 
at smaller tissue-detector separations, the variation in detected light intensity 
emanating from the region of interest will be significantly affected by even slight 
variations in the separation distance. It is in this initial sensitive region that the 
uniform conic model’s prediction deviates most from the simulation data.  
5.6.2.2 NORMAL CONIC MODEL 
Though it is perhaps easiest to envision applications of non-contact pulse oximetry 
or photoplethysmography that operate at larger tissue-detector separations, it is 
conceivable that future applications may also operate close to the tissue surface. A 
conic model based on a normal distribution of the angle between the photon 
trajectories and the normal vector to the tissue is described here, which attempts to 
improve upon the uniform conic model’s prediction, particularly in the initial 
separation region. 
For convenience the conic model depicted in Figure 5.40 is redrawn here as a 
flat elevation view in Figure 5.44. Once again the photons’ trajectories are defined 
by the angle they make with a normal vector to the tissue plane φ. While the 
geometric construction of the cone is as before, an important distinction is made 
here. In the uniform model the angle θ enclosed the trajectories of all backscattered 
photons simultaneously. Now θ is defined to be the solid angle enclosing an 
individual photon’s trajectory. Although θ has the same value and distribution as φ, 
the cone formed by θ and emanating from the point p is constructed to intersect the 
tissue plane through the circumference of the detector area. Thus the cone encloses 
the photon trajectory with angle φ regardless of the point of emergence of the 
photon, obviating the need for an explicit simplifying assumption about the 
distribution of the emergence points within the detector area. The point p is located 
a distance z beneath the tissue surface. The distance z must be sufficiently shallow 
to accommodate the maximum value of θ, which like φ can be arbitrarily close to 
but less than π/2. The maximum value of z is thus given by  
 
1
maxtan
r
z θ−= . (5.10) 
As before, the detector radius is denoted by r and the radius of the cone’s face 
at a given height above either the apex (h) or the tissue surface (h') is denoted by R. 
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Figure 5.44 Elevation view of 3D conic model depicted Figure 5.40. 
For a given detector radius r, the probability that a photon with a trajectory φ 
is detectable at a height h is given by, 
 Probability of detection Prob ( ( ) )R h r= ≤ . (5.11) 
The radius of the cone’s face at a height h is given by, 
 ( ) ( ) tanR h h' z θ= + . (5.12) 
Thus the probability of detection at a height h' above the tissue surface can be 
written as, 
 1 Probability of detection Prob tan
r
h' z
θ −= ≤ +
    
 . (5.13) 
Thus from equation (5.13) the probability that a particular trajectory is 
detectable at a height h' above the tissue surface is given by the cumulative 
distribution function of the continuous random variable θ, which is also the 
cumulative distribution function of the continuous random variable φ. 
Constructing a normal curve with a mean value (µ) of π/4 radians and a 
standard deviation (σ) of π/8 radians produces a bell shaped curve that 
approximates the distribution of the random variable φ (which from the Monte 
Carlo simulations was found to have actual values of µ = 0.8341 radians and 
σ = 0.3240 radians). The curve is depicted in Figure 5.45.  
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Figure 5.45 Normal probability density function. 
The desired cumulative distribution function is obtained by numerically 
integrating the probability density function. The resulting curve is displayed in 
Figure 5.46. For comparison the cumulative distribution of the actual Monte Carlo 
simulation data is also displayed. 
 
Figure 5.46 Normal cumulative distribution function. 
Two points should be noted about using a normal distribution to approximate 
the distribution of the backscattered photon trajectories. First with reference to 
Figure 5.39, the distribution of the simulated photon trajectories is asymmetric 
about its mean value; a normal approximation will be symmetric. The second, more 
consequential point, is that unlike a true continuous normal random variable, the 
photon trajectories, although continuous, are limited to the range 0 ≤ φ < π/2. The 
area under the curve in Figure 5.45 is 0.9850 and only sums to unity as the limits of 
integration become infinite in both directions. In this sense the curve depicted in 
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Figure 5.45 is not a probability distribution. As a direct result, the cumulative 
distribution function depicted in Figure 5.46 has a value of less than one as φ 
approaches π/2, meaning that the conic model will assign a probability of less than 
one to the event that all photons are detectable under contact conditions, despite the 
geometry of the model having being explicitly constructed on this basis. 
It now remains to calculate the distance z, which is a function of the largest 
photon trajectory φ that the angle θ must enclose. In practice it is sufficient to 
choose θmax to be some angle improbably close to π/2 (determinable from 
cumulative distribution function), of the order 19π/40. A comparison of the Monte 
Carlo simulation data and the normal conic model prediction of the decreasing 
number of detectable photons is depicted in Figure 5.47. 
 
Figure 5.47 Comparison of normal conic model prediction and Monte 
Carlo simulation data, showing decreasing number of detectable photons 
with increasing tissue-detector separation. 
Apart from the normal conic model’s underestimation of contact detection, its 
prediction rapidly converges on the simulation data. A comparison of both the 
normal and uniform conic model predictions against the simulation data is depicted 
in Figure 5.48. The data were collected with an injection point at (0, 0, 0), and a 
detector area centred at (15, 15, z) with radius 10 mm. The performance of the two 
models can be compared over three regions distinct regions. For close proximity, 
say 5 mm to 20 mm, the normal model provides the most accurate prediction. 
Between approximately 20 mm and 100 mm the two provide comparable 
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predictions and both are close to the simulation data. For distances greater than 
100 mm the uniform model provides the most accurate prediction while the normal 
model begins to overestimate the number of detectable photons. The steps visible in 
the normal model prediction at large tissue-detector separations result from the 
numerical integration of the probability density function, producing discrete 
samples of the cumulative distribution function. 
 
Figure 5.48 Predictions by uniform and normal conic models, and Monte 
Carlo simulation data, depicting decreasing number of detectable photons 
with increasing tissue-detector separation. 
The performance of both models can be improved upon by replacing the 
normal distribution with the actual cumulative distribution of the simulation data, 
which is depicted as the broken line in Figure 5.46.  
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Rather than pursue further refinement of these models, at this point it is 
prudent instead to note that knowledge of the backscattered photon trajectories is 
paramount to the accuracy of any model—as highlighted by the application of the 
actual cumulative distribution curve to the conic model. While the three-layer tissue 
model employed here broadly replicates the absorptive and scattering characteris-
tics of tissue, the model lacks the intricate fine structure of real tissue, such as the 
vascular bed, parenchymal and fascial tissue, hair, as well as an uneven tissue 
surface. The distribution likely varies with time to some degree, as the pulsing 
blood causes constant rotation of the scattering erythrocytes and mechanical 
displacement of the surrounding tissue. 
As a final point about the achievable separation of tissue and detector, it 
should be noted that the probabilistic geometric models described here, and the 
simulation data against which the models are compared, describe the decrease in the 
detectable number of desired photons—that is the number of photons that emanated 
from a particular region of interest on the tissue surface. For a circular region of 
interest, there exists an annular region of surrounding tissue, from which unwanted 
photons emerge. The number of unwanted photons striking the detector will 
increase (from zero under contact conditions) as the detector is retracted from the 
tissue surface. Where those photons have travelled a similar path to those emanating 
from the region of interest, they may be a serendipitous boon, adding to the signal 
level. In most instances however those photons will likely add only to the noise 
level, and in some instances (as was described in Section 5.5.2) the unwanted 
photons may contain an inverted signal that interferes destructively with the desired 
signal and simultaneously adds to the noise level.  
5.7 CHAPTER SUMMARY AND DISCUSSION 
This chapter has presented a study of a remote non-contact camera-based device, 
capable of simultaneously capturing two PPG signals at different wavelengths in a 
multiplexed fashion. These PPG signals have been shown to be comparable to a 
finger PPG signal captured simultaneously by a conventional contact device, both in 
the characteristics of the waveform and as an indicator of peripheral arterial pulse 
rate. In so doing, the prerequisite for non-contact camera based pulse oximetry has 
been met and two of the three core functions performed by a clinical pulse oximeter 
have been replicated: display of a plethysmogram and measurement of the pulse 
rate.  
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The determination of arterial oxygen saturation by the technique of pulse 
oximetry requires calibration of the device either in vivo (which requires a clinical 
setting as described in Section 3.3.5.1) or in vitro (which requires obtaining and 
artificially oxygenating whole blood as was described in Section 3.3.5.2); both are 
beyond the purview of this research. This chapter has instead focused on identifying 
aspects of pulse oximetry (and indeed photoplethysmography) that are unique to a 
camera-based implementation. Principally the effect of camera-based integrative 
sampling, as opposed to a conventional sample-and-hold method, has been 
highlighted. In summary both analysis and simulation suggest that integrative 
sampling combined with low frame rates will cause a small (but potentially 
significant) error in the calculation of the ratio of ratios variable (ROS) that is a 
function of both pulse rate and arterial oxygen saturation. 
The ultimate solution to integrative sampling error is higher frame rates, since 
the integrative sample value will converge towards the sample-and-hold value as 
the integration time becomes shorter. It may be possible to account for integrative 
sampling error during the calibration phase: pulse oximeters currently store 
calibration curves (which transform ROS values to SpO2) pertaining to all combi-
nations of LED wavelengths used in the probes to which the device may be 
connected; it is conceivable that this could be extended to encompass several pulse 
rate regions and in so doing account for integrative error.  
The effects of camera-based sampling deserve further investigation. The pulse 
rate exhibits a continuous and natural variability and the camera’s sampling 
instances are not phase locked with the pulse waveform. It may be possible to apply 
time-domain system identification techniques to correct the problem prior to the 
calculation of SpO2. 
A nuance of camera-based photoplethysmography discussed in Section 5.5.2, 
which hints at the potential utility of a camera-based device beyond that of non-
contact pulse oximetry, is the detection of inverted PPG signals. This phenomenon 
highlights the sensitivity of a camera-based device to regional variations in the PPG 
signal. Blažek et al. (2000), Hülsbusch and Blažek (2002) and Wieringa et al. 
(2005) highlighted the investigative potential of a device capable of spatially 
mapping variations in the PPG signal. An important caveat about a camera-based 
device’s ability to perform this task should be stated: a signal observed to be 
emanating from a point on the tissue surface bears little if any information about the 
point from which it is emerging; rather, the signal principally contains information 
pertaining to the region of tissue the light has traversed between the point of entry 
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into the tissue and the point from which it is observed leaving the tissue. The use of 
a continuous-wave diffuse illumination scheme (Hülsbusch and Blažek employed a 
ring of LEDs designed to give even diffuse lighting), annular illumination scheme 
(as employed by Wieringa et al.), or, to a lesser degree, a large spot (as employed in 
this study), precludes knowledge of the optical path, making it difficult to attribute a 
particular PPG signal (which is likely due to the superposition of several paths) to a 
specific region of tissue.  
The choice of illumination scheme has ramifications for pulse oximetry as 
well. Section 3.2.1 described a number of simplifying assumptions upon which 
pulse oximetry is based, which free it from the constraints that apply to other forms 
of Beer-Lambert based oximetry. Specifically the wavelength dependent optical 
path length and differential path length factor are eliminated from the calculations 
of oxygen saturation by making two assumptions: first it is assumed that both 
wavelengths encounter a similar amount of scattering and second it is assumed that 
the geometrical separation of the source and detector are the same for both 
wavelengths. Collectively these assumptions imply that both wavelengths of light 
have travelled a similar path between the source and detector. This assumption is 
likely invalid for any source that does not closely resemble a point source. Where 
multiple possible optical paths exist simultaneously between an uncontrolled source 
and the detector point, the detected light must be considered to be due to the 
superposition of all potential paths. In the case of an annular illumination scheme 
illuminating an area of tissue surrounding the imaged region, the detected light at 
the centre of the image would likely have traversed a volume of tissue similar in 
shape to an inverted umbrella—completely undermining the assumption of similar 
paths. The next chapter elaborates on this point to describe how a camera used in 
conjunction with a controllable light source might be employed as a tomographic 
imager yielding 3D images vascular anatomy.  
It is however the contention of this thesis that despite the added complication 
and complexity of a camera-based implementation, neither integrative sampling nor 
restrictions on the illumination scheme preclude the achievement of full pulse 
oximeter functionality by non-contact means. 
Lastly this chapter has presented an illustrative analysis of the effect of tissue-
camera separation on the number of detectable photons compared to the number 
detectable under contact conditions. A conic model of the detectable number of 
photons as a function of the distribution of the photons’ trajectories, the distance 
from the tissue, and the lens radius, has been developed, which in the least is 
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instructive in providing an intuitive understanding of the effects of increasing 
separation and in predicting the characteristics of regions of non-contact operation.
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A CONCEPT FOR NON-CONTACT 
CAMERA-BASED BACKSCATTER 
TOMOGRAPHY 
 
 
 
Equation Chapter 6 Section 1 
The principal subject of this thesis thus far has been the rigorous design, 
development, and analysis of camera-based non-contact pulse oximetry and 
photoplethysmography. In this, the penultimate chapter, both the subject and tone of 
the thesis change somewhat. During the course of this work a number of camera-
based biomedical instruments of novel quality were conceived that might yet spawn 
future research. This chapter contains an extended (though cursory) description of 
one such concept that is of singular novelty and which exemplifies the potential of 
camera-based techniques in biomedical investigations. To that end this chapter 
describes a novel concept for a non-contact diffuse reflection tomographic imaging 
device, comprised of a controlled light source and a single camera. Such a device 
could be an independent investigative tool, capable of imaging and mapping tissue 
morphology close to the body surface, providing complementary information to 
haemodynamic measurements and profusion mapping (provided by a camera-based 
pulse oximeter) or particularly tissue oxygenation mapping measurements 
(provided by camera-based tissue oxygenation monitoring). Such a device could 
also conceivably be amalgamated into an NIR non-contact pulse oximeter or non-
contact vital signs monitoring device. 
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The objective of this chapter is to describe the concept of camera-based 
tomography rather than to establish the feasibility. Some commentary is provided 
on potentially suitable apparatus and on foreseeable issues that will be associated 
with any embodiment of the device. However in the interests of brevity this chapter 
is limited to a description of the concept followed by a presentation of results from 
a simplified simulation utilising qualitative data. Only superficial reference is made 
here to technique’s mathematical basis and to the area of tomography. 
Two examples of camera-based non-contact surface-vascular imaging systems 
have been developed, the first by Zeman et al. (2004) and the second by Wieringa et 
al. (2006). The system developed by Zeman et al., which is comprised of a CCD 
camera and infrared LED ring light source, is intended to provide vein contrast 
enhancement for phlebotomists in clinical environments. The system captures an 
NIR image of a region of tissue and then projects an enhanced visible image back 
onto the same region of tissue, enhancing the contrast of the veins. The system 
displays the 2D location of vasculature but no depth information. The system 
developed by Wieringa et al. is stereoscopic, comprised of two CMOS cameras and 
an LED array providing both visible and NIR (920 nm) light. By combining the 
multi-spectral stereoscopic images, the system is capable of selectively enhancing 
superficial blood vessels, and by virtue of its stereoscopic operation, can perceive 
the depth of the imaged vasculature. Wieringa et al. list the potential clinical 
applications of such a device: blood withdrawal; vein inspection in dark skin; vein 
detection through iodine; varicose vein inspection; and nevi pigmentosum 
inspection.  
Chapter 5 highlighted the importance of knowledge of the likely path light has 
taken through tissue in interpreting the received light intensity as observed at a point 
on the tissue surface. As an alternative to the stereoscopic system (utilising an 
uncontrolled light source) developed by Wieringa et al. (2006), it may be possible to 
construct a device comprising a single camera and a controllable light source that is 
capable of 3D imaging of the vasculature close to the tissue surface, by utilising 
diffuse reflection-based—or more correctly backscatter-based—optical tomogra-
phy. 
Tomography refers to imaging by sections and the most common form is X-
ray computed tomography, which is used in many applications to form 3D images 
of the interior structure of an object. X-rays travel in straight lines through tissue 
though they are absorbed by dense structures. Computed tomography imagers 
simultaneously transmit multiple X-ray beams trough tissue, the beams strike a 
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detector that measures the spatial variation in absorption. The source and detector 
are then rotated relative to the imaged object and another set of measurements 
made. This process results in a large volume of data to which a reconstruction 
algorithm is applied, resulting in an image of the interior structure of the imaged 
object. Two common geometries of computed tomography systems are depicted in 
Figure 6.1, parallel X-rays incident on a flat detector (the original implementation), 
and a fan beam emanating from a point source and incident on a curved detector.  
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Figure 6.1 Two common source and detector geometries used in X-ray 
computed tomography. 
Optical and NIR light is strongly diffused in tissue and transmission imaging as 
depicted for X-rays in Figure 6.1 is not generally possible in diffuse optical 
tomography. Instead the curved path of optical radiation in tissue must be taken into 
account. In such a system the transmission schemes depicted in Figure 6.1 can be 
replaced by a geometry as depicted in Figure 6.2. 
 
 
 
 
 
 
 
 
 
Detector
Point source 
Figure 6.2 Depiction of geometry used in diffuse optical tomography. 
The most prevalent biomedical imaging application of diffuse optical 
tomography is mammography and breast-cancer detection. Though the diffusion of 
light in tissue makes it difficult to obtain clear optical images of the inside of 
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biological tissue, the anticipated safety benefits of optical tomography alone 
(compared to existing X-ray mammography) have spurred research in the area. A 
comprehensive description of a representative device, its principles, and its 
capabilities can be found in Colak et al. (1999).  
The geometry of the breast necessitates a similar detector geometry, and to 
that end the system described by Colak et al. (1999) utilises a cup, the walls of 
which are lined with photodiode detectors. Most of the body surface is however 
comparatively flat (when viewed in small areas), in this respect a camera may serve 
as a suitable detector, allowing diffuse optical tomographic reconstruction methods 
to be employed to form 3D reconstructions of shallow tissue morphology from a 
2D camera derived image and multiple purposefully positioned point light sources. 
The idea is illustrated in Figure 6.3 where the camera images the surface of the 
tissue and measures the emergent light intensity in response to a point source.  
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Figure 6.3 Depiction of camera-based tomography concept. 
Unlike X-ray tomography where the source and detector are rotated relative to 
the object, here it is proposed that the camera remain fixed on an area of tissue 
while the light source is moved across the tissue surface, with each source position 
generating a different path to each region of the frame. Each region of the frame 
effectively constitutes a separate detector position and by collating the detected 
absorption due to many source and detector positions it is proposed to reconstruct a 
tomographic image of the underlying tissue. 
6.1 DESCRIPTION OF CONCEPT 
Consider a point source of light perpendicularly incident on the flat surface of a 
homogenous scattering and absorbing medium. Light from the source enters the 
medium and is scattered in all directions. Some of the light, having travelled a 
distance through the medium, is backscattered and detected by the camera, which is 
observing this region of the medium’s surface. Further portions of the incident light 
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are backscattered from an unobserved area of the surface and a further portion 
continues to propagate in the medium until it has been absorbed. (The medium is 
considered infinitely deep and to extend infinitely in the horizontal plane. 
Furthermore it is assumed that no reflection occurs at the medium’s surface.) For a 
given source position, light detected at a certain position on the medium’s surface 
can be considered most likely to have travelled along a curved path between the 
source and detector points (refer to the Monte Carlo simulations of such a medium 
described in Section 2.3.3). The optical characteristics of the medium define the 
shape of the optical path, while the optical characteristics of the medium in 
conjunction with the source and detector separation determine the depth of the path. 
This concept is illustrated graphically in Figure 6.4, in which the most likely paths 
between five source and detector positions (annotated A – E) are depicted as lines. 
To illustrate the concept the lines have been arbitrarily chosen as ellipses, defined 
by a major axis between the source and detector positions and a lower semi-minor 
axis equal to one third of the major axis’ length. Figure 6.4 represents a 2D cross-
section of the medium, with the top line representing the medium’s surface. 
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Figure 6.4 Depiction of the most likely paths between five source and 
detector positions. 
Imposed on Figure 6.4 are rectangular voxels used to granularly identify 
regions of the medium through which the light propagates.  
If there are n mutually exclusive source and detector positions (columns of 
voxels), then the number of possible source and detector groups, choosing one 
source and detector position at a time, is given by the number of two-element 
permutations of n. Assuming that light is subject to the same attenuation travelling 
along the path between A and B, as between B and A, the number of unique source 
and detector groups is given by the number of two-element combinations of n, 
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The detector locations that form a unique path given a specified source 
location are enumerated in Table 6.1. 
  
  
  
  
  
 
Source position Detector positions 
A B C D E 
B - C D E 
C - - D E 
D - - - E 
Table 6.1 Unique source and detector positions from available permuta-
tions in Figure 6.4. 
It is now suggested that the absorption attributable to each voxel along an 
elliptical path (or a projection in the parlance of tomography) might be determined 
by the application of existing tomographic algorithms, such that an image of the 
absorbing structure of the medium can be formed.  
With reference to Figure 6.4 it can be seen that many voxels are poorly 
interrogated by projections, becoming increasingly ill determined with increasing 
depth, and several are not interrogated at all. This clearly limits the technique to 
imaging shallow features perhaps the first 2 cm – 3 cm of tissue. While the 
dependence on backscattered light limits the technique to surface features, it is 
within the realm targeted by the devices of Zeman et al. (2004) and Wieringa et al. 
(2006). However within this depth constraint, increasing the number of source and 
detector positions—that is narrowing the voxels—greatly increases the determin-
ability of shallow voxels. Figure 6.5 depicts the same area as Figure 6.4 now 
interrogated by three hundred unique projections resulting from twenty-five 
columns of voxels. 
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Figure 6.5 Depiction of elliptical projections for twenty-five source and 
detector points (yielding three hundred unique projections). 
The next section describes the application of an existing tomographic recon-
struction algorithm to data obtained from a 2D phantom by simplified forward 
modelling.  
6.2 FORWARD MODELLING AND RECONSTRUCTION 
To provide a qualitative indication of the degree of reconstruction that can be 
attained by elliptical projections, a simulation is described here that applies an 
algebraic reconstruction algorithm to a set of test data obtained from a simplified 
forward model of elliptical propagation through a 2D phantom.  
6.2.1 FORWARD MODEL 
A simplified 2D phantom was constructed as a monochrome raster graphic 
consisting of several discrete absorbing regions embedded in an otherwise non-
absorbing medium. The pattern used is depicted in Figure 6.6. The phantom itself 
has no inherent scattering properties; rather the projection paths are predetermined 
as a function of the source and detector separation, again they are arbitrarily chosen 
as ellipses with a semi-minor axis to major axis ratio of 1:3.  
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Figure 6.6 2D phantom showing absorbing regions (white) in a non-
absorbing medium (black). 
Prior to projection the 2D phantom is converted to a voxel format, with each 
voxel consisting of one or more pixels. Where a voxel consists of several pixels the 
binary absorbency of that voxel is determined by the fraction of absorptive pixels 
that it contains, with the absorbency of the voxel being set to one if half or more of 
its constituent pixels are absorbing. Figure 6.7 depicts the voxel representation of 
the phantom depicted in Figure 6.6; each voxel in Figure 6.7 has dimensions four 
horizontal and four vertical pixels that span the entire width of the 2D phantom. 
Thus the phantom is divided into fifty columns (and twenty rows) of voxels that 
generate 1225 projections. 
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Figure 6.7 Conversion of original image so that twenty rows and fifty 
columns of voxels, rather than pixels, describe the absorption. 
A projection is made from each source position (columns 1 to 49) to each 
detector position (columns 2 to 50) with an initial weight of one. Each time a 
projection passes through an absorbing voxel it looses half its weight (an arbitrarily 
chosen absorption). The source is then moved to the next position and the process is 
repeated noting the received weight for each source and detector position. In this 
way a matrix is constructed of the form depicted in Table 6.1 in which each row 
corresponds to a source position and each column to a detector position. This matrix 
represents a description of the absorptive characteristics of the medium as observed 
by elliptical projections through the medium.  
It is now sought to evaluate the efficacy of the elliptical projection by applying 
a reconstruction algorithm to the matrix of absorption values. 
6.2.2 ALGEBRAIC RECONSTRUCTION 
Various tomographic techniques exist for reconstructing a model (both 2D and 3D) 
of tissue based on the observed attenuation of radiation. In general these methods 
can be categorised as being direct (including filtered back projections and Fourier 
reconstruction) or iterative. An iterative method of reconstruction is employed here 
based on an algebraic reconstruction technique (ART) (Brooks and Di Chiro 1976; 
Herman 1980). 
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The reconstruction algorithm begins by taking a conservatively small fraction 
of the absorption observed along one projection (obtained by forward modelling) 
and assigning that fraction to each voxel along that projection. This is repeated for 
each projection. Some voxels will be traversed by multiple projections and will thus 
accumulate a fraction of the observable absorption from each of those projections. 
This represents an initial guess at the voxel absorption coefficients and constitutes 
the first iteration. 
On subsequent iterations the expected amount of absorption for a particular 
source and detector combination is calculated using the current absorption 
coefficients of the voxels that lie along that projection. A small fraction of the 
difference between the expected and observed absorption for that projection (which 
can be positive or negative) is now added to the voxel coefficients along that 
projection. The process is repeated for many iterations (typically several hundred). 
While many voxels are erroneously attributed a small level of absorption, over 
many iterations bright spots emerge at the intersection of projections that 
experienced absorption. 
Figure 6.8 displays a reconstruction of the phantom depicted in Figure 6.7. 
The reconstruction can be seen to display each of the components of the phantom 
though they appear smeared. The deeper regions of the phantom are less well 
determined since fewer projections traverse these regions. 
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Figure 6.8 ART reconstruction based on elliptical line projections. 
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The algorithm employed here inherently gives rise to false positives—that is 
many voxels are falsely attributed an absorption because of absorptive regions that 
lie elsewhere along a projection. However since a projection cannot traverse an 
absorbing region without suffering some absorption, the image can be improved by 
zeroing all voxels along projections that registered no absorption—effectively 
discounting reports of absorption where there exists evidence to the contrary. 
Figure 6.9 displays the effect on the reconstruction of zeroing the identifiable false 
positives. 
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Figure 6.9 Reconstruction by elliptical line projection after zeroing of 
false positives. 
The reconstructions depicted in Figure 6.8 and Figure 6.9 are the result of 
projections along elliptical lines—a gross simplification of the distribution of light 
in tissue. A more realistic approach is to assume that the projections form elliptical 
beams. To test the efficacy of reconstruction under this condition the forward 
modelling was repeated replacing the elliptical lines with beams. Each beam is 
formed of several elliptical paths, again with a major axis defined between the 
current source and detector position, however the semi-minor axis is now chosen to 
be one third of the major axis plus a small normally distributed random number 
with a magnitude proportional to the current length of the major axis. For each 
constituent elliptical line in the beam, a small amount of noise (proportional to the 
length of the major axis) is added to the y-coordinate of each point. The resulting 
beams are depicted in Figure 6.10 for five columns of voxels (for clarity only the 
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projections corresponding to the first source position are illustrated). This mimics 
crudely the migration of photons between source and detector that is known from 
photon modelling studies.  
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Figure 6.10 Elliptical beam projections corresponding to source position 
A.  
The reconstruction that results from elliptical beam projections is depicted in 
Figure 6.11. The reconstruction can be seen to incorporate the large features of the 
2D phantom, though the small detail is less well defined and the lower voxels are 
under determined compared to both the phantom and the reconstruction based on 
elliptical line projections. 
 
Figure 6.11 ART reconstruction based on elliptical beam projections. 
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False positives can again be identified and zeroed, which produces the 
reconstruction depicted in Figure 6.12. 
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Figure 6.12 Reconstruction by elliptical beam projection after zeroing of 
false positives. 
6.3 DISCUSSION 
The description that is provided here is deliberately succinct and is intended firstly 
to illustrate the concept, and secondly to illustrate the level of reconstruction that 
might be achieved in ideal circumstances (with elliptical line projections) and under 
more realistic circumstances (elliptical beam projections). That an ART algorithm 
(intended for rectilinear X-ray projection) is suited to this form of projection is not 
at all obvious and no attempt is made here to identify or develop an optimal recon-
struction algorithm.  
The reconstructions based on elliptical beam projections, depicted in 
Figure 6.11 and Figure 6.12, represent a realistic approximation of the path of light 
in tissue, however the model inherently encompasses several important simplifica-
tions. The model assumes a point source of light and a point detector. In practice the 
light source would likely be a laser beam with a small elliptical cross-section. As 
was discussed in Section 2.3.3 in relation to Monte Carlo simulations, distribution 
of the photon paths in tissue resulting from a beam source is obtained by 
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convolving the distribution due to a point source with the shape of the beam. This 
would enlarge the projections. A further complication is the detector, which will not 
be a single point. In the case of a camera the detector will be defined as either a 
single rectangular pixel, a rectangular group of pixels, or a pixel approximation of 
an elliptical (including circular) detector region—adding further to the three 
dimensional broadening of the projection. 
Nonetheless a device based on this concept could be constructed from a 
Galvo-scanner (capable of projecting laser spot on a specified location or in a 
specified pattern) and camera. The requirements of the camera would differ 
markedly from those of a camera intended for pulse oximetry and photoplethys-
mography, sensitivity (SNR and dynamic range) being paramount and frame rate 
being comparatively unimportant. 
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DISCUSSION AND FUTURE WORK 
 
 
 
Equation Chapter 7 Section 1 
7.1 A SYNOPSIS OF THE CONTRIBUTIONS OF THIS THESIS 
This thesis has investigated the feasibility of non-contact remote camera-based 
pulse oximetry. To that end this research has produced the first report of the 
simultaneous detection of two PPG signals at different wavelengths by a non-contact 
camera-based technique. The method and apparatus used have been shown to be 
applicable to a range of test subjects under realistic lighting and environmental 
conditions. 
While other researchers have investigated camera-based photoplethysmog-
raphy, both previously and contemporarily, those that have sought to extend 
camera-based photoplethysmography to pulse oximetry have made two crucial 
assumptions: firstly that the separate capture of PPG signals at multiple wavelengths 
is readily extendable to simultaneous multiplexed capture; and secondly that 
camera-based PPG signals are applicable to the technique of pulse oximetry. These 
two assumptions are important in demarcating this thesis from contemporary 
research by others. Having demonstrated simultaneous dual wavelength photo-
plethysmography, this thesis has subsequently scrutinised the assumption that the 
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resulting PPG signals are either directly or inherently applicable to the method of 
pulse oximetry. 
This thesis has investigated and demonstrated the comparability of a camera-
based device with a conventional contact device, as a means of obtaining a detailed 
plethysmogram and as a means of measuring pulse rate. As a means of determining 
arterial oxygen saturation by the method of pulse oximetry, this thesis has 
highlighted the susceptibility of camera-based devices to two detrimental pheno-
mena that are precluded in contact devices. The first is the combined effect of low 
frame rates and integrative sampling, which collectively distort the camera-derived 
PPGs and introduce error into the ratio calculations from which arterial saturation is 
derived. The second phenomenon is the proclivity (or perhaps ability) of camera-
based systems, when used in conjunction with an uncontrolled light source, to 
detect PPG signals that pertain to unwanted, different, or multiple volumes of tissue, 
which violates an enabling assumption of pulse oximetry—that the two detected 
wavelengths of light have traversed the same path. 
A secondary and perhaps less tangible contribution of this thesis is in 
delineating the capabilities that camera-based SpO2 monitoring can attain as an 
instance of pulse oximetry—estimate SpO2, measure pulse rate and display a PPG—
but not provide a spatial map of arterial oxygen saturation, which should not exhibit 
a spatial variance. In circumstances where a camera-based device may indicate a 
spatial variance in the estimated value of SpO2 (that is greater than the precision of 
the device), it is hoped that the discussion throughout this thesis has highlighted the 
danger in attributing that variation to an actual change in the saturation of the 
passing arterial blood, rather than to any of the multifarious factors that may distort 
the locally observed PPG signals from which the saturation values have been 
derived. Where a camera-based device may possess additional utility, beyond that 
which may come from non-contact pulse oximetry, it is likely in its ability to 
observe spatial variation in PPG signals (with the caveat that the light source is 
controllable), of which more is said in the next section. 
Lastly this thesis describes a concept for a camera-based tomography system 
comprised of a single camera and a controllable point source such as a Galvo-
scanner and laser. Such a device represents a departure from camera-based 
haemodynamic investigations and is presented as an alternative to stereoscopic 
methods of imaging shallow features in tissue. While such a system would not 
necessarily share requirements with a camera-based pulse oximetry device it is an 
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indicator to the potential of camera-based NIR investigations of tissue as both a 
probe of blood and tissue chemistry as well as structure. 
7.2 FUTURE WORK 
In investigating the feasibility and practicalities of non-contact pulse oximetry, this 
research has identified both further unforeseen impediments as well as new 
potential. The objectives of future work should encompass both further research and 
new development and adaptation of these techniques to real-time operation.  
7.2.1 FURTHER RESEARCH INTO CAMERA-BASED PULSE OXIMETRY 
The inherent distortion of PPG signals resulting from camera-based capture was 
highlighted in Section 5.4.4, where simulation results were described that showed 
an error caused by the camera’s integrative sampling and low frame rates. The 
simulation pertained to the ratio of ratios method of calculating ROS, however it is 
worth investigating the susceptibility of the alternative derivative based methods of 
calculating ROS, or indeed investigating if a method of calculating ROS can be 
developed that is insensitive to PPG distortion by integrative sampling. 
Since integrative sampling is inherent to all camera-based observations of 
time-varying signals, a worthwhile alternative or parallel approach would be the 
development of techniques to correct or mitigate the effects of integrative sampling. 
Time-domain system identification techniques may be applicable. 
7.2.2 INVESTIGATION OF CAMERA-DERIVED PPG SIGNALS 
Section 3.4.3 listed some of the applications to which conventional pulse oximeter 
devices have been put since becoming commonplace in clinical and surgical 
environments. Many of those applications utilise the ability of a pulse oximeter 
device to non-invasively measure profusion and spatial variations in profusion 
through the PPG waveform—applications that have been made possible by the 
development of reflectance probes and specialised application specific probes. 
Camera-based photoplethysmography has a great deal of potential in this regard as 
an investigative tool.  
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A further point that should be made is that a PPG signal is comprised of several 
components including the pulse, respiration, and Mayer waves. Pulse oximetry is 
concerned only with the pulse component though other clinical and experimental 
applications may be equally interested in the remaining components. The spectral 
power method of locating PPG signals in a video described in Section 5.3.3 is 
equally applicable to searching a video for respiration or Mayer waves. Indeed with 
reference to Figure 5.15 a signal that is rejected by the spectral power figure of 
merit as not containing a strong pulse may still contain a significant respiration or 
Mayer wave component.  
Whichever the desired PPG component, it should be noted that the video will 
contain multiple instances of the signal from different areas of tissue. Where the 
objective is merely to monitor that signal (rather than to attribute significance to its 
spatial variance), a camera-based technique may offer the potential for high SNR by 
incorporating the signal from multiple detection sites in the frame. 
The richness of a camera signal makes the notion of a non-contact vital signs 
monitoring device seem plausible. A device might be envisioned capable of non-
contact measurement of pulse rate, SpO2, respiration, and display of the peripheral 
arterial pressure waveform. 
7.2.3 DEVELOPMENT OF A CLINICALLY USEFUL DEVICE 
Perhaps the most significant step towards a clinically useful device is the 
development of real-time operating capabilities. A practical device would likely 
require dedicated hardware and software, providing the functionality described in 
this thesis as well as a suitable user interface and mechanism for maintaining the 
desired region of tissue in frame and under illumination.  
CMOS is likely the camera technology of choice particularly because of its ability 
to produce variable frame sizes and consequently varying frame rates. One can 
envision a system that produces large frame sizes (and low frame rates) during a 
signal acquisition period or during periods of subject movement, keeping a large 
area of tissue in view, and smaller frame sizes (at increased frame rates) during 
stable monitoring.  
Real-time operation would also require the development of significant 
ancillary functionality, for example motion artefact reduction or compensation. 
Efficient means of identifying regions of interest within the frame that contain a 
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pulse signal—or a respiration or Mayer wave if they are the sought signals—need 
to be developed.  
A real-time device will require the development of efficient and robust image 
analysis and image and signal processing techniques. 
The second major step in the development of a clinical device is calibration. 
Though the effects of integrative sampling and low frame rates have yet to be 
quantified, assuming they can be mitigated, a non-contact device should be suited to 
a similar in vivo calibration procedure as is currently used with conventional 
devices (see Section 3.3.5). If the pulse rate and saturation dependent effects of 
integrative sampling cannot be mitigated by either system identification techniques 
or a purposefully designed method of calculating ROS, then it may fall to the 
calibration procedure to remove pulse rate and saturation dependent error due to 
integrative sampling.  
7.2.4 INVESTIGATION OF SINGLE CAMERA-BASED TOMOGRAPHY 
Camera-based backscatter tomography utilising one camera and a controlled light 
source is a departure from non-contact pulse oximetry and photoplethysmography. 
Such a system would likely achieve greater synergy with NIR tissue oxygenation 
measurement or as part of a multi-modality tissue morphology imaging system. The 
development of such a device would incorporate a large scope including instrum-
entation and optics design, image processing, image analysis, and reconstruction 
algorithm development.  
7.3 CONCLUDING REMARKS 
Camera-based non-contact pulse oximetry will not replace conventional devices in 
routine bedside monitoring applications or ambulatory monitoring. Its most likely 
field of initial application is as an investigative tool in research, in specialised 
applications and environments, or in conjunction with other modalities such as MRI. 
Obstacles remain to developing a clinically useful device. Other researchers 
investigating camera-based photoplethysmography have pointed to camera 
limitations including low SNR and dynamic range, as well as motion artefacts and 
ambient light interference as current obstacles. While any system would doubtlessly 
benefit from a camera with improved SNR and dynamic range, simultaneous dual 
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wavelength PPG capture has been demonstrated as being achievable with currently 
available technology. Cameras capable of producing comparable or better SNR 
performance at higher frame rates will be beneficial. Motion artefacts will certainly 
be an issue in the future and may be a significant constraint on the applications to 
which a camera device may be put. Further investigation is needed on a wide range 
of subjects to quantify the effects of physical variation among subjects such as fat 
and skin pigmentation and to identify regions of the body from which signals can be 
reliably obtained. 
Despite impediments to developing clinically useful devices the allure of non-
contact pulse oximetry and photoplethysmography is strong. Collectively they 
represent a step towards video based vital signs monitoring and video based 
biometrics in general.  
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APPENDIX A 
 
PUBLICATIONS ARISING FROM THIS 
WORK 
 
 
 
This appendix contains a list of peer-reviewed publications that arose from this 
work. Papers pertaining to camera-based pulse oximetry and camera-based photo-
plethysmography are additionally cited, in context, in the body of this thesis and as 
such appear in the list of references. The full reference of each paper is reproduced 
here along with its published abstract as a guide to its contents. 
The list is preceded by a reference to an article on medical applications of 
Terahertz. Though the body of this thesis reports exclusively on a near infrared 
investigation of pulse oximetry and photoplethysmography, this work originally 
began as a search for a medical application of Terahertz imaging. Terahertz refers to 
a band of the electromagnetic spectrum stretching from the upper microwave 
frequencies, through the far infrared, and into the mid infrared—encompassing 
wavelengths from approximately 3 mm to 10 µm. Terahertz radiation is apt to 
monitoring the moisture content of tissue and has been demonstrated to be capable 
of discerning cancerous tissue from tissue that is healthy, and also from tissue that is 
inflamed but otherwise normal. A dual modality imaging system was sought 
(utilising Terahertz and near infrared) to develop a means of objectively assessing 
and monitoring the progression and condition of pressure ulcers, which can result 
from sustained pressure and shearing force on tissue as may occur in people who 
are immobile. It was envisaged that Terahertz would provide structural information 
about a region of tissue while near infrared imaging would provide information 
about tissue dynamics such as perfusion, oxygenation, and hydration. 
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Humphreys K., J. Loughran, M. Gradziel, W. Lanigan, T. Ward, J.A. Murphy 
and C. O'Sullivan, Medical applications of terahertz imaging: a review of 
current technology and potential applications in biomedical engineering, In 
proceedings of the IEEE Engineering in Medicine and Biology Society 
Conference, 2004. 
Terahertz (THz) imaging is in its early stages of development 
but already the potential clinical impact of this new imaging 
modality is clear.  From cancer research to DNA analysis THz 
technology is improving or even making possible imaging of 
hitherto inaccessible phenomena.  In this paper we present a 
short review of THz imaging from the point of view of 
biomedical engineering. We discuss the current state of the art 
in terms of THz imaging systems; describe current applications, 
future potential and our own approaches to harnessing this 
novel technology. We draw attention to open problems in the 
area with respect to the limitations of the technology before 
concluding with descriptions of our future work in the area. 
Humphreys K., C. Markham and T. Ward, A CMOS camera-based system 
for clinical photoplethysmographic applications, In proceedings of SPIE, 
5823, 88-95, 2005. 
In this work an-image based photoplethysmography (PPG) 
system is developed and tested against a conventional finger-
based system as commonly used in clinical practise. A PPG is 
essentially an optical instrument consisting of a near infrared 
(NIR) source and detector that is capable of tracking blood flow 
changes in body tissue. When used with a number of 
wavelengths in the NIR band blood oxygenation changes as 
well as other blood chemical signatures can be ascertained 
yielding a very useful device in the clinical realm.  
Conventionally such a device requires direct contact with the 
tissue under investigation which eliminates the possibility of its 
use for applications like wound management where the tissue 
oxygenation measurement could be extremely useful.  To 
circumnavigate this shortcoming we have developed a CMOS 
camera-based system, which can successfully extract the PPG 
signal without contact with the tissue under investigation. A 
comparison of our results with conventional techniques has 
yielded excellent results. 
178 
Appendix A 
Humphreys K., T. Ward and C. Markham, A CMOS camera-based pulse 
oximetry imaging system, In proceedings of the IEEE Engineering in 
Medicine and Biology Society Conference, 2005. 
In this paper a CMOS camera-based system for non-contact 
pulse oximetry imaging in transmission mode is described. 
Attention is drawn to the current uses of conventional pulse 
oximetry and the potential application of pulse oximetry 
imaging to developing objective wound assessment systems. 
Humphreys K., T. Ward and C. Markham, A CMOS camera-based system 
for non-contact pulse oximetry imaging, In proceedings of the International 
Federation for Medical and Biological Engineering Conference, 11, 2005. 
In this paper a non-contact pulse oximetry imaging system is 
described. The system utilises a CMOS digital camera and near 
infrared (NIR) light emitting diodes operating in a reflection 
mode to simultaneously capture photoplethysmograph (PPG) 
signals at two wavelengths. The Modified Beer-Lambert law is 
used to extrapolate tissue oxygenation from the PPG signals. 
Attention is drawn to the system’s potential in applications such 
as the assessment and management of wounds. 
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Humphreys K., T. Ward and C. Markham, Noncontact simultaneous dual 
wavelength photoplethysmography: A further step toward noncontact pulse 
oximetry, Review of Scientific Instruments, 78, (4), 2007. 
We present a camera-based device capable of capturing two 
photoplethysmographic (PPG) signals at two different 
wavelengths simultaneously, in a remote noncontact manner. 
The system comprises a complementary metal-oxide 
semiconductor camera and dual wavelength array of light 
emitting diodes _760 and 880 nm_. By alternately illuminating 
a region of tissue with each wavelength of light, and detecting 
the backscattered photons with the camera at a rate of 16 
frames/wavelength s, two multiplexed PPG wave forms are 
simultaneously captured. This process is the basis of pulse 
oximetry, and we describe how, with the inclusion of a 
calibration procedure, this system could be used as a 
noncontact pulse oximeter to measure arterial oxygen 
saturation (SpO2) remotely. Results from an experiment on ten 
subjects, exhibiting normal SpO2 readings, that demonstrate the 
instrument’s ability to capture signals from a range of subjects 
under realistic lighting and environmental conditions are 
presented. We compare the signals captured by the noncontact 
system to a conventional PPG signal captured concurrently 
from a finger, and show by means of a J. Bland and D. Altman 
[Lancet 327, 307 (1986); Statistician 32, 307 (1983)] test, the 
noncontact device to be comparable to a contact device as a 
monitor of heart rate. We highlight some considerations that 
should be made when using camera-based “integrative” 
sampling methods and demonstrate through simulation, the 
suitability of the captured PPG signals for application of 
existing pulse oximetry calibration procedures.  
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APPENDIX B 
 
FURTHER CHARACTERISTICS OF THE 
LIGHT EMITTING DIODES 
 
 
 
As a further indication of the characteristics of the light emitting diodes used in this 
study a sample data sheet is included here illustrating the various electrical, thermal 
and optical parameters of a typical device. 
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HIGH-POWER GaAlAs IR EMITTERS OD-880F
ANODE
(CASE)
.017
.100
CATHODE .036
.041
45°
GLASS
DOME
1.00
MIN.
.030
.040
.197
.205
.015
.209
.212
.183
.186
.152
.154
FEATURES
• High reliability liquid-phase epitaxially grown GaAlAs
• 880nm peak emission for optimum matching with
ODD-45W photodiode
• Wide range of linear power output
• Hermetically sealed TO-46 package
• Narrow angle for long distance applications
• OD-880F1 selected to meet minimum radiant intensity
All surfaces are gold plated. Dimensions are nominal
values in inches unless otherwise specified. Window
caps are welded to the case.
Radiant Intensity, Ie
Peak Emission Wavelength, λP
Spectral Bandwidth at 50%, ∆λ
Half Intensity Beam Angle, θ
Forward Voltage, VF
Reverse Breakdown Voltage, VR
Capacitance, C
Rise Time
Fall Time
IF = 50mA
IF = 100mA
IR = 10µA
VR = 0V
120
5
135
160
880
80
8
1.55
30
17
0.5
0.5
1.9
mW/sr
nm
nm
Deg
Volts
Volts
pF
µsec
µsec
ELECTRO-OPTICAL CHARACTERISTICS AT 25°C
PARAMETERS TEST CONDITIONS MIN TYP MAX UNITS
OD-880F
OD-880F1
OD-880F
OD-880F1
Total Power Output, Po
IF = 100mA
mW
15 17
8
Storage and Operating Temperature Range
Maximum Junction Temperature
Thermal Resistance, RTHJA1
Thermal Resistance, RTHJA2
-55°C to 100°C
100°C
350°C/W Typical
115°C/W Typical
THERMAL PARAMETERS
1Heat transfer minimized by measuring in still air with minimum heat conducting through leads
2Air circulating at a rapid rate to keep case temperature at 25°C
Power Dissipation1
Continuous Forward Current
Peak Forward Current (10µs, 400Hz)2
Reverse Voltage
Lead Soldering Temperature (1/16" from case for 10sec)
190mW
100mA
3A
5V
240°C
ABSOLUTE MAXIMUM RATINGS AT 25°C CASE
1Derate per Thermal Derating Curve above 25°C
2Derate linearly above 25°C
750 Mitchell Road, Newbury Park, California 91320
Phone: (805) 499-0335 Fax: (805) 499-8108
Email: sales@optodiode.com Web Site: www.optodiode.com
Page 1 of 2
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HIGH-POWER GaAlAs IR EMITTERS OD-880F
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